<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Cell Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol. Cell. Biol</journal-id>
<journal-id journal-id-type="hwp">mcb</journal-id>
<journal-id journal-id-type="pmc">mcb</journal-id>
<journal-id journal-id-type="publisher-id">MCB</journal-id>
<journal-title-group>
<journal-title>Molecular and Cellular Biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0270-7306</issn>
<issn pub-type="epub">1098-5549</issn>
<publisher>
<publisher-name>American Society for Microbiology</publisher-name>
<publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29610153</article-id>
<article-id pub-id-type="pmc">5974435</article-id>
<article-id pub-id-type="publisher-id">00070-18</article-id>
<article-id pub-id-type="doi">10.1128/MCB.00070-18</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Minireview</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Signaling Pathways Involved in the Regulation of mRNA Translation</article-title>
<alt-title alt-title-type="running-head">Minireview</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Roux</surname>
<given-names>Philippe P.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Topisirovic</surname>
<given-names>Ivan</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<aff id="aff1"><label>a</label>Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada</aff>
<aff id="aff2"><label>b</label>Department of Pathology and Cell Biology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada</aff>
<aff id="aff3"><label>c</label>Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada</aff>
<aff id="aff4"><label>d</label>Gerald Bronfman Department of Oncology and Departments of Experimental Medicine and Biochemistry, McGill University, Montréal, Québec, Canada</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">Address correspondence to Philippe P. Roux, <email>philippe.roux@umontreal.ca</email>, or Ivan Topisirovic, <email>ivan.topisirovic@mcgill.ca</email>.</corresp>
<fn fn-type="other">
<p><bold>Citation</bold> Roux PP, Topisirovic I. 2018. Signaling pathways involved in the regulation of mRNA translation. Mol Cell Biol 38:e00070-18. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/MCB.00070-18">https://doi.org/10.1128/MCB.00070-18</ext-link>.</p>
</fn>
</author-notes>
<pub-date pub-type="epreprint">
<day>2</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>29</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<day>15</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>29</day>
<month>5</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>38</volume>
<issue>12</issue>
<elocation-id>e00070-18</elocation-id>
<permissions>
<copyright-statement>Copyright © 2018 Roux and Topisirovic.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Roux and Topisirovic</copyright-holder>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="zmb012181777001.pdf"></self-uri>
<abstract>
<title>ABSTRACT</title>
<p>Translation is a key step in the regulation of gene expression and one of the most energy-consuming processes in the cell. In response to various stimuli, multiple signaling pathways converge on the translational machinery to regulate its function. To date, the roles of phosphoinositide 3-kinase (PI3K)/AKT and the mitogen-activated protein kinase (MAPK) pathways in the regulation of translation are among the best understood. Both pathways engage the mechanistic target of rapamycin (mTOR) to regulate a variety of components of the translational machinery. While these pathways regulate protein synthesis in homeostasis, their dysregulation results in aberrant translation leading to human diseases, including diabetes, neurological disorders, and cancer. Here we review the roles of the PI3K/AKT and MAPK pathways in the regulation of mRNA translation. We also highlight additional signaling mechanisms that have recently emerged as regulators of the translational apparatus.</p>
</abstract>
<kwd-group>
<title>KEYWORDS</title>
<kwd>mRNA translation</kwd>
<kwd>mTOR</kwd>
<kwd>MAPK</kwd>
<kwd>MNK</kwd>
<kwd>RSK</kwd>
<kwd>eIF4E</kwd>
<kwd>signal transduction</kwd>
<kwd>mRNA</kwd>
<kwd>mitogen-activated protein kinases</kwd>
<kwd>protein phosphorylation</kwd>
<kwd>translational control</kwd>
</kwd-group>
<funding-group>
<award-group id="award1">
<funding-source id="gs1">
<institution-wrap>
<institution>Gouvernement du Canada | Canadian Institutes of Health Research (CIHR)</institution>
<institution-id>https://doi.org/10.13039/501100000024</institution-id>
</institution-wrap>
</funding-source>
<principal-award-recipient>
<name>
<surname>Roux</surname>
<given-names>Philippe P.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award2">
<funding-source id="gs2">
<institution-wrap>
<institution>Gouvernement du Canada | Canadian Institutes of Health Research (CIHR)</institution>
<institution-id>https://doi.org/10.13039/501100000024</institution-id>
</institution-wrap>
</funding-source>
<principal-award-recipient>
<name>
<surname>Topisirovic</surname>
<given-names>Ivan</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<counts>
<fig-count count="3"></fig-count>
<table-count count="2"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="355"></ref-count>
<page-count count="26"></page-count>
<word-count count="21560"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>June 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec1" sec-type="intro">
<title>INTRODUCTION</title>
<p>Steady-state mRNA levels do not correlate well with the protein composition in the cell (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>), suggesting that posttranscriptional mechanisms of regulation of gene expression play a major role in shaping proteomes. Translation is a key step in the regulation of gene expression (reviewed in references <xref ref-type="bibr" rid="B3">3</xref> and <xref ref-type="bibr" rid="B4">4</xref>) and is energy costly (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). As such, translation is tightly controlled by signaling pathways that sense various stimuli, including environmental stresses (e.g., heat shock or UV irradiation), extracellular stimuli (e.g., hormones or growth factors), and intracellular cues (e.g., nutrients, energy status, or amino acids) (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). Here we summarize the current knowledge on major signaling pathways involved in translational control via phosphorylation of the components of the translational machinery. In particular, we focus on the mammalian/mechanistic target of rapamycin (mTOR) and the mitogen-activated protein kinases (MAPK). Another important pathway in translational control involves eukaryotic initiation factor 2 (eIF2) kinases and phosphatases and has been reviewed elsewhere (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>). Components of the translational machinery actively participate in the regulation of protein synthesis in homeostasis and when dysregulated are thought to contribute to pathological conditions, including cancer. Hence, the regulation and functional consequences of phosphorylation of the components of the translational machinery are described in detail below.</p>
</sec>
<sec id="sec2">
<title>mTOR</title>
<p>mTOR is a conserved Ser/Thr kinase that integrates stimuli including growth factors, hormones, cellular energy status, and nutrient and oxygen availability (<xref ref-type="fig" rid="F1">Fig. 1</xref>) to adjust proliferation (increase in cell number) and growth (increase in cell volume/mass) (<xref ref-type="bibr" rid="B11">11</xref>). mTOR stimulates anabolic processes, such as protein and lipid synthesis, and it is found in two structurally and functionally different complexes: mTOR complexes 1 and 2 (mTORC1 and -2) (<xref ref-type="bibr" rid="B12">12</xref>). mTORC1 is composed of mTOR, the scaffolding protein raptor (regulatory-associated protein of TOR), the GTPase β-subunit like protein (GβL) (also known as mLST8), and deptor (disheveled, Egl-10, pleckstrin [DEP] domain-containing mTOR-interacting protein) (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>). Whereas mLST8 and deptor are found in both mTORC1 and mTORC2 (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>), rictor (rapamycin-insensitive companion of TOR), mSIN1 (mammalian stress-activated protein kinase [SAPK]-interacting protein), and protor (proline-rich protein 5, also known as PRR5) are specific components of mTORC2 (<xref ref-type="bibr" rid="B15">15</xref><xref ref-type="bibr" rid="B16">–</xref><xref ref-type="bibr" rid="B19">19</xref>). In addition to differences in their composition, mTORC1 and mTORC2 govern distinct cellular processes via phosphorylation of largely nonoverlapping substrates. Several mTORC1 substrates are involved in the regulation of mRNA translation, including the eukaryotic translation initiation factor 4E (eIF4E)-binding proteins (4E-BPs), 70-kDa ribosomal S6 kinases (S6Ks) 1 and 2 (reviewed in references <xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>, and <xref ref-type="bibr" rid="B22">22</xref>), and LARP1 (La ribonucleoprotein domain family member 1) (<xref ref-type="bibr" rid="B23">23</xref><xref ref-type="bibr" rid="B24">–</xref><xref ref-type="bibr" rid="B25">25</xref>). With respect to protein synthesis, mTORC2 associates with ribosomes (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>), and it was found to promote cotranslational phosphorylation and folding of nascent AKT polypeptides (<xref ref-type="bibr" rid="B26">26</xref>).</p>
<fig id="F1" orientation="portrait" position="float">
<label>FIG 1</label>
<caption>
<p>Schematic representation of mTOR signaling to the translational machinery. Growth factors stimulate mTORC1 signaling by activating receptor tyrosine kinases (RTKs) located at the plasma membrane. Various adaptor proteins convert these extracellular signals by stimulating the PI3K/AKT and Ras/ERK pathways. Many additional cues promote mTORC1 activation, including glucose and amino acids via small Rag GTPases, which help translocate mTORC1 to the surface of lysosomes. In turn, insufficient energy resources (energy stress) and hypoxia inactivate mTORC1 via the LKB1/AMPK pathway and REDD1, respectively. mTORC2 also responds to agonists that stimulate the production of phosphatidylinositol-3,4,5-triphosphate (PIP3) and promotes the activity of AGC kinase family members (PKC, AKT, and SGK) by phosphorylating residues located in their hydrophobic motifs. mTORC1 modulates mRNA translation by promoting the phosphorylation of downstream substrates, including the 4E-BPs and S6Ks, the latter having phosphorylation substrates of their own (e.g. eIF4B, rpS6, PDCD4, and SKAR). Red T-bars represent inhibitory signals, whereas black arrows indicate stimulatory signals. P denotes phosphorylation. Abbreviations and detailed explanations about this signaling network are provided in the text.</p>
</caption>
<graphic xlink:href="zmb9991017770001"></graphic>
</fig>
<p>In addition to functional and structural distinctions, mTORC1 and mTORC2 are differentially sensitive to rapamycin, which is a naturally occurring allosteric inhibitor of mTOR (<xref ref-type="bibr" rid="B28">28</xref><xref ref-type="bibr" rid="B29">–</xref><xref ref-type="bibr" rid="B30">30</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>). Together with the immunophilin FKBP12 (FK506-binding protein of 12 kDa), rapamycin associates with the FRB (FKBP12-rapamycin-binding) domain of mTOR (<xref ref-type="bibr" rid="B31">31</xref>). These studies led to the alternative conclusion that the rapamycin-FKBP12 complex prevents binding of mTORC1 to its substrates by steric hindrance via reduction in the size of the active-site cleft of mTOR. This steric hindrance model is consistent with the differential sensitivity of mTORC1 substrates to rapamycin. For instance, under most conditions tested, rapamycin potently suppresses S6K phosphorylation whereas it has only a marginal effect on 4E-BP phosphorylation levels (<xref ref-type="bibr" rid="B32">32</xref>). These differences may lie in the intrinsic capacity of particular phosphorylation sites to serve as mTORC1 substrates, which was shown to determine their sensitivity to modulators of the pathway, such as rapamycin (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B33">33</xref>). Unlike mTORC1, mTORC2 appears to be much less sensitive to rapamycin, at least under conditions wherein rapamycin has been applied for less than 12 h in cell culture. These findings paved the way for the identification of a second generation of mTOR inhibitors that target its catalytic site, irrespective of whether mTOR is found in mTORC1 or mTORC2 (<xref ref-type="bibr" rid="B28">28</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>). Many of these compounds are currently being tested in clinical trials in oncology (<xref ref-type="bibr" rid="B34">34</xref>). Rapa-Link1 is a third-generation inhibitor that simultaneously acts as an allosteric inhibitor and targets the active site of mTOR (<xref ref-type="bibr" rid="B35">35</xref>). Notably, Rapa-Link1 is effective against tumor cells which harbor mTOR mutations that render them resistant to rapalogs and active-site mTOR inhibitors (<xref ref-type="bibr" rid="B35">35</xref>) and has shown promising results in preclinical cancer models (<xref ref-type="bibr" rid="B36">36</xref>).</p>
<table-wrap id="T1" orientation="portrait" position="float">
<label>TABLE 1</label>
<caption>
<p>Small-molecule inhibitors of mRNA translation and upstream pathways<xref ref-type="table-fn" rid="T1F1"><sup><italic>a</italic></sup></xref></p>
</caption>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
</colgroup>
<thead>
<tr valign="bottom">
<th align="left" colspan="1" rowspan="1">Target</th>
<th align="left" colspan="1" rowspan="1">Inhibitor(s)</th>
<th align="left" colspan="1" rowspan="1">Mechanism of action</th>
</tr>
</thead>
<tbody>
<tr valign="top">
<td colspan="1" rowspan="1">mTORC1</td>
<td colspan="1" rowspan="1">Rapamycin (sirolimus), everolimus (RAD001), temsirolimus (CCI-779), ridaforolimus (AP23573)</td>
<td colspan="1" rowspan="1">Rapamycin and the rapalogues bind to FKBP12, which allows the formation of a ternary complex with mTOR; the rapamycin-FKBP12 dimer binds mTOR outside its kinase domain, and it is believed that this interaction interferes with the binding of mTOR and its substrates</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">PI3K/mTOR</td>
<td colspan="1" rowspan="1">BEZ235 (dactolisib), PI-103, XL765 (voxtalisib), BGT226, PF-05212384 (gedatolisib)</td>
<td colspan="1" rowspan="1">ATP-competitive inhibitors of mTOR and PI3K (multiple isoforms)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">mTORC1/2</td>
<td colspan="1" rowspan="1">MLN0128 (sapanisertib), AZD8055, Torin1, PP242 (torkinib), OSI-027, Rapa-Link1</td>
<td colspan="1" rowspan="1">ATP-competitive inhibitors of mTOR (inhibit either mTORC1 or mTORC2) (Rapa-Link1 simultaneously acts as ATP-competitive and allosteric inhibitor)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="2">PI3K</td>
<td colspan="1" rowspan="1">BKM120 (buparlisib), GDC-0941 (pictilisib), BAY 80-6946 (copanlisib), ZSTK474, GDC-0032 (taselisib)</td>
<td colspan="1" rowspan="1">Pan-class I PI3K ATP-competitive inhibitors</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">BYL719 (alpelisib), SAR260301, GS-1101 (idelalisib), INCB040093, AMG319, TGR-1202, IPI-145 (duvelisib), GSK2636771</td>
<td colspan="1" rowspan="1">Isoform-specific PI3K ATP-competitive inhibitors</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="4">AKT</td>
<td colspan="1" rowspan="1">MK2206</td>
<td colspan="1" rowspan="1">Pleckstrin homology domain-dependent allosteric inhibitor of AKT that promotes AKT relocalization to the cytoplasm and prevents its phosphorylation by PDK1 and mTORC2; MK2206 is more selective toward AKT1/2 than toward AKT3</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">KRX-0401 (perifosine)</td>
<td colspan="1" rowspan="1">Alkyl-phosphocholine that targets cellular membranes and thereby inhibits AKT activation, as well as many other membrane-dependent events</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">GSK690693</td>
<td colspan="1" rowspan="1">ATP-competitive inhibitor of Akt1/2/3</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">GDC-0068 (ipatasertib)</td>
<td colspan="1" rowspan="1">Non-ATP-competitive inhibitor of Akt1/2/3</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="2">S6K1</td>
<td colspan="1" rowspan="1">PF-4708671</td>
<td colspan="1" rowspan="1">Inhibits S6K1-dependent phosphorylation of substrates; mechanism of action is unavailable</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">LY2584702</td>
<td colspan="1" rowspan="1">ATP-competitive inhibitor of S6K1</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="3">MNK</td>
<td colspan="1" rowspan="1">eFT508</td>
<td colspan="1" rowspan="1">ATP-competitive inhibitor of MNK1/2</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">BAY 1143269</td>
<td colspan="1" rowspan="1">MNK1 inhibitor with undisclosed mechanism of action</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Cercosporamide, CGP57380, CGP052088</td>
<td colspan="1" rowspan="1">Poorly selective MNK inhibitors that target the ATP-binding domain of MNK1/2</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="2">RSK</td>
<td colspan="1" rowspan="1">LJH685 (and related LJI308), SL0101, BI-D1870</td>
<td colspan="1" rowspan="1">ATP-competitive inhibitor of the RSK N-terminal kinase domain</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">FMK</td>
<td colspan="1" rowspan="1">Covalent inhibitor of the C-terminal kinase domain of RSK1/2/4</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="3">eIF4E</td>
<td colspan="1" rowspan="1">LY2275796</td>
<td colspan="1" rowspan="1">Reduction of eIF4E expression using antisense oligonucleotide</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Cap analogues, including 4Ei-1</td>
<td colspan="1" rowspan="1">Inhibition of eIF4E binding to 5′ cap of mRNA</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">4EGI-1, 4E1RCat, 4E2RCat</td>
<td colspan="1" rowspan="1">Inhibition of eIF4E-eIF4G interaction</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">eIF4A</td>
<td colspan="1" rowspan="1">Silvestrol, hippuristanol, pateamine A</td>
<td colspan="1" rowspan="1">Inhibition of eIF4A helicase activity</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn fn-type="other" id="T1F1">
<label>a</label>
<p>This table includes selected small-molecule inhibitors that target components of the translation machinery (eIF4E and eIF4A) or upstream pathways involved in translational control (mTOR, PI3K, AKT, S6K, MNK, and RSK).</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec3">
<title>REGULATION OF mTORC1 BY HORMONES AND GROWTH FACTORS</title>
<p>Hormones and growth factors, including insulin and insulin-like growth factor (IGF), stimulate receptor tyrosine kinases (RTKs), such as insulin receptor or IGF receptor, and activate phosphoinositide 3-kinase (PI3K) via associated adaptor molecules (e.g., IRS-1 and -2). PI3K generates phosphatidylinositol-3,4,5-trisphosphate (PIP<sub>3</sub>) from phosphatidylinositol 4,5-bisphosphate (PIP<sub>2</sub>) (reviewed in reference <xref ref-type="bibr" rid="B37">37</xref>). Conversely, PIP<sub>3</sub> is hydrolyzed to PIP<sub>2</sub> by PTEN (phosphatase and tensin homologue), which thus acts as a negative regulator of PI3K (<xref ref-type="bibr" rid="B38">38</xref>). PIP<sub>3</sub> recruits phosphoinositide-dependent kinase 1 (PDK1) and AKT to the plasma membrane (<xref ref-type="fig" rid="F1">Fig. 1</xref>), where PDK1 activates AKT by phosphorylating a residue localized in its activation loop (Thr308 in human AKT1) (reviewed in reference <xref ref-type="bibr" rid="B39">39</xref>). mTORC2 phosphorylates the hydrophobic motif of AKT (Ser473 in human AKT1) (<xref ref-type="bibr" rid="B40">40</xref>), which increases AKT activity toward a subset of substrates (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B41">41</xref>). Tuberous sclerosis complex (TSC), a negative regulator of mTOR, consists of the TSC1 scaffolding protein and TSC2, which is a GTPase-activating protein (GAP) toward Rheb (Ras homologue enriched in brain) (<xref ref-type="bibr" rid="B42">42</xref>). TSC stimulates hydrolysis of Rheb-GTP to the inactive Rheb-GDP form (<xref ref-type="bibr" rid="B43">43</xref>, <xref ref-type="bibr" rid="B44">44</xref>). In addition to TSC1 and TSC2, TBC1D7 (Tre2-Bub2-Cdc16-1 domain family member 7) acts as a third component of TSC (<xref ref-type="bibr" rid="B45">45</xref>). Rheb is a small GTPase that stimulates mTORC1 in its active, GTP-bound form (<xref ref-type="bibr" rid="B46">46</xref>). Rheb was shown to bind to mTOR and cause a global conformational change that allosterically promotes mTOR activation (<xref ref-type="bibr" rid="B47">47</xref>). It was thought that AKT phosphorylates TSC2 and inhibits its GAP activity, which results in increased Rheb-GTP levels and mTORC1 activation (<xref ref-type="bibr" rid="B43">43</xref>, <xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B48">48</xref>, <xref ref-type="bibr" rid="B49">49</xref>). This model was, however, challenged by the observation that Rheb recruits TSC to the lysosomal surface, whereby TSC2 maintains Rheb in its inactive GDP-bound state (<xref ref-type="bibr" rid="B50">50</xref>). AKT-mediated phosphorylation of TSC2, which only marginally reduces its GAP activity, leads to dissociation of TSC from the lysosome, thereby allowing Rheb-GTP loading and mTORC1 activation (<xref ref-type="bibr" rid="B50">50</xref>).</p>
<p>PRAS40 is a negative regulator of mTORC1 (<xref ref-type="bibr" rid="B51">51</xref><xref ref-type="bibr" rid="B52">–</xref><xref ref-type="bibr" rid="B55">55</xref>). AKT phosphorylates PRAS40 (at Thr246 in humans) and stimulates its dissociation from mTORC1 (<xref ref-type="bibr" rid="B53">53</xref>, <xref ref-type="bibr" rid="B54">54</xref>). mTORC1 phosphorylates multiple residues on PRAS40, which indicates that PRAS40 is also an mTORC1 substrate. PRAS40 contains a TOR signaling (TOS) motif that interacts with raptor and thus may compete for raptor binding with other mTORC1 substrates (e.g., 4E-BPs and S6Ks) (<xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B57">57</xref>).</p>
<p>In addition to PI3K, growth factors (e.g., epidermal growth factor [EGF]) activate mTORC1 via the Ras GTPase (reviewed in reference <xref ref-type="bibr" rid="B58">58</xref>). Oncogenic Ras signaling has been linked to elevated mTORC1 activity. Inactivating mutations in the <italic>NF1</italic> gene, whose protein product (neurofibromin) acts as a GAP and inactivates Ras, leads to mTORC1 hyperactivation (<xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B60">60</xref>). Ras signals via the RAF/MEK/ERK axis to activate mTORC1, whereby extracellular signal-regulated kinase (ERK) phosphorylates TSC2 and raptor directly (<xref ref-type="bibr" rid="B61">61</xref><xref ref-type="bibr" rid="B62">–</xref><xref ref-type="bibr" rid="B64">64</xref>) or via the 90-kDa ribosomal S6 kinases (RSKs) (<xref ref-type="bibr" rid="B65">65</xref><xref ref-type="bibr" rid="B66">–</xref><xref ref-type="bibr" rid="B68">68</xref>).</p>
</sec>
<sec id="sec4">
<title>REGULATION OF mTORC1 BY NUTRIENTS AND METABOLITES</title>
<p>Amino acids stimulate mTORC1 (<xref ref-type="bibr" rid="B69">69</xref>, <xref ref-type="bibr" rid="B70">70</xref>). In <named-content content-type="genus-species">Saccharomyces cerevisiae</named-content>, this is achieved via the Vam6/VPS39-Gtr1/Gtr2 axis. Vam6/VPS39 was shown to promote GTP loading onto the Gtr1 GTPase, which is a subunit of the vacuolar-membrane-associated EGO complex that associates with TORC1, resulting in its activation (<xref ref-type="bibr" rid="B71">71</xref>, <xref ref-type="bibr" rid="B72">72</xref>). RagA/B and RagC/D are mammalian orthologues of Gtr1 and Gtr2, respectively (<xref ref-type="bibr" rid="B73">73</xref>, <xref ref-type="bibr" rid="B74">74</xref>). RagA or RagB forms heterodimers with RagC or RagD, and their activity is controlled by the ragulator (<xref ref-type="bibr" rid="B75">75</xref>), which anchors Rags to the lysosome (<xref ref-type="bibr" rid="B76">76</xref>). Ragulator, or LAMTOR (late endosomal/lysosomal adaptor and MAPK and mTOR activator), is a pentameric complex consisting of p18, p14, MP1 (MEK binding partner 1), HBXIP (hepatitis B virus X-interacting protein), and C7orf59, which are also known as LAMTOR1 to -5. In addition to mTOR, LAMTOR2 (p14) and LAMTOR3 (MP1) are also implicated in MEK1 and ERK1/2 activation (<xref ref-type="bibr" rid="B77">77</xref>). In their active form, wherein RagA/B and RagC/D are GTP and GDP loaded, respectively, Rag GTPases recruit mTORC1 to the lysosomal surface, which facilitates mTORC1 activation by Rheb (<xref ref-type="bibr" rid="B78">78</xref>, <xref ref-type="bibr" rid="B79">79</xref>). p62 interacts with raptor to stimulate mTORC1-Rag association on the lysosomes (<xref ref-type="bibr" rid="B80">80</xref>). GAP activity toward Rags 1 (GATOR1) is a heterotrimeric complex comprising of Nprl3, Nprl2, and DEPDC5, which acts as a RagA/B GAP and inhibits mTORC1 (<xref ref-type="bibr" rid="B81">81</xref>). GATOR2 inhibits GATOR1 via suppression of DEPDC5. Different amino acids activate mTORC1 via distinct pathways. SLC38A9, a lysosomal membrane-associated protein, and the cellular arginine sensor for mTORC1 complex 1/2 (CASTOR1/2) activate mTORC1 in response to arginine (<xref ref-type="bibr" rid="B82">82</xref><xref ref-type="bibr" rid="B83">–</xref><xref ref-type="bibr" rid="B84">84</xref>). The p53-inducible proteins sestrin1 and -2 mediate the effects of leucine on mTORC1 signaling (<xref ref-type="bibr" rid="B85">85</xref>). Akin to CASTOR1/2, sestrins bind to GATOR2 and suppress mTORC1 signaling. Addition of leucine leads to dissociation of sestrin-GATOR2 complexes, leading to mTORC1 activation (<xref ref-type="bibr" rid="B86">86</xref>). During amino acid starvation, GCN2 upregulates ATF4 and increases the expression of sestrin2, which correlates with mTORC1 inhibition (<xref ref-type="bibr" rid="B87">87</xref>). The transport of leucine, arginine, and glutamine into the cell also plays a role in mTORC1 regulation (<xref ref-type="bibr" rid="B88">88</xref>). For instance, cellular uptake of glutamine by ASCT2 and its subsequent rapid efflux by obligatory exchange with essential amino acids (e.g., leucine) by LAT1/2 transporters are required for mTORC1 activation (<xref ref-type="bibr" rid="B89">89</xref>).</p>
<p>mTOR activity is also controlled by metabolic intermediates. Isocitrate dehydrogenases 1 and 2 (IDH1/2) mutations in cancer (<xref ref-type="bibr" rid="B90">90</xref>) result in accumulation of <sc>d</sc>-2-hydroxyglutarate (<sc>d</sc>-2HG) (<xref ref-type="bibr" rid="B91">91</xref>). It was initially reported that <sc>d</sc>-2HG suppresses mTORC1 by binding to ATP5B and interfering with ATP production (<xref ref-type="bibr" rid="B92">92</xref>). mTOR, however, appears to be frequently activated in brain cancers harboring IDH1 or IDH2 mutations (<xref ref-type="bibr" rid="B91">91</xref>, <xref ref-type="bibr" rid="B93">93</xref>). Consistent with this, <sc>d</sc>-2HG was recently shown to positively regulate mTOR (<xref ref-type="bibr" rid="B94">94</xref>, <xref ref-type="bibr" rid="B95">95</xref>), in part by inhibiting KDM4A, an αKG-dependent enzyme of the Jumonji family of lysine demethylases (<xref ref-type="bibr" rid="B94">94</xref>). KDM4A negatively regulates mTORC1 and mTORC2 via associating with deptor (an inhibitor of mTORC1 and mTORC2) and precluding its targeting for degradation by SCF<sup>βTrCP</sup> (<xref ref-type="bibr" rid="B94">94</xref>). Modulation of mTOR activity by intermediate metabolites suggests the presence of regulatory feedback loops whereby mTOR activity, and thus the protein synthesis rate, is adjusted to the flux of specific metabolic pathways to maintain energy homeostasis.</p>
</sec>
<sec id="sec5">
<title>REGULATION OF mTORC1 BY ENERGY STATUS AND OXYGEN AVAILABILITY</title>
<p>Alterations in cellular energetics are sensed by the AMP-activated protein kinase (AMPK) (<xref ref-type="bibr" rid="B96">96</xref>). AMPK is a heterotrimeric Ser/Thr kinase that contains a catalytic α and regulatory β/γ subunits (<xref ref-type="bibr" rid="B97">97</xref>, <xref ref-type="bibr" rid="B98">98</xref>). Increased intracellular AMP/ATP and ADP/ATP ratios coincide with increased AMP or ADP binding to the AMPK γ subunit, which stimulates phosphorylation of the α subunit (on Thr172 in human protein) by serine/threonine kinase 11 (STK11/LKB1) (<xref ref-type="bibr" rid="B98">98</xref>). Glucose serves as a major energy source, and reductions in glucose flux are paralleled by reduced mTORC1 signaling (<xref ref-type="fig" rid="F1">Fig. 1</xref>). Reduction in the glycolytic intermediate fructose-1,6-bisphosphate results in aldolase-mediated formation of a lysosomal-membrane associated complex, comprising AMPK, LKB1, axin, v-ATPase and ragulator, which leads to AMPK activation (<xref ref-type="bibr" rid="B99">99</xref>). AMPK conserves cellular energy by downregulating anabolic processes, including protein synthesis, which is mediated via mTORC1 inhibition (<xref ref-type="bibr" rid="B98">98</xref>, <xref ref-type="bibr" rid="B100">100</xref>). AMPK phosphorylates and activates TSC2 (<xref ref-type="bibr" rid="B101">101</xref>) and phosphorylates and sequesters raptor in concert with 14-3-3 proteins (<xref ref-type="bibr" rid="B102">102</xref>).</p>
<p>Reduction in oxygen hinders ATP production, thereby activating AMPK (<xref ref-type="bibr" rid="B100">100</xref>). Hypoxia also inhibits mTORC1 via REDD1 (regulated in development and DNA damage response 1) (<xref ref-type="bibr" rid="B103">103</xref>). REDD1 downregulates mTORC1 by preventing the 14-3-3–TSC2 interaction and stabilizing TSC (<xref ref-type="bibr" rid="B104">104</xref>). Hypoxia-inducible proapoptotic protein BNIP3 (BCL2/adenovirus E1B 19-kDa-protein-interacting protein 3) also inhibits mTORC1 by directly associating with and inhibiting Rheb (<xref ref-type="bibr" rid="B105">105</xref>).</p>
<p>How mTORC1 activity is modulated by nutrients and/or alterations in cellular energetics to adjust protein synthesis rates <italic>in vivo</italic> is still poorly understood. Indeed, at the organismal level, nutrients regulate mTORC1 signaling in a fashion that appears to be significantly more multifarious than was previously expected (reviewed in reference <xref ref-type="bibr" rid="B11">11</xref>).</p>
</sec>
<sec id="sec6">
<title>REGULATION OF mTOR BY PHOSPHORYLATION</title>
<p>Within its kinase domain, mTOR contains two phosphoacceptor sites (Ser2159 and Thr2164 in human mTOR) (<xref ref-type="bibr" rid="B106">106</xref>) that stimulate mTOR autophosphorylation (on Ser2481 in human protein) (<xref ref-type="bibr" rid="B107">107</xref>) and impact cell growth and proliferation (<xref ref-type="bibr" rid="B106">106</xref>). Phosphorylation of Ser2159 was recently shown to be mediated by the innate immune kinase TANK-binding kinase 1 (TBK1) (<xref ref-type="bibr" rid="B108">108</xref>), which activates mTORC1 in response to growth factors and innate immune agonists. In addition, phosphorylation of mTOR at the residue located in its HEAT (Huntington, elongation factor 3, PR65/A, TOR) repeat (Ser1261 in human protein) results in mTOR autophosphorylation and induction of cell growth (<xref ref-type="bibr" rid="B109">109</xref>). Raptor is also phosphorylated by mTOR on a number of residues (e.g., Ser863 in human protein), which upregulates mTORC1 activity (<xref ref-type="bibr" rid="B110">110</xref>). Some of the mTOR-dependent sites on raptor overlap those phosphorylated by ERK1/2 (<xref ref-type="bibr" rid="B61">61</xref>), suggesting that raptor is an important point of convergence for multiple signaling pathways.</p>
</sec>
<sec id="sec7">
<title>mTORC1 SIGNALING TO THE TRANSLATIONAL MACHINERY</title>
<p>The most extensively studied mediators of the effects of mTORC1 on translation are 4E-BPs and S6Ks (<xref ref-type="bibr" rid="B29">29</xref>) (<xref ref-type="table" rid="T2">Table 2</xref>). More recently, La-related protein 1 (LARP1) emerged as a likely mediator of the effects of mTORC1 on translation of 5′-terminal oligopyrimidine tract (TOP) mRNAs (<xref ref-type="bibr" rid="B111">111</xref>, <xref ref-type="bibr" rid="B112">112</xref>) (<xref ref-type="fig" rid="F2">Fig. 2</xref>).</p>
<table-wrap id="T2" orientation="portrait" position="float">
<label>TABLE 2</label>
<caption>
<p>Phosphorylation sites in human translation factors and associated proteins, regulatory kinases, and functional consequences of the phosphorylation<xref ref-type="table-fn" rid="T2F1"><sup><italic>a</italic></sup></xref></p>
</caption>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
</colgroup>
<thead>
<tr valign="bottom">
<th align="left" colspan="1" rowspan="1">Protein</th>
<th align="left" colspan="1" rowspan="1">Phosphorylation site(s)<xref ref-type="table-fn" rid="T2F2"><sup><italic>b</italic></sup></xref> (reference) [main kinase(s)]</th>
<th align="left" colspan="1" rowspan="1">Biological function(s) (reference[s])</th>
</tr>
</thead>
<tbody>
<tr valign="top">
<td colspan="1" rowspan="3">4E-BP1</td>
<td colspan="1" rowspan="1">Thr37 (<xref ref-type="bibr" rid="B317">317</xref>), Thr46 (<xref ref-type="bibr" rid="B317">317</xref>) [mTORC1 (<xref ref-type="bibr" rid="B117">117</xref>), GSK3β (<xref ref-type="bibr" rid="B126">126</xref>)]</td>
<td colspan="1" rowspan="1">Priming sites (<xref ref-type="bibr" rid="B118">118</xref>, <xref ref-type="bibr" rid="B119">119</xref>, <xref ref-type="bibr" rid="B116">116</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Ser65 (<xref ref-type="bibr" rid="B317">317</xref>) [mTORC1 (<xref ref-type="bibr" rid="B117">117</xref>)], Thr70 (<xref ref-type="bibr" rid="B317">317</xref>) [mTORC1?/CDK1?]</td>
<td colspan="1" rowspan="1">Dissociation from eIF4E (<xref ref-type="bibr" rid="B118">118</xref>, <xref ref-type="bibr" rid="B119">119</xref>, <xref ref-type="bibr" rid="B116">116</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Ser83 (<xref ref-type="bibr" rid="B129">129</xref>) [CDK1?], Ser85 (<xref ref-type="bibr" rid="B318">318</xref>) [?], Ser94 (<xref ref-type="bibr" rid="B319">319</xref>) [ATM?], Ser101 (<xref ref-type="bibr" rid="B320">320</xref>) [?], Ser112 (<xref ref-type="bibr" rid="B321">321</xref>) [CK2A1 (<xref ref-type="bibr" rid="B320">320</xref>)]</td>
<td colspan="1" rowspan="1">Unknown</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="2">4E-BP2</td>
<td colspan="1" rowspan="1">Thr37 (<xref ref-type="bibr" rid="B322">322</xref>), Thr46 (<xref ref-type="bibr" rid="B322">322</xref>) [mTORC1]</td>
<td colspan="1" rowspan="1">Priming sites (by analogy with 4E-BP1)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Ser65 [mTORC1], Thr70 [mTORC1?/CDK1?]</td>
<td colspan="1" rowspan="1">Dissociation from eIF4E (by analogy with 4E-BP1)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">eIF4E</td>
<td colspan="1" rowspan="1">Ser209 (<xref ref-type="bibr" rid="B243">243</xref>) [MNK1/2 (<xref ref-type="bibr" rid="B245">245</xref>)]</td>
<td colspan="1" rowspan="1">Unknown (<xref ref-type="bibr" rid="B244">244</xref>, <xref ref-type="bibr" rid="B245">245</xref>), increases oncogenic activity and promotes translation of a subset of mRNAs (e.g., Mcl-1, MMPs, CCLs) (<xref ref-type="bibr" rid="B252">252</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="4">eIF4GI</td>
<td colspan="1" rowspan="1">Ser1185 [PKCα (<xref ref-type="bibr" rid="B323">323</xref>), TBK1? (<xref ref-type="bibr" rid="B324">324</xref>)]</td>
<td colspan="1" rowspan="1">Modulates MNK binding (<xref ref-type="bibr" rid="B323">323</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Ser1106, Ser1147, Ser1194 [mTORC1] (<xref ref-type="bibr" rid="B184">184</xref>)</td>
<td colspan="1" rowspan="1">Stimulation of translation of mRNAs containing uORFs (<xref ref-type="bibr" rid="B227">227</xref>) (?)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Ser896 [Pak2] (<xref ref-type="bibr" rid="B310">310</xref>)</td>
<td colspan="1" rowspan="1">Inhibition of cap-dependent translation (<xref ref-type="bibr" rid="B310">310</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Ser1231 (<xref ref-type="bibr" rid="B325">325</xref>) [CDK1?]</td>
<td colspan="1" rowspan="1">Inhibition of eIF4A/mRNA binding? (<xref ref-type="bibr" rid="B325">325</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">eIF2α</td>
<td colspan="1" rowspan="1">Ser52 (<xref ref-type="bibr" rid="B326">326</xref>) [HRI, PKR, GCN2, PERK (reviewed in reference <xref ref-type="bibr" rid="B4">4</xref>)]</td>
<td colspan="1" rowspan="1">Stabilizes the eIF2/GDP/eIF2B complex, thus preventing recycling of eIF2 (reviewed in reference <xref ref-type="bibr" rid="B4">4</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">eIF2β</td>
<td colspan="1" rowspan="1">S2, S67 [CK2 (<xref ref-type="bibr" rid="B327">327</xref>), mTORC1? (<xref ref-type="bibr" rid="B232">232</xref>)]</td>
<td colspan="1" rowspan="1">Stimulates translation and proliferation (<xref ref-type="bibr" rid="B327">327</xref>); stimulates eIF2α dephosphorylation (<xref ref-type="bibr" rid="B232">232</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">rpS6</td>
<td colspan="1" rowspan="1">Ser235 (<xref ref-type="bibr" rid="B328">328</xref>) and Ser236 [S6K1/2, RSK (<xref ref-type="bibr" rid="B147">147</xref>)], Ser240, Ser244, and Ser247 [S6K1/2]</td>
<td colspan="1" rowspan="1">Unknown (<xref ref-type="bibr" rid="B329">329</xref>, <xref ref-type="bibr" rid="B330">330</xref>, <xref ref-type="bibr" rid="B122">122</xref>, <xref ref-type="bibr" rid="B147">147</xref>), global translation rates increased in MEFs expressing a nonphosphorylatable form of rpS6 (<xref ref-type="bibr" rid="B148">148</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">PDCD4</td>
<td colspan="1" rowspan="1">Ser67 [S6K1/2, AKT (<xref ref-type="bibr" rid="B163">163</xref>, <xref ref-type="bibr" rid="B165">165</xref>)], Ser71 [?], Ser76 [RSK (<xref ref-type="bibr" rid="B331">331</xref>, <xref ref-type="bibr" rid="B164">164</xref>)], Ser94 [?], Ser457 [S6K1/2, AKT (<xref ref-type="bibr" rid="B163">163</xref>, <xref ref-type="bibr" rid="B165">165</xref>), RSK (<xref ref-type="bibr" rid="B164">164</xref>), PLK1? (<xref ref-type="bibr" rid="B332">332</xref>)]</td>
<td colspan="1" rowspan="1">Degradation by the ubiquitin-proteasome system and subsequent activation of eIF4A (<xref ref-type="bibr" rid="B163">163</xref>, <xref ref-type="bibr" rid="B164">164</xref>, <xref ref-type="bibr" rid="B165">165</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">eIF4B</td>
<td colspan="1" rowspan="1">Ser406 (<xref ref-type="bibr" rid="B172">172</xref>) [?], Ser422 [S6K1/2 (<xref ref-type="bibr" rid="B170">170</xref>), AKT (<xref ref-type="bibr" rid="B172">172</xref>), RSK (<xref ref-type="bibr" rid="B171">171</xref>)], Ser422 [MELK? (<xref ref-type="bibr" rid="B333">333</xref>)]</td>
<td colspan="1" rowspan="1">Increases binding to eIF3 (<xref ref-type="bibr" rid="B173">173</xref>, <xref ref-type="bibr" rid="B171">171</xref>), affects translation and proliferation (<xref ref-type="bibr" rid="B170">170</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">eIF4H</td>
<td colspan="1" rowspan="1">Tyr12 (<xref ref-type="bibr" rid="B334">334</xref>), Tyr45 (<xref ref-type="bibr" rid="B334">334</xref>), Tyr101 (<xref ref-type="bibr" rid="B334">334</xref>), Ser193 (<xref ref-type="bibr" rid="B334">334</xref>) [?]</td>
<td colspan="1" rowspan="1">Unknown</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="3">eIF2Bε</td>
<td colspan="1" rowspan="1">Ser540 [GSK3] (<xref ref-type="bibr" rid="B335">335</xref>)</td>
<td colspan="1" rowspan="1">Inhibits recycling of eIF2 (<xref ref-type="bibr" rid="B335">335</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Ser544 [DYRK] (<xref ref-type="bibr" rid="B336">336</xref>)</td>
<td colspan="1" rowspan="1">Priming site for GSK3 (<xref ref-type="bibr" rid="B336">336</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Ser717/718 [CK2] (<xref ref-type="bibr" rid="B337">337</xref>)</td>
<td colspan="1" rowspan="1">Facilitates eIF2 binding (<xref ref-type="bibr" rid="B337">337</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="7">eIF3</td>
<td colspan="1" rowspan="1">Subunit? [S6K1/2 (<xref ref-type="bibr" rid="B175">175</xref>)]</td>
<td colspan="1" rowspan="1">Paip1-eIF3 interaction (<xref ref-type="bibr" rid="B175">175</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">eIF3b: Ser83 (<xref ref-type="bibr" rid="B338">338</xref>), Ser85 (<xref ref-type="bibr" rid="B338">338</xref>), Ser125 (<xref ref-type="bibr" rid="B338">338</xref>) [?]</td>
<td colspan="1" rowspan="1">Unknown</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">eIF3c: Ser39 (<xref ref-type="bibr" rid="B339">339</xref>), Ser166 (<xref ref-type="bibr" rid="B338">338</xref>), Thr524 (<xref ref-type="bibr" rid="B338">338</xref>), Ser909 (<xref ref-type="bibr" rid="B340">340</xref>) [?]</td>
<td colspan="1" rowspan="1">Unknown</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">eIF3f: Ser46, Thr119 [CDK11] (<xref ref-type="bibr" rid="B341">341</xref>, <xref ref-type="bibr" rid="B311">311</xref>)</td>
<td colspan="1" rowspan="1">Regulation of protein synthesis and apoptosis (<xref ref-type="bibr" rid="B341">341</xref>, <xref ref-type="bibr" rid="B311">311</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">eIF3g: Thr41 (<xref ref-type="bibr" rid="B175">175</xref>), Ser42 (<xref ref-type="bibr" rid="B175">175</xref>) [?]</td>
<td colspan="1" rowspan="1">Unknown</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">eIF3h: Ser183 (<xref ref-type="bibr" rid="B342">342</xref>) [?]</td>
<td colspan="1" rowspan="1">Increased oncogenic activity (<xref ref-type="bibr" rid="B342">342</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">eIF3i: Tyr445 (<xref ref-type="bibr" rid="B334">334</xref>) [?]</td>
<td colspan="1" rowspan="1">Unknown</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="2">eIF1</td>
<td colspan="1" rowspan="1">Tyr30 (<xref ref-type="bibr" rid="B334">334</xref>) [?]</td>
<td colspan="1" rowspan="1">Unknown</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Tyr72 (<xref ref-type="bibr" rid="B343">343</xref>) [?]</td>
<td colspan="1" rowspan="1">Stimulation of mRNA translation (<xref ref-type="bibr" rid="B343">343</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">eIF5</td>
<td colspan="1" rowspan="1">Ser389, Ser390 [CK2] (<xref ref-type="bibr" rid="B344">344</xref>)</td>
<td colspan="1" rowspan="1">Promotes cell cycle progression (<xref ref-type="bibr" rid="B344">344</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">eIF5B</td>
<td colspan="1" rowspan="1">Ser107 (<xref ref-type="bibr" rid="B338">338</xref>), Ser113 (<xref ref-type="bibr" rid="B338">338</xref>), S135 (<xref ref-type="bibr" rid="B338">338</xref>), S137 (<xref ref-type="bibr" rid="B340">340</xref>), S164 (<xref ref-type="bibr" rid="B338">338</xref>), S182 (<xref ref-type="bibr" rid="B338">338</xref>), S183 (<xref ref-type="bibr" rid="B340">340</xref>), S186 (<xref ref-type="bibr" rid="B338">338</xref>), S190 (<xref ref-type="bibr" rid="B338">338</xref>), S214 (<xref ref-type="bibr" rid="B345">345</xref>), S1168 (<xref ref-type="bibr" rid="B338">338</xref>) [?]</td>
<td colspan="1" rowspan="1">Unknown</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="2">eIF6</td>
<td colspan="1" rowspan="1">Ser174/175 [CK1] (<xref ref-type="bibr" rid="B346">346</xref>)</td>
<td colspan="1" rowspan="1">Nucleocytoplasmic shuttling (<xref ref-type="bibr" rid="B346">346</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Ser235 [PKCβII] (<xref ref-type="bibr" rid="B347">347</xref>)</td>
<td colspan="1" rowspan="1">Dissociation of eIF6 from the 60S, 80S assembly (<xref ref-type="bibr" rid="B347">347</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="3">eEF1A1</td>
<td colspan="1" rowspan="1">Thr432 [PKCδ] (<xref ref-type="bibr" rid="B348">348</xref>)</td>
<td colspan="1" rowspan="1">Activation (?) (<xref ref-type="bibr" rid="B348">348</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Ser21 (<xref ref-type="bibr" rid="B349">349</xref>) [BRAF?]</td>
<td colspan="1" rowspan="1">Apoptosis (<xref ref-type="bibr" rid="B349">349</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Ser300 [TβR-I] (<xref ref-type="bibr" rid="B350">350</xref>)</td>
<td colspan="1" rowspan="1">Inhibition of mRNA translation (<xref ref-type="bibr" rid="B350">350</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">eEF1A2</td>
<td colspan="1" rowspan="1">Ser205, Ser358 [JNK (<xref ref-type="bibr" rid="B351">351</xref>)]</td>
<td colspan="1" rowspan="1">Degradation of newly synthesized polypeptides (<xref ref-type="bibr" rid="B351">351</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">eEF2</td>
<td colspan="1" rowspan="1">Thr56 [eEF2K] (<xref ref-type="bibr" rid="B352">352</xref>)</td>
<td colspan="1" rowspan="1">Inhibits binding to the ribosome (<xref ref-type="bibr" rid="B353">353</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="5">eEF2K</td>
<td colspan="1" rowspan="1">Ser78 (<xref ref-type="bibr" rid="B157">157</xref>) [mTOR?]</td>
<td colspan="1" rowspan="1">Inhibits CaM binding (<xref ref-type="bibr" rid="B157">157</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Ser359 (<xref ref-type="bibr" rid="B155">155</xref>) [SAPK/p38δ?]</td>
<td colspan="1" rowspan="1">Inhibition (?) (<xref ref-type="bibr" rid="B155">155</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Ser366 [S6K1, RSK] (<xref ref-type="bibr" rid="B150">150</xref>)</td>
<td colspan="1" rowspan="1">Inhibition (<xref ref-type="bibr" rid="B150">150</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Ser398 [AMPK] (<xref ref-type="bibr" rid="B354">354</xref>)</td>
<td colspan="1" rowspan="1">Activation (<xref ref-type="bibr" rid="B354">354</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Ser500 [PKA] (<xref ref-type="bibr" rid="B355">355</xref>)</td>
<td colspan="1" rowspan="1">Induces Ca<sup>2+</sup>-independent activity (<xref ref-type="bibr" rid="B355">355</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn fn-type="other" id="T2F1">
<label>a</label>
<p>This table includes selected phosphoacceptor sites identified in large-scale mass spectrometry-based experiments which await functional characterization (e.g., eIF5B; unknown kinase/function is indicated by a question mark), as well as phosphorylation sites with established role in translational control (e.g., 4E-BPs and eIF2α<bold>)</bold>. Further information on the as-of-yet functionally noncharacterized phosphorylated residues of the components of the translational apparatus can be found in the PhosphoSitePlus (<ext-link ext-link-type="uri" xlink:href="http://www.phosphosite.org">www.phosphosite.org</ext-link>) or UniProt (<ext-link ext-link-type="uri" xlink:href="http://www.uniprot.org">www.uniprot.org</ext-link>) database. In the case of eIF4G1, the phosphorylation sites indicated are corrected from the published article (Ser1108, Ser1148, and Ser1192). Abbreviations: CDK, cyclin-dependent kinase; PKC, protein kinase C; Pak2, p21-activated kinase 2; HRI, heme-regulated eIF2α kinase; PKR, double-stranded-RNA-activated eIF2α kinase; GCN2, general control nonrepressed eIF2α kinase; PERK, double-stranded-RNA-activated protein kinase-like ER kinase; DYRK, dual-specificity tyrosine phosphorylation-regulated kinase; CK2, protein kinase CK2 (formerly known as casein kinase II); TβR-I, transforming growth factor β1 (TGF-β1) receptor; eEF2K, eukaryotic translation elongation factor 2 kinase; PKA, protein kinase A; SAPK, stress-activated protein kinase; TBK1, TANK-binding kinase 1, PLK1, polo-like kinase 1, MELK, maternal embryonic leucine zipper kinase; Paip1, polyadenylate-binding protein-interacting protein 1. Additional abbreviations are provided in the text.</p>
</fn>
<fn fn-type="other" id="T2F2">
<label>b</label>
<p>Amino acid numbering is based on human proteins.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="F2" orientation="portrait" position="float">
<label>FIG 2</label>
<caption>
<p>The mTOR and MAPK pathways affect the translatome by modulating the expression of specific subsets of mRNAs. Phosphorylation of the 4E-BPs by mTOR leads to their dissociation from eIF4E, which stimulates the interaction of eIF4E with eIF4G and assembly of the eIF4F complex. mTOR also promotes S6K-dependent phosphorylation of PDCD4 and eIF4B, which in turn regulate eIF4A levels and activity, respectively. eIF4E is the most limiting subunit of the eIF4F complex and is thus critical for the recruitment of eIF4A to the mRNA and unwinding of the secondary structure of its 5′UTR during ribosome scanning toward the initiation codon. The Ras/ERK pathway also regulates eIF4A activity by promoting RSK-dependent phosphorylation of eIF4B and PDCD4. eIF4E activity is also regulated by MAPK pathways by direct phosphorylation of eIF4E by the MNK protein kinases. Although the eIF4F complex regulates the translatome at a global scale, each subunit also appears to modulate the translation of specific subsets of transcripts. For instance, overexpression of eIF4E appears to selectively affect translation of mRNAs encoding proteins involved in tumor initiation and maintenance (e.g., cyclins, vascular endothelial growth factor [VEGF], and BCL-xL). Phosphorylation of eIF4E also seems to bolster the translation of mRNAs encoding proteins involved in tumor dissemination (e.g., SNAIL and MMP3). Various stresses activate eIF2 kinases (PERK, PKR, GCN2, and HRI) that phosphorylate eIF2 (alpha subunit), which reduces global protein synthesis but promotes the translation of mRNAs containing upstream open reading frames (uORFs), such as those encoding ATF4, CHOP, and GADD34. eIF4A promotes the translation of mRNAs with G/C-rich 5′ UTR sequences, such as the 12-nucleotide guanine quartet (CGG)<sub>4</sub> motif, which can form RNA G-quadruplex structures. Red T-bars represent inhibitory signals, whereas black arrows indicate stimulatory signals. P denotes phosphorylation. Abbreviations and detailed explanations about this signaling network are provided in the text.</p>
</caption>
<graphic xlink:href="zmb9991017770002"></graphic>
</fig>
<sec id="sec7-1">
<title>4E-BPS.</title>
<p>Most cellular mRNAs are recruited to the ribosome via the 5′-mRNA cap structure (<xref ref-type="bibr" rid="B12">12</xref>). eIF4F is a heterotrimeric complex composed of eIF4E, eIF4G, and eIF4A (<xref ref-type="bibr" rid="B113">113</xref>). eIF4E acts as the cap-binding subunit, whereas eIF4A is an ATP-dependent DEAD box RNA helicase (<xref ref-type="bibr" rid="B12">12</xref>). eIF4G is a scaffold that bridges eIF4E-eIF4A interaction and that also associates with additional translation factors, including poly(A)-binding protein (PABP) and eIF3 (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B114">114</xref>, <xref ref-type="bibr" rid="B115">115</xref>). eIF4F recruits mRNA to the ribosome via interactions between eIF4E and the cap as well as eIF4G and eIF3 (<xref ref-type="bibr" rid="B12">12</xref>). 4E-BPs (4E-BP1, -2, and -3 in mammals) are repressors of eIF4F complex assembly (<xref ref-type="bibr" rid="B4">4</xref>). In their nonphosphorylated forms, 4E-BPs interfere with eIF4F complex assembly by binding to the site on eIF4E that overlaps with the eIF4G-binding motif, which blocks eIF4E-eIF4G association (<xref ref-type="bibr" rid="B116">116</xref>). mTORC1 activation results in hierarchical phosphorylation of 4E-BPs, whereby in human 4E-BP1, phosphorylation of Thr37 and Thr46 precedes phosphorylation of Thr70 and Ser65 (<xref ref-type="bibr" rid="B117">117</xref><xref ref-type="bibr" rid="B118">–</xref><xref ref-type="bibr" rid="B119">119</xref>). Phosphorylation of 4E-BPs facilitates their dissociation from eIF4E, which allows eIF4E-eIF4G interaction and eIF4F complex assembly (<xref ref-type="bibr" rid="B116">116</xref>, <xref ref-type="bibr" rid="B118">118</xref>, <xref ref-type="bibr" rid="B119">119</xref>) (<xref ref-type="fig" rid="F2">Fig. 2</xref>). 4E-BPs are recruited to mTORC1 via raptor, which is mediated by the C-terminal TOS motif (FEMDI) (<xref ref-type="bibr" rid="B57">57</xref>). In mammals, 4E-BPs appear to chiefly mediate the effects of mTORC1 on proliferation, while S6Ks act as major effectors of mTORC1 on cell size (<xref ref-type="bibr" rid="B120">120</xref><xref ref-type="bibr" rid="B121">–</xref><xref ref-type="bibr" rid="B122">122</xref>). In contrast, in phylogenetically lower species, including <named-content content-type="genus-species">Drosophila melanogaster</named-content>, which express a single 4E-BP protein (d4E-BP), 4E-BP regulates both proliferation and cell size (<xref ref-type="bibr" rid="B123">123</xref>).</p>
<p>Although mTORC1 acts as a major 4E-BP kinase, additional kinases may also be involved (reviewed in reference <xref ref-type="bibr" rid="B124">124</xref>). For instance, Ser/Thr kinase Pim-2 phosphorylates 4E-BPs (including the mTORC1-sensitive Ser65 site) in a number of leukemia and lymphoma cells (<xref ref-type="bibr" rid="B125">125</xref>). In addition, glycogen synthase kinase 3β (GSK3β) phosphorylates 4E-BP1 at Thr37/Thr46 (<xref ref-type="bibr" rid="B126">126</xref>). Casein kinase 1ε (CK1ε) phosphorylates 4E-BP1 (residues Thr41 and Thr50 in humans), which appears to be required for the phosphorylation of mTORC1-regulated sites and coincides with 4E-BP1 dissociation from eIF4E (<xref ref-type="bibr" rid="B127">127</xref>). Finally, cyclin-dependent kinase 1 (CDK1) phosphorylates 4E-BP1 at Thr70 and Ser83 during mitosis (<xref ref-type="bibr" rid="B128">128</xref>, <xref ref-type="bibr" rid="B129">129</xref>). The mechanisms governing these alternative pathways of 4E-BP phosphorylation are not well established, and little is known regarding their physiological relevance.</p>
</sec>
<sec id="sec7-2">
<title>S6Ks.</title>
<p>In addition to the 4E-BPs, S6Ks also mediate effects of mTOR on protein synthesis (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B130">130</xref>) (<xref ref-type="fig" rid="F2">Fig. 2</xref>). There are two S6Ks in mammals (S6K1 and S6K2 [also referred to as S6Kα and S6Kβ]) (<xref ref-type="bibr" rid="B131">131</xref>). Notwithstanding that two separate genes (<italic>RPS6KB1</italic> and <italic>RPS6KB2</italic>) encode S6K1 and S6K2, the enzymes are highly homologous (reviewed in reference <xref ref-type="bibr" rid="B132">132</xref>). Both mammalian S6Ks exist in distinct isoforms (p70- and p85-S6K1 and p54- and p56-S6K2), which are produced by alternative selection of translational start sites (<xref ref-type="bibr" rid="B133">133</xref>, <xref ref-type="bibr" rid="B134">134</xref>). A third isoform of S6K1 (p31-S6K1) has also been described, which is generated via alternative splicing and results in a truncated kinase domain (<xref ref-type="bibr" rid="B135">135</xref>). p31-S6K1 plays an important role in cancer (<xref ref-type="bibr" rid="B136">136</xref>, <xref ref-type="bibr" rid="B137">137</xref>). S6Ks have an evolutionarily conserved role in the regulation of cellular and organismal size. In mammals, S6Ks act as major effectors of mTORC1 on cell growth (<xref ref-type="bibr" rid="B138">138</xref>), whereas their effect on proliferation appears to be less pronounced (<xref ref-type="bibr" rid="B120">120</xref><xref ref-type="bibr" rid="B121">–</xref><xref ref-type="bibr" rid="B122">122</xref>). S6K1/S6K2 knockout mice are ∼15 to 20% smaller than their wild-type counterparts and suffer from perinatal lethality (<xref ref-type="bibr" rid="B122">122</xref>), which is consistent with the increased death of flies at the larval stage upon dS6K ablation (<xref ref-type="bibr" rid="B139">139</xref>). Size reduction is observed in S6K1 knockout mice (<xref ref-type="bibr" rid="B140">140</xref>) but not S6K2 knockout mice, which exhibit a modest increase in size (<xref ref-type="bibr" rid="B122">122</xref>). A similar reduction in cell size was observed in <named-content content-type="genus-species">Drosophila</named-content> upon ablation of its single S6K isoform (<xref ref-type="bibr" rid="B139">139</xref>). These findings suggest that S6K1 and S6K2 may play some nonoverlapping roles. For instance, S6K2, but not S6K1, has been implicated in the regulation of cell proliferation in cancer (<xref ref-type="bibr" rid="B141">141</xref>). S6K1 and S6K2 also play distinct roles in microRNA (miRNA) biogenesis (<xref ref-type="bibr" rid="B142">142</xref>). Finally, protein kinase C (PKC) has been shown to phosphorylate S6K2 (on S486 in humans) but not S6K1 (<xref ref-type="bibr" rid="B143">143</xref>).</p>
<p>The first step in activation of S6Ks is phosphorylation of several residues located in the C-terminal pseudosubstrate domain (<xref ref-type="bibr" rid="B144">144</xref>, <xref ref-type="bibr" rid="B145">145</xref>). This is followed by phosphorylation of Thr residues within their activation loop (Thr229 in human p70-S6K1) and hydrophobic motif (Thr389 in human p70-S6K1) by PDK1 and mTORC1, respectively (reviewed in references <xref ref-type="bibr" rid="B132">132</xref> and <xref ref-type="bibr" rid="B131">131</xref>). S6Ks are recruited to mTORC1 by raptor via their TOS motif (FDIDL in human S6Ks) (<xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B57">57</xref>). In addition, GSK3 also phosphorylates S6Ks in their turn motif (Ser371 in human S6K1), which is thought to contribute to S6K activation (<xref ref-type="bibr" rid="B146">146</xref>).</p>
<p>The S6Ks regulate the phosphorylation of multiple components of the translational machinery (<xref ref-type="fig" rid="F1">Fig. 1</xref> and <xref ref-type="fig" rid="F2">2</xref>). S6Ks phosphorylate five residues in the C terminus of rpS6 (Ser235, Ser236, Ser240, Ser244, and Ser247 in humans). In turn, RSKs phosphorylate only Ser235 and Ser236 (<xref ref-type="bibr" rid="B122">122</xref>, <xref ref-type="bibr" rid="B147">147</xref>) (<xref ref-type="fig" rid="F2">Fig. 2</xref> and <xref ref-type="fig" rid="F3">3</xref>). Expression of a nonphosphorylatable rpS6 mutant mirrors growth defects observed in S6K1/2 knockout mice (<xref ref-type="bibr" rid="B148">148</xref>), thereby indicating that the phosphorylation of rpS6 is involved in the regulation of cell growth. Expression of the nonphosphorylatable rpS6 mutant, however, moderately upregulates overall protein synthesis, whereas loss of S6Ks has only a marginal effect on global translation (<xref ref-type="bibr" rid="B122">122</xref>, <xref ref-type="bibr" rid="B148">148</xref>). Finally, the S6K/rpS6 axis has been implicated in ribosome biogenesis (<xref ref-type="bibr" rid="B149">149</xref>).</p>
<fig id="F3" orientation="portrait" position="float">
<label>FIG 3</label>
<caption>
<p>Schematic representation of MAPK signaling to the translational machinery. The Ras/ERK and p38MAPK pathways are activated by a wide range of stimuli, including cytokines, growth factors, and diverse environmental stresses. While many stimuli activate both MAPK pathways, stress stimuli and growth factors typically activate the p38MAPK and Ras/ERK signaling, respectively. While Ras/ERK signaling stimulates the activity of both RSK and MNK, the latter is also responsive to agonists of the p38MAPK pathway. MNK interacts with eIF4G and phosphorylates eIF4E on Ser209, a site that increases its oncogenic potential and facilitates the translation of specific mRNAs. Following activation of the Ras/ERK pathway, RSK phosphorylates rpS6, eIF4B, PDCD4, and eEF2K, which are important regulators of translation. RSK also modulates mTORC1 signaling by phosphorylating TSC2 and deptor. ERK and RSK regulate LKB1-dependent and -independent phosphorylation of raptor, resulting in increased mTORC1 signaling. ERK and RSK also collaborate in the regulation of ribosome biogenesis by promoting TIF-1A phosphorylation. Red T-bars represent inhibitory signals, whereas black arrows indicate stimulatory signals. P denotes phosphorylation. Abbreviations and detailed explanations about this signaling network are provided in the text.</p>
</caption>
<graphic xlink:href="zmb9991017770003"></graphic>
</fig>
<p>S6Ks also phosphorylate eukaryotic elongation factor 2 (eEF2) kinase (eEF2K) (Ser366 in humans) (<xref ref-type="bibr" rid="B150">150</xref>) (<xref ref-type="fig" rid="F2">Fig. 2</xref>). eEF2K belongs to a small group of proteins containing an α-kinase catalytic domain, and it functions as a negative regulator of protein synthesis through its ability to phosphorylate and inhibit eEF2 (<xref ref-type="bibr" rid="B151">151</xref>). eEF2K phosphorylates eEF2 (Thr56 in humans), which is a GTPase that promotes translocation of peptidyl-tRNA from the A site to the P site of the ribosome (<xref ref-type="bibr" rid="B152">152</xref>, <xref ref-type="bibr" rid="B153">153</xref>). eEF2K is inactivated by insulin and other growth factors, which increase eEF2 function and elongation rates (<xref ref-type="bibr" rid="B150">150</xref>). This is mediated by the mTORC1/S6K axis, which phosphorylates eEF2K (at Ser366 in humans). While this site is also phosphorylated by RSK (<xref ref-type="bibr" rid="B150">150</xref>), ERK1/2 phosphorylates eEF2K at Ser359 (in humans) (<xref ref-type="bibr" rid="B154">154</xref>) and inhibits its function (<xref ref-type="bibr" rid="B155">155</xref>) (<xref ref-type="fig" rid="F3">Fig. 3</xref>). Moreover, mTORC1 has been suggested to interfere with calmodulin-eEF2K binding by directly phosphorylating eEF2K (at Ser78 and Ser396 in humans) (<xref ref-type="bibr" rid="B150">150</xref>, <xref ref-type="bibr" rid="B154">154</xref>). AMPK activates eEF2K via mTORC1 inhibition (<xref ref-type="bibr" rid="B156">156</xref>) and direct phosphorylation (at Ser398 in humans) (<xref ref-type="bibr" rid="B157">157</xref>). Understanding of the functional consequences of eEF2K phosphorylation is still incomplete. For instance, it has been shown that disruption of eEF2K mitigates the antineoplastic effects of mTORC1 inhibition, suggesting tumor-suppressive properties of eEF2K (<xref ref-type="bibr" rid="B158">158</xref>) (<xref ref-type="fig" rid="F2">Fig. 2</xref>). Cell culture and xenograft experiments using a variety of cancer cell lines, however, point out that eEF2K may exhibit tumor-protective effects by decreasing energy consumption when nutrients are limiting (<xref ref-type="bibr" rid="B151">151</xref>, <xref ref-type="bibr" rid="B159">159</xref>).</p>
<p>Programmed cell death 4 (PDCD4) is a proapoptotic factor that blocks eIF4G-eIF4A interaction (<xref ref-type="bibr" rid="B160">160</xref>, <xref ref-type="bibr" rid="B161">161</xref>). This represses eIF4A activity and results in inhibition of cap-dependent translation (<xref ref-type="bibr" rid="B161">161</xref>, <xref ref-type="bibr" rid="B162">162</xref>). S6Ks phosphorylate PDCD4 (on Ser67 and Ser457 in humans), which triggers its SCF<sup>βTrCP</sup>-dependent degradation (<xref ref-type="bibr" rid="B163">163</xref>). AKT and RSK can also target some of these PDCD4 sites (<xref ref-type="bibr" rid="B164">164</xref>, <xref ref-type="bibr" rid="B165">165</xref>) (<xref ref-type="fig" rid="F3">Fig. 3</xref>). eIF4B and eIF4H stimulate the RNA-unwinding activity of eIF4A by bolstering its processivity and establishing its directionality (<xref ref-type="bibr" rid="B116">116</xref>, <xref ref-type="bibr" rid="B166">166</xref><xref ref-type="bibr" rid="B167">–</xref><xref ref-type="bibr" rid="B169">169</xref>). Several AGC kinases phosphorylate eIF4B on Ser406 (RSK and S6K) and Ser422 (S6K, AKT, and RSK), which appears to occur in a context-dependent manner (<xref ref-type="bibr" rid="B170">170</xref><xref ref-type="bibr" rid="B171">–</xref><xref ref-type="bibr" rid="B172">172</xref>) (<xref ref-type="fig" rid="F3">Fig. 3</xref>). eIF4B stimulates cellular proliferation and survival, and its phosphorylation correlates with increased translation (<xref ref-type="bibr" rid="B171">171</xref>). It was also implied that eIF4B phosphorylation facilitates its association with eIF3, which was proposed to act as a scaffold for mTORC1 and S6K1 (<xref ref-type="bibr" rid="B173">173</xref>). S6Ks associate with eIF3 via the eIF3f subunit, whereby S6K-dependent phosphorylation of eIF3 increases eIF3-PABP-interacting protein 1 (Paip1) association, which correlates with upregulated translation (<xref ref-type="bibr" rid="B174">174</xref>, <xref ref-type="bibr" rid="B175">175</xref>).</p>
<p>In addition, S6K1 has been suggested to stimulate translation of newly spliced mRNAs. According to this model, S6K1 is recruited to the exon-junction complex (EJC) by SKAR (S6K1 Aly/REF-like target) (<xref ref-type="bibr" rid="B176">176</xref>). Formation of S6K1-SKAR complexes with the EJC coincides with the phosphorylation of a number of mRNA-binding proteins, which is paralleled by increased translational activity of spliced mRNAs (<xref ref-type="bibr" rid="B177">177</xref>).</p>
</sec>
<sec id="sec7-3">
<title>LARP1.</title>
<p>La-related protein 1 (LARP1) is a conserved RNA-binding protein of the La motif (LAM)-containing factor family (<xref ref-type="bibr" rid="B111">111</xref>). LARP1 interacts with raptor and is phosphorylated by mTORC1, which is thought to modulate its mRNA-binding activity (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B178">178</xref>). While mTORC1 phosphorylates LARP1 on Ser689 and Thr692, other sites (Ser770 and Ser979) are phosphorylated by S6K1 and/or AKT (<xref ref-type="bibr" rid="B23">23</xref>), suggesting several layers of LARP1 phosphoregulation (<xref ref-type="fig" rid="F2">Fig. 2</xref>).</p>
<p>LARP1 has been proposed to play a role in modulating stability and/or translation of TOP mRNAs (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B178">178</xref>, <xref ref-type="bibr" rid="B179">179</xref>) (<xref ref-type="fig" rid="F2">Fig. 2</xref>). The interaction with TOP mRNAs requires the LARP1 family-specific DM15 region (<xref ref-type="bibr" rid="B180">180</xref>). Recent findings suggest that the DM15 region plays a role in specialized cap binding of TOP mRNAs (<xref ref-type="bibr" rid="B181">181</xref>), which may impede access of eIF4E to the cap. LARP1 was also shown to interact with the poly(A) tail of TOP transcripts (<xref ref-type="bibr" rid="B179">179</xref>), but the region within LARP1 responsible for this interaction remains unknown.</p>
<p>The exact role of LARP1 in the regulation of TOP mRNAs remains controversial. While LARP1 was shown to regulate TOP mRNA stability, it has also been described as a positive or negative regulator of TOP mRNA translation, depending on the context. Current evidence indicate that LARP1 binding to TOP mRNAs may inhibit their translation in response to mTORC1 inhibitors (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B178">178</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>). LARP1 may thus serve as a phosphorylation-sensitive switch that regulates the translation of TOP mRNAs. This model was recently supported by <italic>in vitro</italic> evidence using cell-free translation systems (<xref ref-type="bibr" rid="B182">182</xref>). Complementary strategies involving cell type- and organ-specific conditional knockout of LARP1 in whole animals will also be required in the future. Together, these approaches should help determine whether LARP1 is the long-sought regulator of TOP mRNA translation downstream of mTORC1. A recent study has shown that LARP1 is lost in <italic>5q</italic><sup>−</sup> syndrome, which is a macrocytic anemia characterized by defects in ribosome biogenesis (<xref ref-type="bibr" rid="B183">183</xref>).</p>
</sec>
<sec id="sec7-4">
<title>Additional mTOR targets implicated in translational control.</title>
<p>Besides LARP1, 4E-BPs, and S6Ks, mTORC1 directly phosphorylates eIF4G at multiple residues (<xref ref-type="bibr" rid="B184">184</xref>), but the functional consequences remain unknown. mTORC1 also increases ribosome biogenesis and tRNA synthesis rates. This is mediated chiefly by TIF-IA (<xref ref-type="bibr" rid="B185">185</xref>) and the RNA polymerase III repressor Maf1, respectively (<xref ref-type="bibr" rid="B186">186</xref><xref ref-type="bibr" rid="B187">–</xref><xref ref-type="bibr" rid="B189">189</xref>) (<xref ref-type="fig" rid="F1">Fig. 1</xref>). mTORC1 may also promote mRNA translation by suppressing a selective autophagic pathway for 60S ribosomal subunits (i.e., ribophagy) (<xref ref-type="bibr" rid="B190">190</xref>, <xref ref-type="bibr" rid="B191">191</xref>), but the specificity of this response in mammalian cells compared to bulk autophagy remains poorly understood (<xref ref-type="bibr" rid="B192">192</xref>).</p>
</sec>
</sec>
<sec id="sec8">
<title>SELECTIVE TRANSLATION REGULATION BY mTOR</title>
<p>mRNAs exhibit differential translation activity based on their intrinsic features, which can sometime determine the rate of ribosome attachment (e.g., for mRNAs coding for α- versus β-globin) (<xref ref-type="bibr" rid="B193">193</xref>). This allows selective induction of translation of a subset of mRNAs in response to a variety of extracellular stimuli and intracellular cues, which is achieved by modulating the activities of components of the translational machinery by signaling pathways (<xref ref-type="table" rid="T2">Table 2</xref>). New technologies, including ribosome and polysome profiling, enabled investigation of translation on a transcriptome-wide scale (<xref ref-type="bibr" rid="B194">194</xref>, <xref ref-type="bibr" rid="B195">195</xref>). These analyses further corroborated the tenet that translation plays an evolutionarily conserved role in shaping the proteomes, in particular during acute responses to stimuli.</p>
<p>TOP mRNAs harbor an extreme 5-terminal oligopyrimidine tract (5′TOP) which is characterized by a cytosine immediately following the cap followed by 4 to 15 uninterrupted pyrimidines (reviewed in reference <xref ref-type="bibr" rid="B112">112</xref>). TOP mRNAs almost exclusively encode components of the translational apparatus (reviewed in reference <xref ref-type="bibr" rid="B112">112</xref>). Inhibition of mTOR signaling leads to a reduction in TOP mRNA translation due to impaired initiation. Based on the observation that TOP mRNA translation is suppressed upon amino acid withdrawal, which is paralleled by downregulation of S6K activity and rpS6 phosphorylation, it was proposed that the S6Ks/rpS6 axis promotes TOP mRNA translation (<xref ref-type="bibr" rid="B140">140</xref>, <xref ref-type="bibr" rid="B196">196</xref>, <xref ref-type="bibr" rid="B197">197</xref>). Subsequent studies, however, demonstrated that neither ablation of S6Ks nor alterations in rpS6 phosphorylation influence TOP mRNA translation (<xref ref-type="bibr" rid="B122">122</xref>, <xref ref-type="bibr" rid="B148">148</xref>, <xref ref-type="bibr" rid="B198">198</xref>). More recently, ribosome profiling studies suggested that TOP mRNA translation is regulated by 4E-BPs (<xref ref-type="bibr" rid="B199">199</xref>). This conclusion was based on the findings that mTOR inhibitors suppress translation of TOP mRNAs more strongly in wild-type than in 4E-BP1/2 knockout mouse embryonic fibroblasts (MEFs). This was in contrast to previous findings of relative insensitivity of TOP mRNA translation to changes in eIF4E availability (<xref ref-type="bibr" rid="B200">200</xref>). Moreover, physiological stimuli, such as oxygen, growth factors, or nutrients, alter TOP mRNA translation in an mTOR-dependent but 4E-BP-independent manner (<xref ref-type="bibr" rid="B201">201</xref>). Hence, it appears likely that mTOR-mediated regulation of TOP mRNAs includes pathways that are independent from the 4E-BPs.</p>
<p>In addition to LARP1, which was described above, T-cell intracellular antigen 1 (TIA-1) and TIA-1-related protein (TIAR) were shown to suppress TOP mRNA translation specifically upon amino acid withdrawal (<xref ref-type="bibr" rid="B202">202</xref>) (<xref ref-type="fig" rid="F2">Fig. 2</xref>). TIA-1 and TIAR are mRNA-binding proteins that aggregate within stress granules (<xref ref-type="bibr" rid="B203">203</xref>), but the role of mTOR in TIA-1/TIAR-mediated repression of TOP mRNAs remains unclear. These findings highlight the need to further investigate the mechanisms by which mTOR mediates TOP mRNA translation. Intriguingly, although mTOR depletion abrogates the effects of physiological stimuli on TOP mRNA translation, this is not the case when raptor or rictor is depleted (<xref ref-type="bibr" rid="B204">204</xref>, <xref ref-type="bibr" rid="B205">205</xref>), suggesting that an mTOR complex other than mTORC1 or mTORC2 may be implicated in regulation of TOP mRNA translation.</p>
<p>Ribosome profiling studies suggested that mTOR almost exclusively regulates translation of mRNAs that harbor TOP or TOP-like motifs (<xref ref-type="bibr" rid="B199">199</xref>, <xref ref-type="bibr" rid="B206">206</xref>), although the significance of the latter motifs has been questioned (<xref ref-type="bibr" rid="B207">207</xref>). Comparative analyses of several data sets derived from such analyses revealed the loss of representation of a large majority of bona fide non-TOP mRNAs (<xref ref-type="bibr" rid="B112">112</xref>). Indeed, polysome profiling studies suggested that, in addition to TOP mRNAs, alterations in mTOR activity impact non-TOP mRNAs (<xref ref-type="bibr" rid="B208">208</xref>).</p>
<p>Non-TOP mRNAs include a large proportion of transcripts whose translation is highly dependent on changes in 4E-BP activity and/or eIF4E levels (<xref ref-type="bibr" rid="B209">209</xref>, <xref ref-type="bibr" rid="B210">210</xref>). Changes in 4E-BPs levels and/or phosphorylation dramatically alter translation of a subset of mRNAs (e.g., <italic>IRF7</italic>, <italic>GAS2</italic>, <italic>CCND3</italic>, <italic>ODC1</italic>, and <italic>VEGFA</italic>), while having relatively modest effects on global protein synthesis (<xref ref-type="bibr" rid="B120">120</xref>, <xref ref-type="bibr" rid="B211">211</xref><xref ref-type="bibr" rid="B212">–</xref><xref ref-type="bibr" rid="B213">213</xref>) (<xref ref-type="fig" rid="F2">Fig. 2</xref>). This pool of mRNAs largely overlaps those whose translation activity is dramatically affected by alterations in eIF4E levels (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B209">209</xref>, <xref ref-type="bibr" rid="B210">210</xref>, <xref ref-type="bibr" rid="B214">214</xref>). These “eIF4E-sensitive mRNAs” are thought to harbor long and structured 5′ untranslated regions (5′UTRs) that render them critically dependent on the unwinding activity of the eIF4A subunit of the eIF4F complex (<xref ref-type="bibr" rid="B209">209</xref>, <xref ref-type="bibr" rid="B215">215</xref><xref ref-type="bibr" rid="B216">–</xref><xref ref-type="bibr" rid="B217">217</xref>). The ability of eIF4A to efficiently unwind secondary RNA structures is strongly induced in the eIF4F complex (<xref ref-type="bibr" rid="B218">218</xref>, <xref ref-type="bibr" rid="B219">219</xref>), and thus it is thought that recruitment of eIF4A to the eIF4F complex by eIF4E underpins the observed “eIF4E sensitivity” (reviewed in references <xref ref-type="bibr" rid="B9">9</xref> and <xref ref-type="bibr" rid="B4">4</xref>). In contrast, mRNAs with 5′UTRs that are of the optimal length (70 to 150 nucleotides [nt] in mammalian cells) (<xref ref-type="bibr" rid="B220">220</xref>), including those encoding housekeeping proteins (e.g., actins and tubulins), exhibit minimal sensitivity to eIF4E (reviewed in reference <xref ref-type="bibr" rid="B210">210</xref>).</p>
<p>The discrepancy between the ribosome and polysome profiling studies can be explained by the differences in the technology biases and experimental conditions that were used (<xref ref-type="bibr" rid="B221">221</xref>). NanoCAGE technology, which allows determination of transcription start sites on a genome-wide scale, confirmed that a large number of non-TOP mRNAs are mTOR sensitive (<xref ref-type="bibr" rid="B222">222</xref>). Among these non-TOP mRNAs, a subclass of transcripts with exceedingly short 5′UTRs (&lt;50 nt) were also identified as being translationally regulated via the mTOR/4E-BP/eIF4E axis (<xref ref-type="fig" rid="F2">Fig. 2</xref>). The vast majority of these mRNAs correspond to nuclear genes with mitochondrial functions, including components of the respiratory chain complexes (e.g., <italic>ATP5O</italic>, <italic>ATP5D</italic>, <italic>UQCC2</italic>, and <italic>NDUF6</italic>) (<xref ref-type="bibr" rid="B222">222</xref>). These transcripts frequently harbor a TISU (translation initiator of short 5′ UTR) element, and their translation is strongly affected by alterations in eIF4E but not eIF4A (<xref ref-type="bibr" rid="B222">222</xref>, <xref ref-type="bibr" rid="B223">223</xref>). Mechanisms underlying the translation of TISU mRNAs are still not completely clear, but they may involve an interaction between eIF4G1 and eIF1, which facilitates dissociation of eIF4E from the 5′mRNA cap (<xref ref-type="bibr" rid="B224">224</xref>), followed by the eIF1A-directed association between the TISU element and RPS3 and RPS10e in the 48S complex and 80S monosome, respectively (<xref ref-type="bibr" rid="B225">225</xref>). Collectively, these findings suggest that mTOR regulates translation of mRNAs with specific 5′UTR features, including a number of non-TOP mRNAs.</p>
<p>mTORC1 can independently regulate each component of the eIF4F complex (eIF4E and eIF4A via modulating 4E-BP and PDCD4 phosphorylation, respectively, and eIF4G by direct phosphorylation). This suggests that the effects of mTOR on the translatome may be influenced by factors such as stoichiometry of the eIF4F components in the cell and/or the nature of the stimulus. Indeed, although changes in the levels and/or activity of the eIF4F complex subunits correspond to overlapping changes in the translatome, there are many notable differences. eIF4A and eIF4G affect different transcripts, and these are often distinct from those exhibiting eIF4E sensitivity (<xref ref-type="bibr" rid="B226">226</xref><xref ref-type="bibr" rid="B227">–</xref><xref ref-type="bibr" rid="B229">229</xref>). Moreover, mTOR regulates the phosphorylation of eIFs other than eIF4F components that selectively affect translation. For instance, eIF4B, which acts as an auxiliary factor that bolsters eIF4A helicase activity, is a substrate of S6Ks that has been demonstrated to selectively upregulate translation of mRNAs encoding survival and proliferation-promoting factors, including c-Myc, XIAP Cdc25, ODC, and Bcl-2 (<xref ref-type="bibr" rid="B230">230</xref>, <xref ref-type="bibr" rid="B231">231</xref>) (<xref ref-type="fig" rid="F2">Fig. 2</xref>). eIF4A was shown to possess oncogenic properties in T-cell acute lymphoblastic leukemia, as it was found to be particularly important for the translation of <italic>MYC</italic>, <italic>NOTCH1</italic>, and <italic>MDM2</italic> mRNAs (<xref ref-type="bibr" rid="B229">229</xref>). mTOR also seems to collaborate with CK2 in phosphorylating eIF2β (on Ser2 and Ser67 in human protein), which leads to translational inactivation of upstream open reading frame (uORF)-containing mRNAs (<xref ref-type="bibr" rid="B232">232</xref>). Finally, it has been suggested that mTORC1 can bolster translation of cyclin D3 mRNA by increasing its elongation rates via the eEF2K/eEF2 axis (<xref ref-type="bibr" rid="B158">158</xref>).</p>
<p>Altogether, these findings demonstrate that further studies are warranted to fully catalogue mTOR-sensitive mRNAs and identify the precise mechanism underpinning the qualitative and quantitative alterations of the translatome by mTOR.</p>
</sec>
<sec id="sec9">
<title>MAPK SIGNALING TO THE TRANSLATIONAL MACHINERY</title>
<p>The mitogen-activated protein kinases (MAPKs) are Ser/Thr kinases that regulate many essential processes, including gene expression, mitosis, metabolism, motility, survival, apoptosis, and differentiation (<xref ref-type="bibr" rid="B233">233</xref>). In mammalian cells, three MAPK families, i.e., ERK1/2, Jun N-terminal protein kinase (JNK), and p38 kinase, have been extensively characterized (reviewed in references <xref ref-type="bibr" rid="B234">234</xref>, <xref ref-type="bibr" rid="B235">235</xref>, <xref ref-type="bibr" rid="B236">236</xref>, and <xref ref-type="bibr" rid="B237">237</xref>). Each group of MAPKs function within a module composed of conserved, sequentially acting kinases: a MAPK, a MAPK kinase (MAPKK), and a MAPKK kinase (MAPKKK) (<xref ref-type="fig" rid="F3">Fig. 3</xref>). The MAPK-activated protein kinases (MAPKAPKs), one of the many substrates of ERK1/2 and p38, are a family of Ser/Thr kinases which includes the p90 ribosomal S6 kinases (RSKs) and the MAPK-interacting kinases (MNKs) (<xref ref-type="bibr" rid="B238">238</xref>, <xref ref-type="bibr" rid="B239">239</xref>). While multiple MAPKAPs have been shown to regulate gene expression, the RSKs and MNKs have been directly implicated in the regulation of mRNA translation (<xref ref-type="bibr" rid="B240">240</xref>, <xref ref-type="bibr" rid="B241">241</xref>) (<xref ref-type="fig" rid="F3">Fig. 3</xref>).</p>
<sec id="sec9-1">
<title>MNKs.</title>
<p>In mammals, eIF4E is regulated by phosphorylation of a C-terminal residue (Ser209 in human eIF4E) (<xref ref-type="bibr" rid="B242">242</xref>, <xref ref-type="bibr" rid="B243">243</xref>) by the MNKs (<xref ref-type="bibr" rid="B244">244</xref>, <xref ref-type="bibr" rid="B245">245</xref>) (<xref ref-type="fig" rid="F3">Fig. 3</xref>). There are two <italic>MNK</italic> genes in the human genome (<italic>MKNK1</italic> and <italic>MKNK2</italic>), each encoding two spliced isoforms (MNK1a and -b and MNK2a and -b) (reviewed in reference <xref ref-type="bibr" rid="B240">240</xref>). While the longer forms, MNK1a and MNK2a, are primarily cytoplasmic, MNK1b and MNK2b are equally distributed between the nucleus and the cytoplasm (<xref ref-type="bibr" rid="B246">246</xref>, <xref ref-type="bibr" rid="B247">247</xref>). Although both MNK1a and MNK2a contain a canonical MAPK-binding motif, their sequences differ slightly such that MNK1a binds both ERK1/2 and p38 kinases, while MNK2a associates only with ERK1/2 (<xref ref-type="bibr" rid="B245">245</xref>). The basal activity of MNK2a is high relative to that of MNK1a due to its sustained association with ERK1/2 (<xref ref-type="bibr" rid="B248">248</xref>). MNK1a has low basal activity but is responsive to the ERK1/2 and p38 activation (<xref ref-type="bibr" rid="B150">150</xref>, <xref ref-type="bibr" rid="B248">248</xref>). Although MNK1b and MNK2b lack MAPK-binding motifs, these isoforms were shown to have high and low basal activity, respectively (<xref ref-type="bibr" rid="B247">247</xref>, <xref ref-type="bibr" rid="B249">249</xref>). In mice, however, only MNK1a and MNK2a isoforms have been identified (reviewed in reference <xref ref-type="bibr" rid="B240">240</xref>).</p>
<p>MNKs are recruited to eIF4E through association of their N-terminal regions with the C-terminal part of eIF4G (<xref ref-type="bibr" rid="B250">250</xref>). Phosphorylation of eIF4E is restricted to metazoans, as yeast lacks MNK orthologues. Although studies in <named-content content-type="genus-species">Drosophila</named-content> revealed that eIF4E phosphorylation is required for normal development (<xref ref-type="bibr" rid="B251">251</xref>), studies in MNK1/2 double knockout (DKO) mice or mice in which wild-type eIF4E was replaced with a nonphosphorylatable mutant (S209A) develop normally (<xref ref-type="bibr" rid="B252">252</xref>, <xref ref-type="bibr" rid="B253">253</xref>). eIF4E phosphorylation, however, appears to be important in cancer (reviewed in reference <xref ref-type="bibr" rid="B254">254</xref>). The nonphosphorylatable eIF4E mutant is less effective in transforming cells than the wild-type protein, <italic>in vitro</italic> and <italic>in vivo</italic> (<xref ref-type="bibr" rid="B255">255</xref>, <xref ref-type="bibr" rid="B256">256</xref>). Similarly, mouse embryonic fibroblasts derived from MNK1/2 DKO animals were found to be resistant to Ras-mediated transformation (<xref ref-type="bibr" rid="B257">257</xref>), suggesting the importance of the MNK/eIF4E pathway in tumorigenesis.</p>
<p>MNKs are recruited to eIF4E via eIF4G (<xref ref-type="bibr" rid="B250">250</xref>), and thus, it is likely that eIF4E phosphorylation occurs during or after the eIF4F complex assembly. Ser209 is located near the cap-binding pocket of eIF4E, and its phosphorylation was initially predicted to stabilize eIF4E-cap interaction (<xref ref-type="bibr" rid="B258">258</xref>, <xref ref-type="bibr" rid="B259">259</xref>). Subsequent studies revealed, however, that eIF4E phosphorylation reduces its cap affinity (<xref ref-type="bibr" rid="B260">260</xref>, <xref ref-type="bibr" rid="B261">261</xref>), and depending on the experimental conditions, eIF4E phosphorylation was shown to correlate with increased (<xref ref-type="bibr" rid="B262">262</xref><xref ref-type="bibr" rid="B263">–</xref><xref ref-type="bibr" rid="B265">265</xref>) or decreased (<xref ref-type="bibr" rid="B266">266</xref><xref ref-type="bibr" rid="B267">–</xref><xref ref-type="bibr" rid="B268">268</xref>) global mRNA translation rates. Intriguingly, mRNAs which are sensitive to eIF4E level changes do not significantly overlap those whose translation is altered by changes in the eIF4E phosphorylation. Phosphorylated eIF4E appears to stimulate translation of mRNAs (e.g., <italic>SNAI1</italic>, <italic>MMP3</italic>, and <italic>VIM</italic>) encoding proteins involved in migration and metastasis and/or inflammation (cytokines) (<xref ref-type="bibr" rid="B252">252</xref>, <xref ref-type="bibr" rid="B269">269</xref>, <xref ref-type="bibr" rid="B270">270</xref>) (<xref ref-type="fig" rid="F2">Fig. 2</xref>). This suggests that unlike eIF4E overexpression, which stimulates tumor initiation, eIF4E phosphorylation facilitates tumor progression by increasing metastatic potential via selective upregulation of translation of mRNAs encoding proteins critical for remodeling of the extracellular matrix, epithelial-to-mesenchymal transition, and inflammation. Given the roles of MNKs in tumorigenesis and the fact they are dispensable for animal growth and development (<xref ref-type="bibr" rid="B271">271</xref>), recently identified MNK1/2 inhibitors (eFT508 and BAY 1143269) (<xref ref-type="table" rid="T1">Table 1</xref>) are currently being tested in phase I/II clinical trials in patients suffering from hematological malignancies or solid tumors (<xref ref-type="bibr" rid="B272">272</xref>).</p>
</sec>
<sec id="sec9-2">
<title>RSKs.</title>
<p>The RSK family comprises four highly similar members (RSK1, RSK2, RSK3, and RSK4) that are activated by Ras/MAPK signaling (reviewed in references <xref ref-type="bibr" rid="B241">241</xref> and <xref ref-type="bibr" rid="B273">273</xref>) (<xref ref-type="fig" rid="F3">Fig. 3</xref>). ERK1/2 interact with a D-type docking motif in the RSK C-terminal region (<xref ref-type="bibr" rid="B274">274</xref>) and promote the phosphorylation of several Ser/Thr residues present in all RSK isoforms. RSK proteins exist in all vertebrate species, and related orthologues have been identified in <named-content content-type="genus-species">Drosophila</named-content> and <named-content content-type="genus-species">Caenorhabditis elegans</named-content> but not in yeast. With the exception of RSK4, all RSK are ubiquitously expressed in developing and adult tissues (<xref ref-type="bibr" rid="B275">275</xref>). RSK1, RSK2, and RSK3 are usually present in the cytoplasm but translocate into the nucleus in response to stimulation (<xref ref-type="bibr" rid="B276">276</xref>, <xref ref-type="bibr" rid="B277">277</xref>). RSK4 does not significantly accumulate in the nucleus following stimulation of the Ras/MAPK pathway (<xref ref-type="bibr" rid="B278">278</xref>). An important feature of RSK is that it contains two distinct and functional kinase domains. The C-terminal kinase domain (CTKD), which belongs to the CAMK (Ca<sup>2+</sup>/calmodulin-dependent protein kinase), family is responsible for receiving an activating signal from ERK1/2 which is transmitted to the N-terminal kinase domain (NTKD) that phosphorylates substrates (<xref ref-type="bibr" rid="B279">279</xref>, <xref ref-type="bibr" rid="B280">280</xref>). The NTKD belongs to the AGC family of protein kinases and targets basic phosphorylation motifs (<xref ref-type="bibr" rid="B164">164</xref>), explaining why many RSK substrates are shared with AKT and S6Ks (<xref ref-type="bibr" rid="B273">273</xref>).</p>
<p>Over 30 years ago, RSK was identified as an rpS6 kinase in unfertilized <named-content content-type="genus-species">Xenopus laevis</named-content> eggs, which suggested that it may regulate translation (<xref ref-type="bibr" rid="B281">281</xref>). S6K1 and S6K2 were later shown to be the predominant rpS6 kinases in somatic cells (<xref ref-type="bibr" rid="B282">282</xref>, <xref ref-type="bibr" rid="B283">283</xref>). Subsequent studies using S6K1<sup>−/−</sup> S6K2<sup>−/−</sup> cells confirmed these findings but also showed residual rpS6 phosphorylation by RSK (<xref ref-type="bibr" rid="B122">122</xref>). Both RSK1 and RSK2 were found to specifically phosphorylate rpS6 on Ser235 and Ser236 (<xref ref-type="bibr" rid="B147">147</xref>). The functional role of rpS6 phosphorylation is largely unknown (<xref ref-type="bibr" rid="B148">148</xref>, <xref ref-type="bibr" rid="B284">284</xref>); however, these results suggest that RSK provides an mTOR/S6K-independent input linking MAPK signaling to the potential regulation of mRNA translation.</p>
<p>Ras/MAPK signaling impinges on the PI3K/mTOR pathway at various levels to regulate translation. In addition, RSK directly regulates components of the translation apparatus (<xref ref-type="table" rid="T2">Table 2</xref>), such as rpS6 (Ser235/236 in humans) (<xref ref-type="bibr" rid="B147">147</xref>), eIF4B (Ser422 in humans) (<xref ref-type="bibr" rid="B171">171</xref>), and eEF2K (Ser366 in humans) (<xref ref-type="bibr" rid="B150">150</xref>) (<xref ref-type="fig" rid="F3">Fig. 3</xref>). Phosphorylation of eIF4B promotes its interaction with eIF3, which correlates with increased translation rates (<xref ref-type="bibr" rid="B171">171</xref>, <xref ref-type="bibr" rid="B173">173</xref>). RSKs and S6Ks regulate eIF4B phosphorylation with different kinetics, which may explain the biphasic pattern of eIF4B phosphorylation observed in response to growth factors (<xref ref-type="bibr" rid="B171">171</xref>). RSKs stimulate PDCD4 phosphorylation and degradation (<xref ref-type="bibr" rid="B164">164</xref>) and phosphorylate eEF2K at Ser366 (<xref ref-type="bibr" rid="B150">150</xref>), which leads to its inhibition. As was shown with AKT and S6K (<xref ref-type="bibr" rid="B285">285</xref>), RSK-mediated phosphorylation and inhibition of GSK3β (on Ser9 in humans) (<xref ref-type="bibr" rid="B286">286</xref>) may activate eIF2B, a key regulator of protein synthesis (<xref ref-type="bibr" rid="B287">287</xref>). In collaboration with ERK1/2, RSKs was suggested to contribute to rRNA synthesis by phosphorylating TIF-1A (Ser633 and Ser649 in humans, respectively), but these sites do not appear to lie within RSK consensus phosphorylation sequences (<xref ref-type="bibr" rid="B288">288</xref>). Nonetheless, these phosphorylation events were shown to be dependent on the Ras/MAPK pathway. Together these data demonstrate that RSKs play a major role in the regulation of mRNA translation (<xref ref-type="fig" rid="F3">Fig. 3</xref>).</p>
</sec>
</sec>
<sec id="sec10">
<title>REGULATION OF TRANSLATIONAL MACHINERY BY PHOSPHATASES</title>
<p>In contrast to the extensive literature on the role of protein kinases in the regulation of translation, the role of protein phosphatases in protein synthesis remains largely underexplored. As described elsewhere (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>), serine/threonine phosphatase complexes containing PPP1R15 family member GADD34 or CReP, in conjunction with protein phosphatase 1C (PP1C), play a major role in regulation of eIF2α phosphorylation and thus ternary complex recycling (<xref ref-type="bibr" rid="B289">289</xref>, <xref ref-type="bibr" rid="B290">290</xref>). In addition, phosphatases other than lipid phosphatase PTEN have been shown to regulate mTOR signaling and thus mRNA translation. For instance, TORC1 inhibition in <named-content content-type="genus-species">S. cerevisiae</named-content> leads to dissociation of the serine/threonine phosphatase SIT4 from its inhibitor TAP42, which results in dephosphorylation and activation of the eIF2α kinase GCN2 (<xref ref-type="bibr" rid="B291">291</xref>). In mammals, inhibition of mTORC1 activates the SIT4 orthologue PP6C, which stimulates GCN2 and induces eIF2α phosphorylation (<xref ref-type="bibr" rid="B292">292</xref>).</p>
<p>A number of serine/threonine phosphatases have also been proposed to act upstream of mTOR. For example, protein phosphatase 2A (PP2A) inactivates AKT by dephosphorylating its active site (Thr308 in humans) (<xref ref-type="bibr" rid="B293">293</xref>). In turn, the PH domain leucine-rich repeat protein phosphatases (PHLPP1 and PHLPP2) dephosphorylate AKT on its hydrophobic motif (Ser473 in humans) (<xref ref-type="bibr" rid="B294">294</xref>), whereby the loss of PHLPP activity, which appears to frequently occur in cancer, results in AKT hyperphosphorylation (<xref ref-type="bibr" rid="B295">295</xref>). Mechanisms whereby phosphatases act downstream of mTOR have also been proposed. It was suggested that mTOR controls phosphorylation of S6Ks and 4E-BPs by suppressing their dephosphorylation by PP2A. PP2A was shown to associate with S6Ks and be activated by rapamycin (<xref ref-type="bibr" rid="B296">296</xref>). It also appears that 4E-BP1 may be dephosphorylated by the serine/threonine phosphatase PPM1G, which in glioblastoma cell lines leads to translational upregulation of the helix-loop-helix transcriptional modulator Id1 (<xref ref-type="bibr" rid="B297">297</xref>, <xref ref-type="bibr" rid="B298">298</xref>). Moreover, attachment of lung fibroblasts to the collagen matrix has been reported to activate the β1 integrin/Src/PP2A axis, leading to 4E-BP1 degradation and increased cap-dependent translation (<xref ref-type="bibr" rid="B299">299</xref>). In contrast, PP2A-dependent dephosphorylation of 4E-BP1 has been proposed to underpin PKCα-mediated suppression of cap-dependent translation and proliferation of intestinal epithelial cells (<xref ref-type="bibr" rid="B300">300</xref>). Finally, inhibition of protein synthesis by 2-deoxyglucose (2-DG), which acts as a potent inhibitor of glycolysis, is thought to be at least in part mediated by dephosphorylation of 4E-BP1 by PP1/PP2A and PPM1 phosphatases (<xref ref-type="bibr" rid="B297">297</xref>, <xref ref-type="bibr" rid="B301">301</xref>).</p>
<p>In addition to 4E-BPs and S6Ks, other downstream effectors of mTORC1 implicated in regulation of protein synthesis have been shown to be controlled by phosphatases. For example, insulin regulates eEF2 dephosphorylation via PP2A (<xref ref-type="bibr" rid="B302">302</xref>). Phosphatases are also thought to regulate eIF4E phosphorylation levels. PP2A, for example, has been shown to decrease eIF4E phosphorylation at Ser209, which occurs both directly and indirectly via suppression of MNKs. Decreased phosphorylation subsequently impedes assembly of the eIF4F complex (<xref ref-type="bibr" rid="B303">303</xref>). In turn, it has been suggested that translation of immunoglobulin-binding protein 1 (Igbp1), which is a regulatory subunit of PP2A, is eIF4E sensitive (<xref ref-type="bibr" rid="B304">304</xref>). Finally, ribosomal proteins, including rpL5 and rpS6, have also been shown to be targeted by PP1 (<xref ref-type="bibr" rid="B305">305</xref>, <xref ref-type="bibr" rid="B306">306</xref>). Collectively, these findings strongly suggest an important role for phosphatases in the regulation of translation, but future studies are required to establish the precise molecular mechanisms underpinning the action of phosphatases toward the translational apparatus, as well as the biological significance of these phenomena.</p>
</sec>
<sec id="sec11">
<title>CONCLUDING REMARKS</title>
<p>While significant progress has been made toward understanding how signaling pathways, such as PI3K/mTOR and Ras/MAPK, regulate the phosphorylation of components of the translation apparatus, very little is known about how these events regulate mRNA translation or the translatome. This is particularly important, as these signaling pathways are comprised of several oncogenes and tumor suppressors, which are often dysregulated in cancer (<xref ref-type="bibr" rid="B58">58</xref>). Notwithstanding the relatively comprehensive understanding of mTOR signaling to the translational apparatus (<xref ref-type="bibr" rid="B221">221</xref>, <xref ref-type="bibr" rid="B307">307</xref>), outstanding questions regarding the mechanisms of selective modulation of the translatome by mTOR still remain (<xref ref-type="bibr" rid="B112">112</xref>). Perhaps the biggest riddle of all is the TOP mRNAs, whose regulation remains poorly understood despite decades of work since their discovery as rapamycin-sensitive transcripts (<xref ref-type="bibr" rid="B308">308</xref>). Notwithstanding the large body of work surrounding the regulation of mRNAs with structured 5′UTRs or with extremely short 5′UTRs (reviewed in reference <xref ref-type="bibr" rid="B221">221</xref>), several questions remain about the mechanisms by which mTOR regulates their translation. Recent efforts to catalogue mTOR-sensitive transcripts using ribosome or polysome profiling resulted in conflicting results that are likely explained by analytical and technical biases (<xref ref-type="bibr" rid="B222">222</xref>). Moreover, the lack of reliable UTR databases reduces the accuracy of experimental findings. Future efforts will have to consider all these points to improve study design and data analysis. Recent advances in pharmacological tools (e.g., compounds that specifically inhibit mTOR or eIF4F components), genetic tools (e.g., clustered regularly interspaced short palindromic repeat [CRISPR]/Cas9-based genome manipulations), and technologies that enable genome-wide monitoring of changes in the translatome (e.g., ribosome profiling/transcriptome sequencing [RNA-seq]) or the proteome (e.g., quantitative mass spectrometry) will undoubtedly help decipher the role of signaling pathways in translation regulation as it relates to homeostasis and disease.</p>
<p>While mTOR and MAPK pathways, as well as eIF2α kinases, play pivotal roles in the regulation of protein synthesis, several additional signaling pathways have been implicated in the phosphorylation of components of the translational machinery and auxiliary factors (e.g., PAK2, GSK3, Cdk11, CK1, PKC, and CK2) (<xref ref-type="bibr" rid="B126">126</xref>, <xref ref-type="bibr" rid="B127">127</xref>, <xref ref-type="bibr" rid="B232">232</xref>, <xref ref-type="bibr" rid="B309">309</xref><xref ref-type="bibr" rid="B310">–</xref><xref ref-type="bibr" rid="B311">311</xref>). Notwithstanding the fact that these protein kinases specifically regulate components of the translation machinery, their physiological role in translational control remains obscure. Together with the differential expression of ribosomal proteins and rRNA, these phosphorylation events may participate in the generation of specialized ribosomes, which would have a substantial impact on how mRNAs are translated into functional proteins (reviewed in reference <xref ref-type="bibr" rid="B312">312</xref>). Related to this is the recent demonstration that rpS6 phosphorylation has a broad influence on the transcription of genes involved in the ribosome biogenesis (RiBi) program (<xref ref-type="bibr" rid="B149">149</xref>), suggesting that posttranslational modification of a ribosomal protein may facilitate the synthesis of RiBi factors. While many questions remain, the next few years are anticipated to bring new and exciting discoveries on the role of signaling pathways in global and specific mRNA translation. These results are likely to improve understanding of the etiopathology of many human disorders and diseases that are linked to defective translational control, such as cancer (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B206">206</xref>), neurological disorders (<xref ref-type="bibr" rid="B313">313</xref>, <xref ref-type="bibr" rid="B314">314</xref>), and aging (<xref ref-type="bibr" rid="B315">315</xref>, <xref ref-type="bibr" rid="B316">316</xref>).</p>
</sec>
</body>
<back>
<ack>
<title>ACKNOWLEDGMENTS</title>
<p>We apologize to those authors whose work was not cited due to space constraints. We thank Oded Meyuhas for invaluable suggestions and comments, as well as Frédérick A. Mallette, Diane C. Fingar, Lynne-Marie Postovit, Leos Shivaya Valasek, and members of the Roux and Topisirovic labs for critical reading of the manuscript.</p>
<p>P.P.R. and I.T. are scholars of the Fonds de Recherche du Québec-Santé (FRQS). Research in the laboratory of I.T. is funded in part by grants from Prostate Cancer Canada, the Cancer Research Society, the Canadian Cancer Society Research Institute, the Canadian Institutes of Health Research, the Terry Fox Research Institute, the National Institutes of Health, and the Joint Canada-Israel Health Research Program. Research in the laboratory of P.P.R. is supported by grants from the Canadian Institutes of Health Research, the Canadian Cancer Society Research Institute, the Natural Sciences and Engineering Research Council of Canada (NSERC), and the Human Frontier Science Program (HFSP).</p>
</ack>
<ref-list>
<title>REFERENCES</title>
<ref id="B1">
<label>1.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghazalpour</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bennett</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Petyuk</surname><given-names>VA</given-names></name>, <name name-style="western"><surname>Orozco</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Hagopian</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Mungrue</surname><given-names>IN</given-names></name>, <name name-style="western"><surname>Farber</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Sinsheimer</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Furlotte</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Wen</surname><given-names>PZ</given-names></name>, <name name-style="western"><surname>Brewer</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Weitz</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Camp</surname><given-names>DG</given-names><suffix>II</suffix></name>, <name name-style="western"><surname>Pan</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Yordanova</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Neuhaus</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Tilford</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Siemers</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Gargalovic</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Eskin</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Kirchgessner</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Lusis</surname><given-names>AJ</given-names></name></person-group>
<year>2011</year>
<article-title>Comparative analysis of proteome and transcriptome variation in mouse</article-title>. <source/>PLoS Genet
<volume>7</volume>:<fpage>e1001393</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pgen.1001393</pub-id>.<pub-id pub-id-type="pmid">21695224</pub-id></mixed-citation>
</ref>
<ref id="B2">
<label>2.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vogel</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Abreu Rde</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ko</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Le</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Shapiro</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Burns</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Sandhu</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Boutz</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Marcotte</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Penalva</surname><given-names>LO</given-names></name></person-group>
<year>2010</year>
<article-title>Sequence signatures and mRNA concentration can explain two-thirds of protein abundance variation in a human cell line</article-title>. <source/>Mol Syst Biol
<volume>6</volume>:<fpage>400</fpage>. doi:<pub-id pub-id-type="doi">10.1038/msb.2010.59</pub-id>.<pub-id pub-id-type="pmid">20739923</pub-id></mixed-citation>
</ref>
<ref id="B3">
<label>3.</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Mathews</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Hershey</surname><given-names>JWB</given-names></name> (ed)</person-group>
<year>2007</year>
<source/>Translational control in biology and medicine, <edition>3rd ed.</edition>
<publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>, <publisher-loc>Cold Spring Harbor, NY</publisher-loc>.</mixed-citation>
</ref>
<ref id="B4">
<label>4.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Hinnebusch</surname><given-names>AG</given-names></name></person-group>
<year>2009</year>
<article-title>Regulation of translation initiation in eukaryotes: mechanisms and biological targets</article-title>. <source/>Cell
<volume>136</volume>:<fpage>731</fpage>–<lpage>745</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2009.01.042</pub-id>.<pub-id pub-id-type="pmid">19239892</pub-id></mixed-citation>
</ref>
<ref id="B5">
<label>5.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buttgereit</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Brand</surname><given-names>MD</given-names></name></person-group>
<year>1995</year>
<article-title>A hierarchy of ATP-consuming processes in mammalian cells</article-title>. <source/>Biochem J
<volume>312</volume>:<fpage>163</fpage>–<lpage>167</lpage>. doi:<pub-id pub-id-type="doi">10.1042/bj3120163</pub-id>.<pub-id pub-id-type="pmid">7492307</pub-id></mixed-citation>
</ref>
<ref id="B6">
<label>6.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rolfe</surname><given-names>DF</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>GC</given-names></name></person-group>
<year>1997</year>
<article-title>Cellular energy utilization and molecular origin of standard metabolic rate in mammals</article-title>. <source/>Physiol Rev
<volume>77</volume>:<fpage>731</fpage>–<lpage>758</lpage>. doi:<pub-id pub-id-type="doi">10.1152/physrev.1997.77.3.731</pub-id>.<pub-id pub-id-type="pmid">9234964</pub-id></mixed-citation>
</ref>
<ref id="B7">
<label>7.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>XM</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name></person-group>
<year>2009</year>
<article-title>Molecular mechanisms of mTOR-mediated translational control</article-title>. <source/>Nat Rev Mol Cell Biol
<volume>10</volume>:<fpage>307</fpage>–<lpage>318</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrm2672</pub-id>.<pub-id pub-id-type="pmid">19339977</pub-id></mixed-citation>
</ref>
<ref id="B8">
<label>8.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wek</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>HY</given-names></name>, <name name-style="western"><surname>Anthony</surname><given-names>TG</given-names></name></person-group>
<year>2006</year>
<article-title>Coping with stress: eIF2 kinases and translational control</article-title>. <source/>Biochem Soc Trans
<volume>34</volume>:<fpage>7</fpage>–<lpage>11</lpage>. doi:<pub-id pub-id-type="doi">10.1042/BST0340007</pub-id>.<pub-id pub-id-type="pmid">16246168</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hinnebusch</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Ivanov</surname><given-names>IP</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>
<year>2016</year>
<article-title>Translational control by 5′-untranslated regions of eukaryotic mRNAs</article-title>. <source/>Science
<volume>352</volume>:<fpage>1413</fpage>–<lpage>1416</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.aad9868</pub-id>.<pub-id pub-id-type="pmid">27313038</pub-id></mixed-citation>
</ref>
<ref id="B10">
<label>10.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koromilas</surname><given-names>AE</given-names></name></person-group>
<year>2015</year>
<article-title>Roles of the translation initiation factor eIF2alpha serine 51 phosphorylation in cancer formation and treatment</article-title>. <source/>Biochim Biophys Acta
<volume>1849</volume>:<fpage>871</fpage>–<lpage>880</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbagrm.2014.12.007</pub-id>.<pub-id pub-id-type="pmid">25497381</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saxton</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Sabatini</surname><given-names>DM</given-names></name></person-group>
<year>2017</year>
<article-title>mTOR signaling in growth, metabolism, and disease</article-title>. <source/>Cell
<volume>168</volume>:<fpage>960</fpage>–<lpage>976</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2017.02.004</pub-id>.<pub-id pub-id-type="pmid">28283069</pub-id></mixed-citation>
</ref>
<ref id="B12">
<label>12.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hinnebusch</surname><given-names>AG</given-names></name></person-group>
<year>2014</year>
<article-title>The scanning mechanism of eukaryotic translation initiation</article-title>. <source/>Annu Rev Biochem
<volume>83</volume>:<fpage>779</fpage>–<lpage>812</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev-biochem-060713-035802</pub-id>.<pub-id pub-id-type="pmid">24499181</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guertin</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Sabatini</surname><given-names>DM</given-names></name></person-group>
<year>2007</year>
<article-title>Defining the role of mTOR in cancer</article-title>. <source/>Cancer Cell
<volume>12</volume>:<fpage>9</fpage>–<lpage>22</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ccr.2007.05.008</pub-id>.<pub-id pub-id-type="pmid">17613433</pub-id></mixed-citation>
</ref>
<ref id="B14">
<label>14.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peterson</surname><given-names>TR</given-names></name>, <name name-style="western"><surname>Laplante</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Thoreen</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Sancak</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Kuehl</surname><given-names>WM</given-names></name>, <name name-style="western"><surname>Gray</surname><given-names>NS</given-names></name>, <name name-style="western"><surname>Sabatini</surname><given-names>DM</given-names></name></person-group>
<year>2009</year>
<article-title>DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival</article-title>. <source/>Cell
<volume>137</volume>:<fpage>873</fpage>–<lpage>886</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2009.03.046</pub-id>.<pub-id pub-id-type="pmid">19446321</pub-id></mixed-citation>
</ref>
<ref id="B15">
<label>15.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frias</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Thoreen</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Jaffe</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Schroder</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Sculley</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Carr</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Sabatini</surname><given-names>DM</given-names></name></person-group>
<year>2006</year>
<article-title>mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s</article-title>. <source/>Curr Biol
<volume>16</volume>:<fpage>1865</fpage>–<lpage>1870</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cub.2006.08.001</pub-id>.<pub-id pub-id-type="pmid">16919458</pub-id></mixed-citation>
</ref>
<ref id="B16">
<label>16.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jacinto</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Facchinetti</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Soto</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Jung</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Qin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Su</surname><given-names>B</given-names></name></person-group>
<year>2006</year>
<article-title>SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity</article-title>. <source/>Cell
<volume>127</volume>:<fpage>125</fpage>–<lpage>137</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2006.08.033</pub-id>.<pub-id pub-id-type="pmid">16962653</pub-id></mixed-citation>
</ref>
<ref id="B17">
<label>17.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pearce</surname><given-names>LR</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Boudeau</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Pawlowski</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Wullschleger</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Deak</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ibrahim</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Gourlay</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Magnuson</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Alessi</surname><given-names>DR</given-names></name></person-group>
<year>2007</year>
<article-title>Identification of Protor as a novel Rictor-binding component of mTOR complex-2</article-title>. <source/>Biochem J
<volume>405</volume>:<fpage>513</fpage>–<lpage>522</lpage>. doi:<pub-id pub-id-type="doi">10.1042/BJ20070540</pub-id>.<pub-id pub-id-type="pmid">17461779</pub-id></mixed-citation>
</ref>
<ref id="B18">
<label>18.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thedieck</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Polak</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Molle</surname><given-names>KD</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Jeno</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Arrieumerlou</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>MN</given-names></name></person-group>
<year>2007</year>
<article-title>PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis</article-title>. <source/>PLoS One
<volume>2</volume>:<elocation-id>e1217</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0001217</pub-id>.<pub-id pub-id-type="pmid">18030348</pub-id></mixed-citation>
</ref>
<ref id="B19">
<label>19.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Woo</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>DH</given-names></name>, <name name-style="western"><surname>Jun</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>YM</given-names></name>, <name name-style="western"><surname>Haar</surname><given-names>EV</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>SI</given-names></name>, <name name-style="western"><surname>Hegg</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Bandhakavi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Griffin</surname><given-names>TJ</given-names></name></person-group>
<year>2007</year>
<article-title>PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling</article-title>. <source/>J Biol Chem
<volume>282</volume>:<fpage>25604</fpage>–<lpage>25612</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M704343200</pub-id>.<pub-id pub-id-type="pmid">17599906</pub-id></mixed-citation>
</ref>
<ref id="B20">
<label>20.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caron</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Ghosh</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Matsuoka</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ashton-Beaucage</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Therrien</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lemieux</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Perreault</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Roux</surname><given-names>PP</given-names></name>, <name name-style="western"><surname>Kitano</surname><given-names>H</given-names></name></person-group>
<year>2010</year>
<article-title>A comprehensive map of the mTOR signaling network</article-title>. <source/>Mol Syst Biol
<volume>6</volume>:<fpage>453</fpage>. doi:<pub-id pub-id-type="doi">10.1038/msb.2010.108</pub-id>.<pub-id pub-id-type="pmid">21179025</pub-id></mixed-citation>
</ref>
<ref id="B21">
<label>21.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yea</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Fruman</surname><given-names>DA</given-names></name></person-group>
<year>2011</year>
<article-title>Cell signaling. New mTOR targets Grb attention</article-title>. <source/>Science
<volume>332</volume>:<fpage>1270</fpage>–<lpage>1271</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1208071</pub-id>.<pub-id pub-id-type="pmid">21659593</pub-id></mixed-citation>
</ref>
<ref id="B22">
<label>22.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zoncu</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Efeyan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sabatini</surname><given-names>DM</given-names></name></person-group>
<year>2011</year>
<article-title>mTOR: from growth signal integration to cancer, diabetes and ageing</article-title>. <source/>Nat Rev Mol Cell Biol
<volume>12</volume>:<fpage>21</fpage>–<lpage>35</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrm3025</pub-id>.<pub-id pub-id-type="pmid">21157483</pub-id></mixed-citation>
</ref>
<ref id="B23">
<label>23.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hong</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Freeberg</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kamath</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Yao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Fukuda</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Inoki</surname><given-names>K</given-names></name></person-group>
<year>2017</year>
<article-title>LARP1 functions as a molecular switch for mTORC1-mediated translation of an essential class of mRNAs</article-title>. <source/>Elife
<volume>6</volume>:<elocation-id>e25237</elocation-id>. doi:<pub-id pub-id-type="doi">10.7554/eLife.25237</pub-id>.<pub-id pub-id-type="pmid">28650797</pub-id></mixed-citation>
</ref>
<ref id="B24">
<label>24.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kang</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Pacold</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Cervantes</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Lou</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Ottina</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Gray</surname><given-names>NS</given-names></name>, <name name-style="western"><surname>Turk</surname><given-names>BE</given-names></name>, <name name-style="western"><surname>Yaffe</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Sabatini</surname><given-names>DM</given-names></name></person-group>
<year>2013</year>
<article-title>mTORC1 phosphorylation sites encode their sensitivity to starvation and rapamycin</article-title>. <source/>Science
<volume>341</volume>:<fpage>1236566</fpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1236566</pub-id>.<pub-id pub-id-type="pmid">23888043</pub-id></mixed-citation>
</ref>
<ref id="B25">
<label>25.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tcherkezian</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cargnello</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Romeo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Huttlin</surname><given-names>EL</given-names></name>, <name name-style="western"><surname>Lavoie</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Gygi</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Roux</surname><given-names>PP</given-names></name></person-group>
<year>2014</year>
<article-title>Proteomic analysis of cap-dependent translation identifies LARP1 as a key regulator of 5′TOP mRNA translation</article-title>. <source/>Genes Dev
<volume>28</volume>:<fpage>357</fpage>–<lpage>371</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gad.231407.113</pub-id>.<pub-id pub-id-type="pmid">24532714</pub-id></mixed-citation>
</ref>
<ref id="B26">
<label>26.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oh</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Facchinetti</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Julien</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Finlan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Roux</surname><given-names>PP</given-names></name>, <name name-style="western"><surname>Su</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Jacinto</surname><given-names>E</given-names></name></person-group>
<year>2010</year>
<article-title>mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide</article-title>. <source/>EMBO J
<volume>29</volume>:<fpage>3939</fpage>–<lpage>3951</lpage>. doi:<pub-id pub-id-type="doi">10.1038/emboj.2010.271</pub-id>.<pub-id pub-id-type="pmid">21045808</pub-id></mixed-citation>
</ref>
<ref id="B27">
<label>27.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zinzalla</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Stracka</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Oppliger</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>MN</given-names></name></person-group>
<year>2011</year>
<article-title>Activation of mTORC2 by association with the ribosome</article-title>. <source/>Cell
<volume>144</volume>:<fpage>757</fpage>–<lpage>768</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2011.02.014</pub-id>.<pub-id pub-id-type="pmid">21376236</pub-id></mixed-citation>
</ref>
<ref id="B28">
<label>28.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guertin</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Sabatini</surname><given-names>DM</given-names></name></person-group>
<year>2009</year>
<article-title>The pharmacology of mTOR inhibition</article-title>. <source/>Sci Signal
<volume>2</volume>:<fpage>pe24</fpage>. doi:<pub-id pub-id-type="doi">10.1126/scisignal.267pe24</pub-id>.<pub-id pub-id-type="pmid">19383975</pub-id></mixed-citation>
</ref>
<ref id="B29">
<label>29.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hay</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>
<year>2004</year>
<article-title>Upstream and downstream of mTOR</article-title>. <source/>Genes Dev
<volume>18</volume>:<fpage>1926</fpage>–<lpage>1945</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gad.1212704</pub-id>.<pub-id pub-id-type="pmid">15314020</pub-id></mixed-citation>
</ref>
<ref id="B30">
<label>30.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petroulakis</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Mamane</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Le Bacquer</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Shahbazian</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>
<year>2006</year>
<article-title>mTOR signaling: implications for cancer and anticancer therapy</article-title>. <source/>Br J Cancer
<volume>94</volume>:<fpage>195</fpage>–<lpage>199</lpage>. doi:<pub-id pub-id-type="doi">10.1038/sj.bjc.6602902</pub-id>.<pub-id pub-id-type="pmid">16404421</pub-id></mixed-citation>
</ref>
<ref id="B31">
<label>31.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>XF</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Schreiber</surname><given-names>SL</given-names></name></person-group>
<year>1995</year>
<article-title>Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>92</volume>:<fpage>4947</fpage>–<lpage>4951</lpage>.<pub-id pub-id-type="pmid">7539137</pub-id></mixed-citation>
</ref>
<ref id="B32">
<label>32.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choo</surname><given-names>AY</given-names></name>, <name name-style="western"><surname>Yoon</surname><given-names>SO</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Roux</surname><given-names>PP</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name></person-group>
<year>2008</year>
<article-title>Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>105</volume>:<fpage>17414</fpage>–<lpage>17419</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0809136105</pub-id>.<pub-id pub-id-type="pmid">18955708</pub-id></mixed-citation>
</ref>
<ref id="B33">
<label>33.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoon</surname><given-names>SO</given-names></name>, <name name-style="western"><surname>Roux</surname><given-names>PP</given-names></name></person-group>
<year>2013</year>
<article-title>Rapamycin resistance: mTORC1 substrates hold some of the answers</article-title>. <source/>Curr Biol
<volume>23</volume>:<fpage>R880</fpage>–<lpage>R883</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cub.2013.08.030</pub-id>.<pub-id pub-id-type="pmid">24112984</pub-id></mixed-citation>
</ref>
<ref id="B34">
<label>34.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bhat</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Robichaud</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Hulea</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Pelletier</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Topisirovic</surname><given-names>I</given-names></name></person-group>
<year>2015</year>
<article-title>Targeting the translation machinery in cancer</article-title>. <source/>Nat Rev Drug Discov
<volume>14</volume>:<fpage>261</fpage>–<lpage>278</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrd4505</pub-id>.<pub-id pub-id-type="pmid">25743081</pub-id></mixed-citation>
</ref>
<ref id="B35">
<label>35.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodrik-Outmezguine</surname><given-names>VS</given-names></name>, <name name-style="western"><surname>Okaniwa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yao</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Novotny</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>McWhirter</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Banaji</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Won</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Berger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>de Stanchina</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Barratt</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Cosulich</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Klinowska</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Rosen</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Shokat</surname><given-names>KM</given-names></name></person-group>
<year>2016</year>
<article-title>Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor</article-title>. <source/>Nature
<volume>534</volume>:<fpage>272</fpage>–<lpage>276</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature17963</pub-id>.<pub-id pub-id-type="pmid">27279227</pub-id></mixed-citation>
</ref>
<ref id="B36">
<label>36.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fan</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Aksoy</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Ilkhanizadeh</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Novotny</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Gustafson</surname><given-names>WC</given-names></name>, <name name-style="western"><surname>Truong</surname><given-names>AY</given-names></name>, <name name-style="western"><surname>Cayanan</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Simonds</surname><given-names>EF</given-names></name>, <name name-style="western"><surname>Haas-Kogan</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Phillips</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Nicolaides</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Okaniwa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Shokat</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Weiss</surname><given-names>WA</given-names></name></person-group>
<year>2017</year>
<article-title>A kinase inhibitor targeted to mTORC1 drives regression in glioblastoma</article-title>. <source/>Cancer Cell
<volume>31</volume>:<fpage>424</fpage>–<lpage>435</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ccell.2017.01.014</pub-id>.<pub-id pub-id-type="pmid">28292440</pub-id></mixed-citation>
</ref>
<ref id="B37">
<label>37.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fruman</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Chiu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hopkins</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Bagrodia</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cantley</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Abraham</surname><given-names>RT</given-names></name></person-group>
<year>2017</year>
<article-title>The PI3K pathway in human disease</article-title>. <source/>Cell
<volume>170</volume>:<fpage>605</fpage>–<lpage>635</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2017.07.029</pub-id>.<pub-id pub-id-type="pmid">28802037</pub-id></mixed-citation>
</ref>
<ref id="B38">
<label>38.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maehama</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Dixon</surname><given-names>JE</given-names></name></person-group>
<year>1998</year>
<article-title>The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate</article-title>. <source/>J Biol Chem
<volume>273</volume>:<fpage>13375</fpage>–<lpage>13378</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.273.22.13375</pub-id>.<pub-id pub-id-type="pmid">9593664</pub-id></mixed-citation>
</ref>
<ref id="B39">
<label>39.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pearce</surname><given-names>LR</given-names></name>, <name name-style="western"><surname>Komander</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Alessi</surname><given-names>DR</given-names></name></person-group>
<year>2010</year>
<article-title>The nuts and bolts of AGC protein kinases</article-title>. <source/>Nat Rev Mol Cell Biol
<volume>11</volume>:<fpage>9</fpage>–<lpage>22</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrm2822</pub-id>.<pub-id pub-id-type="pmid">20027184</pub-id></mixed-citation>
</ref>
<ref id="B40">
<label>40.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sarbassov</surname><given-names>DD</given-names></name>, <name name-style="western"><surname>Guertin</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Ali</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Sabatini</surname><given-names>DM</given-names></name></person-group>
<year>2005</year>
<article-title>Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex</article-title>. <source/>Science
<volume>307</volume>:<fpage>1098</fpage>–<lpage>1101</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1106148</pub-id>.<pub-id pub-id-type="pmid">15718470</pub-id></mixed-citation>
</ref>
<ref id="B41">
<label>41.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guertin</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Stevens</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Thoreen</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Burds</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Kalaany</surname><given-names>NY</given-names></name>, <name name-style="western"><surname>Moffat</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fitzgerald</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Sabatini</surname><given-names>DM</given-names></name></person-group>
<year>2006</year>
<article-title>Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1</article-title>. <source/>Dev Cell
<volume>11</volume>:<fpage>859</fpage>–<lpage>871</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.devcel.2006.10.007</pub-id>.<pub-id pub-id-type="pmid">17141160</pub-id></mixed-citation>
</ref>
<ref id="B42">
<label>42.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kwiatkowski</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Manning</surname><given-names>BD</given-names></name></person-group>
<year>2005</year>
<article-title>Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways</article-title>. <source/>Hum Mol Genet
<volume>14</volume><comment>(Spec No 2)</comment>:<fpage>R251</fpage>–<lpage>R258</lpage>. doi:<pub-id pub-id-type="doi">10.1093/hmg/ddi260</pub-id>.<pub-id pub-id-type="pmid">16244323</pub-id></mixed-citation>
</ref>
<ref id="B43">
<label>43.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Inoki</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Guan</surname><given-names>KL</given-names></name></person-group>
<year>2003</year>
<article-title>Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling</article-title>. <source/>Genes Dev
<volume>17</volume>:<fpage>1829</fpage>–<lpage>1834</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gad.1110003</pub-id>.<pub-id pub-id-type="pmid">12869586</pub-id></mixed-citation>
</ref>
<ref id="B44">
<label>44.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tee</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Manning</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Roux</surname><given-names>PP</given-names></name>, <name name-style="western"><surname>Cantley</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name></person-group>
<year>2003</year>
<article-title>Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb</article-title>. <source/>Curr Biol
<volume>13</volume>:<fpage>1259</fpage>–<lpage>1268</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0960-9822(03)00506-2</pub-id>.<pub-id pub-id-type="pmid">12906785</pub-id></mixed-citation>
</ref>
<ref id="B45">
<label>45.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dibble</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Elis</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Menon</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Qin</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Klekota</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Asara</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Finan</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Kwiatkowski</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>LO</given-names></name>, <name name-style="western"><surname>Manning</surname><given-names>BD</given-names></name></person-group>
<year>2012</year>
<article-title>TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1</article-title>. <source/>Mol Cell
<volume>47</volume>:<fpage>535</fpage>–<lpage>546</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molcel.2012.06.009</pub-id>.<pub-id pub-id-type="pmid">22795129</pub-id></mixed-citation>
</ref>
<ref id="B46">
<label>46.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamagata</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Sanders</surname><given-names>LK</given-names></name>, <name name-style="western"><surname>Kaufmann</surname><given-names>WE</given-names></name>, <name name-style="western"><surname>Yee</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Barnes</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Nathans</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Worley</surname><given-names>PF</given-names></name></person-group>
<year>1994</year>
<article-title>rheb, a growth factor- and synaptic activity-regulated gene, encodes a novel Ras-related protein</article-title>. <source/>J Biol Chem
<volume>269</volume>:<fpage>16333</fpage>–<lpage>16339</lpage>.<pub-id pub-id-type="pmid">8206940</pub-id></mixed-citation>
</ref>
<ref id="B47">
<label>47.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dhar</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pavletich</surname><given-names>NP</given-names></name></person-group>
<year>2017</year>
<article-title>Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40</article-title>. <source/>Nature
<volume>552</volume>:<fpage>368</fpage>–<lpage>373</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature25023</pub-id>.<pub-id pub-id-type="pmid">29236692</pub-id></mixed-citation>
</ref>
<ref id="B48">
<label>48.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garami</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Zwartkruis</surname><given-names>FJ</given-names></name>, <name name-style="western"><surname>Nobukuni</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Joaquin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Roccio</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Stocker</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kozma</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Hafen</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Bos</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>G</given-names></name></person-group>
<year>2003</year>
<article-title>Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2</article-title>. <source/>Mol Cell
<volume>11</volume>:<fpage>1457</fpage>–<lpage>1466</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1097-2765(03)00220-X</pub-id>.<pub-id pub-id-type="pmid">12820960</pub-id></mixed-citation>
</ref>
<ref id="B49">
<label>49.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manning</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Tee</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Logsdon</surname><given-names>MN</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cantley</surname><given-names>LC</given-names></name></person-group>
<year>2002</year>
<article-title>Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway</article-title>. <source/>Mol Cell
<volume>10</volume>:<fpage>151</fpage>–<lpage>162</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1097-2765(02)00568-3</pub-id>.<pub-id pub-id-type="pmid">12150915</pub-id></mixed-citation>
</ref>
<ref id="B50">
<label>50.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Menon</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Dibble</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Talbott</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Hoxhaj</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Valvezan</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Takahashi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Cantley</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Manning</surname><given-names>BD</given-names></name></person-group>
<year>2014</year>
<article-title>Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome</article-title>. <source/>Cell
<volume>156</volume>:<fpage>771</fpage>–<lpage>785</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2013.11.049</pub-id>.<pub-id pub-id-type="pmid">24529379</pub-id></mixed-citation>
</ref>
<ref id="B51">
<label>51.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fonseca</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>VH</given-names></name>, <name name-style="western"><surname>MacKintosh</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Proud</surname><given-names>CG</given-names></name></person-group>
<year>2007</year>
<article-title>PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signaling downstream of this complex</article-title>. <source/>J Biol Chem
<volume>282</volume>:<fpage>24514</fpage>–<lpage>24524</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M704406200</pub-id>.<pub-id pub-id-type="pmid">17604271</pub-id></mixed-citation>
</ref>
<ref id="B52">
<label>52.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oshiro</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Takahashi</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Yoshino</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tanimura</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Nakashima</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Eguchi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Miyamoto</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Hara</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Takehana</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Avruch</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kikkawa</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Yonezawa</surname><given-names>K</given-names></name></person-group>
<year>2007</year>
<article-title>The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1</article-title>. <source/>J Biol Chem
<volume>282</volume>:<fpage>20329</fpage>–<lpage>20339</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M702636200</pub-id>.<pub-id pub-id-type="pmid">17517883</pub-id></mixed-citation>
</ref>
<ref id="B53">
<label>53.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sancak</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Thoreen</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Peterson</surname><given-names>TR</given-names></name>, <name name-style="western"><surname>Lindquist</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Spooner</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Carr</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Sabatini</surname><given-names>DM</given-names></name></person-group>
<year>2007</year>
<article-title>PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase</article-title>. <source/>Mol Cell
<volume>25</volume>:<fpage>903</fpage>–<lpage>915</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molcel.2007.03.003</pub-id>.<pub-id pub-id-type="pmid">17386266</pub-id></mixed-citation>
</ref>
<ref id="B54">
<label>54.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vander Haar</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>SI</given-names></name>, <name name-style="western"><surname>Bandhakavi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Griffin</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>DH</given-names></name></person-group>
<year>2007</year>
<article-title>Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40</article-title>. <source/>Nat Cell Biol
<volume>9</volume>:<fpage>316</fpage>–<lpage>323</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ncb1547</pub-id>.<pub-id pub-id-type="pmid">17277771</pub-id></mixed-citation>
</ref>
<ref id="B55">
<label>55.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>TE</given-names></name>, <name name-style="western"><surname>Roth</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Lawrence</surname><given-names>JC</given-names><suffix>Jr</suffix></name></person-group>
<year>2007</year>
<article-title>PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding</article-title>. <source/>J Biol Chem
<volume>282</volume>:<fpage>20036</fpage>–<lpage>20044</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M702376200</pub-id>.<pub-id pub-id-type="pmid">17510057</pub-id></mixed-citation>
</ref>
<ref id="B56">
<label>56.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schalm</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name></person-group>
<year>2002</year>
<article-title>Identification of a conserved motif required for mTOR signaling</article-title>. <source/>Curr Biol
<volume>12</volume>:<fpage>632</fpage>–<lpage>639</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0960-9822(02)00762-5</pub-id>.<pub-id pub-id-type="pmid">11967149</pub-id></mixed-citation>
</ref>
<ref id="B57">
<label>57.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schalm</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Fingar</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Sabatini</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name></person-group>
<year>2003</year>
<article-title>TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function</article-title>. <source/>Curr Biol
<volume>13</volume>:<fpage>797</fpage>–<lpage>806</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0960-9822(03)00329-4</pub-id>.<pub-id pub-id-type="pmid">12747827</pub-id></mixed-citation>
</ref>
<ref id="B58">
<label>58.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shaw</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Cantley</surname><given-names>LC</given-names></name></person-group>
<year>2006</year>
<article-title>Ras, PI(3)K and mTOR signalling controls tumour cell growth</article-title>. <source/>Nature
<volume>441</volume>:<fpage>424</fpage>–<lpage>430</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature04869</pub-id>.<pub-id pub-id-type="pmid">16724053</pub-id></mixed-citation>
</ref>
<ref id="B59">
<label>59.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johannessen</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>BW</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>Reczek</surname><given-names>EE</given-names></name>, <name name-style="western"><surname>Lynch</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Rioth</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>McClatchey</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ryeom</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cichowski</surname><given-names>K</given-names></name></person-group>
<year>2008</year>
<article-title>TORC1 is essential for NF1-associated malignancies</article-title>. <source/>Curr Biol
<volume>18</volume>:<fpage>56</fpage>–<lpage>62</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cub.2007.11.066</pub-id>.<pub-id pub-id-type="pmid">18164202</pub-id></mixed-citation>
</ref>
<ref id="B60">
<label>60.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johannessen</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Reczek</surname><given-names>EE</given-names></name>, <name name-style="western"><surname>James</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Brems</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Legius</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Cichowski</surname><given-names>K</given-names></name></person-group>
<year>2005</year>
<article-title>The NF1 tumor suppressor critically regulates TSC2 and mTOR</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>102</volume>:<fpage>8573</fpage>–<lpage>8578</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0503224102</pub-id>.<pub-id pub-id-type="pmid">15937108</pub-id></mixed-citation>
</ref>
<ref id="B61">
<label>61.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carriere</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Romeo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Acosta-Jaquez</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Moreau</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bonneil</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Thibault</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Fingar</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Roux</surname><given-names>PP</given-names></name></person-group>
<year>2011</year>
<article-title>ERK1/2 phosphorylate Raptor to promote Ras-dependent activation of mTOR complex 1 (mTORC1)</article-title>. <source/>J Biol Chem
<volume>286</volume>:<fpage>567</fpage>–<lpage>577</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M110.159046</pub-id>.<pub-id pub-id-type="pmid">21071439</pub-id></mixed-citation>
</ref>
<ref id="B62">
<label>62.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hobbs</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Der</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Rossman</surname><given-names>KL</given-names></name></person-group>
<year>2016</year>
<article-title>RAS isoforms and mutations in cancer at a glance</article-title>. <source/>J Cell Sci
<volume>129</volume>:<fpage>1287</fpage>–<lpage>1292</lpage>. doi:<pub-id pub-id-type="doi">10.1242/jcs.182873</pub-id>.<pub-id pub-id-type="pmid">26985062</pub-id></mixed-citation>
</ref>
<ref id="B63">
<label>63.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Erdjument-Bromage</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Tempst</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Pandolfi</surname><given-names>PP</given-names></name></person-group>
<year>2005</year>
<article-title>Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis</article-title>. <source/>Cell
<volume>121</volume>:<fpage>179</fpage>–<lpage>193</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2005.02.031</pub-id>.<pub-id pub-id-type="pmid">15851026</pub-id></mixed-citation>
</ref>
<ref id="B64">
<label>64.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rajalingam</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Schreck</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Rapp</surname><given-names>UR</given-names></name>, <name name-style="western"><surname>Albert</surname><given-names>S</given-names></name></person-group>
<year>2007</year>
<article-title>Ras oncogenes and their downstream targets</article-title>. <source/>Biochim Biophys Acta
<volume>1773</volume>:<fpage>1177</fpage>–<lpage>1195</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbamcr.2007.01.012</pub-id>.<pub-id pub-id-type="pmid">17428555</pub-id></mixed-citation>
</ref>
<ref id="B65">
<label>65.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ballif</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Roux</surname><given-names>PP</given-names></name>, <name name-style="western"><surname>Gerber</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>MacKeigan</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Gygi</surname><given-names>SP.</given-names></name></person-group>
<year>2005</year>
<article-title>Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>102</volume>:<fpage>667</fpage>–<lpage>672</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0409143102</pub-id>.<pub-id pub-id-type="pmid">15647351</pub-id></mixed-citation>
</ref>
<ref id="B66">
<label>66.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carriere</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Cargnello</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Julien</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Bonneil</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Thibault</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Roux</surname><given-names>PP</given-names></name></person-group>
<year>2008</year>
<article-title>Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation</article-title>. <source/>Curr Biol
<volume>18</volume>:<fpage>1269</fpage>–<lpage>1277</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cub.2008.07.078</pub-id>.<pub-id pub-id-type="pmid">18722121</pub-id></mixed-citation>
</ref>
<ref id="B67">
<label>67.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Romeo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Moreau</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zindy</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Saba-El-Leil</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lavoie</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Dandachi</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Baptissart</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Borden</surname><given-names>KLB</given-names></name>, <name name-style="western"><surname>Meloche</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Roux</surname><given-names>PP</given-names></name></person-group>
<year>2013</year>
<article-title>RSK regulates activated BRAF signalling to mTORC1 and promotes melanoma growth</article-title>. <source/>Oncogene
<volume>32</volume>:<fpage>2917</fpage>–<lpage>2926</lpage>. doi:<pub-id pub-id-type="doi">10.1038/onc.2012.312</pub-id>.<pub-id pub-id-type="pmid">22797077</pub-id></mixed-citation>
</ref>
<ref id="B68">
<label>68.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roux</surname><given-names>PP</given-names></name>, <name name-style="western"><surname>Ballif</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Anjum</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Gygi</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name></person-group>
<year>2004</year>
<article-title>Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>101</volume>:<fpage>13489</fpage>–<lpage>13494</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0405659101</pub-id>.<pub-id pub-id-type="pmid">15342917</pub-id></mixed-citation>
</ref>
<ref id="B69">
<label>69.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hara</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Yonezawa</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Weng</surname><given-names>QP</given-names></name>, <name name-style="western"><surname>Kozlowski</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Belham</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Avruch</surname><given-names>J</given-names></name></person-group>
<year>1998</year>
<article-title>Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism</article-title>. <source/>J Biol Chem
<volume>273</volume>:<fpage>14484</fpage>–<lpage>14494</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.273.23.14484</pub-id>.<pub-id pub-id-type="pmid">9603962</pub-id></mixed-citation>
</ref>
<ref id="B70">
<label>70.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Proud</surname><given-names>CG</given-names></name></person-group>
<year>1998</year>
<article-title>Amino acid availability regulates p70 S6 kinase and multiple translation factors</article-title>. <source/>Biochem J
<volume>334</volume>:<fpage>261</fpage>–<lpage>267</lpage>. doi:<pub-id pub-id-type="doi">10.1042/bj3340261</pub-id>.<pub-id pub-id-type="pmid">9693128</pub-id></mixed-citation>
</ref>
<ref id="B71">
<label>71.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Binda</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Peli-Gulli</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Bonfils</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Panchaud</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Urban</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sturgill</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Loewith</surname><given-names>R</given-names></name>, <name name-style="western"><surname>De Virgilio</surname><given-names>C</given-names></name></person-group>
<year>2009</year>
<article-title>The Vam6 GEF controls TORC1 by activating the EGO complex</article-title>. <source/>Mol Cell
<volume>35</volume>:<fpage>563</fpage>–<lpage>573</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molcel.2009.06.033</pub-id>.<pub-id pub-id-type="pmid">19748353</pub-id></mixed-citation>
</ref>
<ref id="B72">
<label>72.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Guan</surname><given-names>KL</given-names></name></person-group>
<year>2011</year>
<article-title>Amino acid signaling in TOR activation</article-title>. <source/>Annu Rev Biochem
<volume>80</volume>:<fpage>1001</fpage>–<lpage>1032</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev-biochem-062209-094414</pub-id>.<pub-id pub-id-type="pmid">21548787</pub-id></mixed-citation>
</ref>
<ref id="B73">
<label>73.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bun-Ya</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Harashima</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Oshima</surname><given-names>Y</given-names></name></person-group>
<year>1992</year>
<article-title>Putative GTP-binding protein, Gtr1, associated with the function of the Pho84 inorganic phosphate transporter in Saccharomyces cerevisiae</article-title>. <source/>Mol Cell Biol
<volume>12</volume>:<fpage>2958</fpage>–<lpage>2966</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.12.7.2958</pub-id>.<pub-id pub-id-type="pmid">1620108</pub-id></mixed-citation>
</ref>
<ref id="B74">
<label>74.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hirose</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Nakashima</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Sekiguchi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nishimoto</surname><given-names>T</given-names></name></person-group>
<year>1998</year>
<article-title>RagA is a functional homologue of S. cerevisiae Gtr1p involved in the Ran/Gsp1-GTPase pathway</article-title>. <source/>J Cell Sci
<volume>111</volume>:<fpage>11</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">9394008</pub-id></mixed-citation>
</ref>
<ref id="B75">
<label>75.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sengupta</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Peterson</surname><given-names>TR</given-names></name>, <name name-style="western"><surname>Sabatini</surname><given-names>DM</given-names></name></person-group>
<year>2010</year>
<article-title>Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress</article-title>. <source/>Mol Cell
<volume>40</volume>:<fpage>310</fpage>–<lpage>322</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molcel.2010.09.026</pub-id>.<pub-id pub-id-type="pmid">20965424</pub-id></mixed-citation>
</ref>
<ref id="B76">
<label>76.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sancak</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Bar-Peled</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zoncu</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Markhard</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Nada</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sabatini</surname><given-names>DM</given-names></name></person-group>
<year>2010</year>
<article-title>Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids</article-title>. <source/>Cell
<volume>141</volume>:<fpage>290</fpage>–<lpage>303</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2010.02.024</pub-id>.<pub-id pub-id-type="pmid">20381137</pub-id></mixed-citation>
</ref>
<ref id="B77">
<label>77.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Teis</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wunderlich</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Huber</surname><given-names>LA</given-names></name></person-group>
<year>2002</year>
<article-title>Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction</article-title>. <source/>Dev Cell
<volume>3</volume>:<fpage>803</fpage>–<lpage>814</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1534-5807(02)00364-7</pub-id>.<pub-id pub-id-type="pmid">12479806</pub-id></mixed-citation>
</ref>
<ref id="B78">
<label>78.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Goraksha-Hicks</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Neufeld</surname><given-names>TP</given-names></name>, <name name-style="western"><surname>Guan</surname><given-names>KL</given-names></name></person-group>
<year>2008</year>
<article-title>Regulation of TORC1 by Rag GTPases in nutrient response</article-title>. <source/>Nat Cell Biol
<volume>10</volume>:<fpage>935</fpage>–<lpage>945</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ncb1753</pub-id>.<pub-id pub-id-type="pmid">18604198</pub-id></mixed-citation>
</ref>
<ref id="B79">
<label>79.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sancak</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Peterson</surname><given-names>TR</given-names></name>, <name name-style="western"><surname>Shaul</surname><given-names>YD</given-names></name>, <name name-style="western"><surname>Lindquist</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Thoreen</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Bar-Peled</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Sabatini</surname><given-names>DM</given-names></name></person-group>
<year>2008</year>
<article-title>The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1</article-title>. <source/>Science
<volume>320</volume>:<fpage>1496</fpage>–<lpage>1501</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1157535</pub-id>.<pub-id pub-id-type="pmid">18497260</pub-id></mixed-citation>
</ref>
<ref id="B80">
<label>80.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duran</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Amanchy</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Linares</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Joshi</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Abu-Baker</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Porollo</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hansen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Moscat</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Diaz-Meco</surname><given-names>MT</given-names></name></person-group>
<year>2011</year>
<article-title>p62 is a key regulator of nutrient sensing in the mTORC1 pathway</article-title>. <source/>Mol Cell
<volume>44</volume>:<fpage>134</fpage>–<lpage>146</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molcel.2011.06.038</pub-id>.<pub-id pub-id-type="pmid">21981924</pub-id></mixed-citation>
</ref>
<ref id="B81">
<label>81.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bar-Peled</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chantranupong</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Cherniack</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>WW</given-names></name>, <name name-style="western"><surname>Ottina</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Grabiner</surname><given-names>BC</given-names></name>, <name name-style="western"><surname>Spear</surname><given-names>ED</given-names></name>, <name name-style="western"><surname>Carter</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Meyerson</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sabatini</surname><given-names>DM</given-names></name></person-group>
<year>2013</year>
<article-title>A tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1</article-title>. <source/>Science
<volume>340</volume>:<fpage>1100</fpage>–<lpage>1106</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1232044</pub-id>.<pub-id pub-id-type="pmid">23723238</pub-id></mixed-citation>
</ref>
<ref id="B82">
<label>82.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chantranupong</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Scaria</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Saxton</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Gygi</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Wyant</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Harper</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Gygi</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Sabatini</surname><given-names>DM</given-names></name></person-group>
<year>2016</year>
<article-title>The CASTOR proteins are arginine sensors for the mTORC1 pathway</article-title>. <source/>Cell
<volume>165</volume>:<fpage>153</fpage>–<lpage>164</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2016.02.035</pub-id>.<pub-id pub-id-type="pmid">26972053</pub-id></mixed-citation>
</ref>
<ref id="B83">
<label>83.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rebsamen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pochini</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Stasyk</surname><given-names>T</given-names></name>, <name name-style="western"><surname>de Araujo</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Galluccio</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kandasamy</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Snijder</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Fauster</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Rudashevskaya</surname><given-names>EL</given-names></name>, <name name-style="western"><surname>Bruckner</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Scorzoni</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Filipek</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Huber</surname><given-names>KV</given-names></name>, <name name-style="western"><surname>Bigenzahn</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Heinz</surname><given-names>LX</given-names></name>, <name name-style="western"><surname>Kraft</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bennett</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Indiveri</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Huber</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Superti-Furga</surname><given-names>G</given-names></name></person-group>
<year>2015</year>
<article-title>SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1</article-title>. <source/>Nature
<volume>519</volume>:<fpage>477</fpage>–<lpage>481</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature14107</pub-id>.<pub-id pub-id-type="pmid">25561175</pub-id></mixed-citation>
</ref>
<ref id="B84">
<label>84.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saxton</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Chantranupong</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Knockenhauer</surname><given-names>KE</given-names></name>, <name name-style="western"><surname>Schwartz</surname><given-names>TU</given-names></name>, <name name-style="western"><surname>Sabatini</surname><given-names>DM</given-names></name></person-group>
<year>2016</year>
<article-title>Mechanism of arginine sensing by CASTOR1 upstream of mTORC1</article-title>. <source/>Nature
<volume>536</volume>:<fpage>229</fpage>–<lpage>233</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature19079</pub-id>.<pub-id pub-id-type="pmid">27487210</pub-id></mixed-citation>
</ref>
<ref id="B85">
<label>85.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolfson</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Chantranupong</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Saxton</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Scaria</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Cantor</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Sabatini</surname><given-names>DM</given-names></name></person-group>
<year>2016</year>
<article-title>Sestrin2 is a leucine sensor for the mTORC1 pathway</article-title>. <source/>Science
<volume>351</volume>:<fpage>43</fpage>–<lpage>48</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.aab2674</pub-id>.<pub-id pub-id-type="pmid">26449471</pub-id></mixed-citation>
</ref>
<ref id="B86">
<label>86.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saxton</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Knockenhauer</surname><given-names>KE</given-names></name>, <name name-style="western"><surname>Wolfson</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Chantranupong</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Pacold</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Schwartz</surname><given-names>TU</given-names></name>, <name name-style="western"><surname>Sabatini</surname><given-names>DM</given-names></name></person-group>
<year>2016</year>
<article-title>Structural basis for leucine sensing by the Sestrin2-mTORC1 pathway</article-title>. <source/>Science
<volume>351</volume>:<fpage>53</fpage>–<lpage>58</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.aad2087</pub-id>.<pub-id pub-id-type="pmid">26586190</pub-id></mixed-citation>
</ref>
<ref id="B87">
<label>87.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ye</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Palm</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Peng</surname><given-names>M</given-names></name>, <name name-style="western"><surname>King</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Lindsten</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>MO</given-names></name>, <name name-style="western"><surname>Koumenis</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>CB</given-names></name></person-group>
<year>2015</year>
<article-title>GCN2 sustains mTORC1 suppression upon amino acid deprivation by inducing Sestrin2</article-title>. <source/>Genes Dev
<volume>29</volume>:<fpage>2331</fpage>–<lpage>2336</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gad.269324.115</pub-id>.<pub-id pub-id-type="pmid">26543160</pub-id></mixed-citation>
</ref>
<ref id="B88">
<label>88.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Peng</surname><given-names>J</given-names></name></person-group>
<year>2016</year>
<article-title>Recent advances in understanding amino acid sensing mechanisms that regulate mTORC1</article-title>. <source/>Int J Mol Sci
<volume>17</volume>:<fpage>E1636</fpage>.<pub-id pub-id-type="pmid">27690010</pub-id></mixed-citation>
</ref>
<ref id="B89">
<label>89.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nicklin</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Bergman</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Triantafellow</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Nyfeler</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hild</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kung</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Wilson</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Myer</surname><given-names>VE</given-names></name>, <name name-style="western"><surname>MacKeigan</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Porter</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>YK</given-names></name>, <name name-style="western"><surname>Cantley</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Finan</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>LO</given-names></name></person-group>
<year>2009</year>
<article-title>Bidirectional transport of amino acids regulates mTOR and autophagy</article-title>. <source/>Cell
<volume>136</volume>:<fpage>521</fpage>–<lpage>534</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2008.11.044</pub-id>.<pub-id pub-id-type="pmid">19203585</pub-id></mixed-citation>
</ref>
<ref id="B90">
<label>90.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ye</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Guan</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Xiong</surname><given-names>Y</given-names></name></person-group>
<year>2012</year>
<article-title>IDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectives</article-title>. <source/>Clin Cancer Res
<volume>18</volume>:<fpage>5562</fpage>–<lpage>5571</lpage>. doi:<pub-id pub-id-type="doi">10.1158/1078-0432.CCR-12-1773</pub-id>.<pub-id pub-id-type="pmid">23071358</pub-id></mixed-citation>
</ref>
<ref id="B91">
<label>91.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>White</surname><given-names>DW</given-names></name>, <name name-style="western"><surname>Gross</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bennett</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Bittinger</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Driggers</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Fantin</surname><given-names>VR</given-names></name>, <name name-style="western"><surname>Jang</surname><given-names>HG</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Keenan</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Marks</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Prins</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Ward</surname><given-names>PS</given-names></name>, <name name-style="western"><surname>Yen</surname><given-names>KE</given-names></name>, <name name-style="western"><surname>Liau</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Rabinowitz</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Cantley</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Vander Heiden</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Su</surname><given-names>SM</given-names></name></person-group>
<year>2009</year>
<article-title>Cancer-associated IDH1 mutations produce 2-hydroxyglutarate</article-title>. <source/>Nature
<volume>462</volume>:<fpage>739</fpage>–<lpage>744</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature08617</pub-id>.<pub-id pub-id-type="pmid">19935646</pub-id></mixed-citation>
</ref>
<ref id="B92">
<label>92.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Chin</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Vergnes</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Hwang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Xing</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Pai</surname><given-names>MY</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ta</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Fazlollahi</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Prins</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Teitell</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Nathanson</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Lai</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Faull</surname><given-names>KF</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Clarke</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Cloughesy</surname><given-names>TF</given-names></name>, <name name-style="western"><surname>Graeber</surname><given-names>TG</given-names></name>, <name name-style="western"><surname>Braas</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Christofk</surname><given-names>HR</given-names></name>, <name name-style="western"><surname>Jung</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Reue</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>J</given-names></name></person-group>
<year>2015</year>
<article-title>2-Hydroxyglutarate inhibits ATP synthase and mTOR signaling</article-title>. <source/>Cell Metab
<volume>22</volume>:<fpage>508</fpage>–<lpage>515</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cmet.2015.06.009</pub-id>.<pub-id pub-id-type="pmid">26190651</pub-id></mixed-citation>
</ref>
<ref id="B93">
<label>93.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gagne</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Boulay</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Topisirovic</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Huot</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Mallette</surname><given-names>FA</given-names></name></person-group>
<year>2017</year>
<article-title>Oncogenic activities of IDH1/2 mutations: from epigenetics to cellular signaling</article-title>. <source/>Trends Cell Biol
<volume>27</volume>:<fpage>738</fpage>–<lpage>752</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tcb.2017.06.002</pub-id>.<pub-id pub-id-type="pmid">28711227</pub-id></mixed-citation>
</ref>
<ref id="B94">
<label>94.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carbonneau</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lalonde</surname><given-names>MGLME</given-names></name>, <name name-style="western"><surname>Germain</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Motorina</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Guiot</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Secco</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Vincent</surname><given-names>EE</given-names></name>, <name name-style="western"><surname>Tumber</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hulea</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Bergeman</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Oppermann</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>Laplante</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Topisirovic</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Petrecca</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Huot</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Mallette</surname><given-names>FA</given-names></name></person-group>
<year>2016</year>
<article-title>The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway</article-title>. <source/>Nat Commun
<volume>7</volume>:<fpage>12700</fpage>. doi:<pub-id pub-id-type="doi">10.1038/ncomms12700</pub-id>.<pub-id pub-id-type="pmid">27624942</pub-id></mixed-citation>
</ref>
<ref id="B95">
<label>95.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Qiu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Xia</surname><given-names>C</given-names></name></person-group>
<year>2017</year>
<article-title>IDH1 R132H mutation enhances cell migration by activating AKT-mTOR signaling pathway, but sensitizes cells to 5-FU treatment as NADPH and GSH are reduced</article-title>. <source/>PLoS One
<volume>12</volume>:<fpage>e0169038</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0169038</pub-id>.<pub-id pub-id-type="pmid">28052098</pub-id></mixed-citation>
</ref>
<ref id="B96">
<label>96.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hardie</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Schaffer</surname><given-names>BE</given-names></name>, <name name-style="western"><surname>Brunet</surname><given-names>A</given-names></name></person-group>
<year>2016</year>
<article-title>AMPK: an energy-sensing pathway with multiple inputs and outputs</article-title>. <source/>Trends Cell Biol
<volume>26</volume>:<fpage>190</fpage>–<lpage>201</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tcb.2015.10.013</pub-id>.<pub-id pub-id-type="pmid">26616193</pub-id></mixed-citation>
</ref>
<ref id="B97">
<label>97.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Hardie</surname><given-names>DG</given-names></name></person-group>
<year>2018</year>
<article-title>AMPK: sensing glucose as well as cellular energy status</article-title>. <source/>Cell Metab
<volume>27</volume>:<fpage>299</fpage>–<lpage>313</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cmet.2017.10.009</pub-id>.<pub-id pub-id-type="pmid">29153408</pub-id></mixed-citation>
</ref>
<ref id="B98">
<label>98.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shaw</surname><given-names>RJ</given-names></name></person-group>
<year>2009</year>
<article-title>LKB1 and AMP-activated protein kinase control of mTOR signalling and growth</article-title>. <source/>Acta Physiol (Oxf)
<volume>196</volume>:<fpage>65</fpage>–<lpage>80</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1748-1716.2009.01972.x</pub-id>.<pub-id pub-id-type="pmid">19245654</pub-id></mixed-citation>
</ref>
<ref id="B99">
<label>99.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Hawley</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Zong</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Gray</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Cui</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>YQ</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>TY</given-names></name>, <name name-style="western"><surname>Ye</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Yin</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Piao</surname><given-names>HL</given-names></name>, <name name-style="western"><surname>Hardie</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>SC</given-names></name></person-group>
<year>2017</year>
<article-title>Fructose-1,6-bisphosphate and aldolase mediate glucose sensing by AMPK</article-title>. <source/>Nature
<volume>548</volume>:<fpage>112</fpage>–<lpage>116</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature23275</pub-id>.<pub-id pub-id-type="pmid">28723898</pub-id></mixed-citation>
</ref>
<ref id="B100">
<label>100.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kahn</surname><given-names>BB</given-names></name>, <name name-style="western"><surname>Alquier</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Carling</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Hardie</surname><given-names>DG</given-names></name></person-group>
<year>2005</year>
<article-title>AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism</article-title>. <source/>Cell Metab
<volume>1</volume>:<fpage>15</fpage>–<lpage>25</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cmet.2004.12.003</pub-id>.<pub-id pub-id-type="pmid">16054041</pub-id></mixed-citation>
</ref>
<ref id="B101">
<label>101.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corradetti</surname><given-names>MN</given-names></name>, <name name-style="western"><surname>Inoki</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Bardeesy</surname><given-names>N</given-names></name>, <name name-style="western"><surname>DePinho</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Guan</surname><given-names>KL</given-names></name></person-group>
<year>2004</year>
<article-title>Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome</article-title>. <source/>Genes Dev
<volume>18</volume>:<fpage>1533</fpage>–<lpage>1538</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gad.1199104</pub-id>.<pub-id pub-id-type="pmid">15231735</pub-id></mixed-citation>
</ref>
<ref id="B102">
<label>102.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gwinn</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Shackelford</surname><given-names>DB</given-names></name>, <name name-style="western"><surname>Egan</surname><given-names>DF</given-names></name>, <name name-style="western"><surname>Mihaylova</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Mery</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Vasquez</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Turk</surname><given-names>BE</given-names></name>, <name name-style="western"><surname>Shaw</surname><given-names>RJ</given-names></name></person-group>
<year>2008</year>
<article-title>AMPK phosphorylation of raptor mediates a metabolic checkpoint</article-title>. <source/>Mol Cell
<volume>30</volume>:<fpage>214</fpage>–<lpage>226</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molcel.2008.03.003</pub-id>.<pub-id pub-id-type="pmid">18439900</pub-id></mixed-citation>
</ref>
<ref id="B103">
<label>103.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brugarolas</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lei</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hurley</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Manning</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Reiling</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Hafen</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Witters</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Ellisen</surname><given-names>LW</given-names></name>, and <name name-style="western"><surname>Kaelin</surname><given-names>WG</given-names><suffix>Jr</suffix></name></person-group>
<year>2004</year>
<article-title>Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex</article-title>. <source/>Genes Dev
<volume>18</volume>:<fpage>2893</fpage>–<lpage>2904</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gad.1256804</pub-id>.<pub-id pub-id-type="pmid">15545625</pub-id></mixed-citation>
</ref>
<ref id="B104">
<label>104.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DeYoung</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Horak</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Sofer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sgroi</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ellisen</surname><given-names>LW</given-names></name></person-group>
<year>2008</year>
<article-title>Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling</article-title>. <source/>Genes Dev
<volume>22</volume>:<fpage>239</fpage>–<lpage>251</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gad.1617608</pub-id>.<pub-id pub-id-type="pmid">18198340</pub-id></mixed-citation>
</ref>
<ref id="B105">
<label>105.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Beemiller</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>CY</given-names></name>, <name name-style="western"><surname>Swanson</surname><given-names>J</given-names></name>, <name name-style="western"><surname>You</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Guan</surname><given-names>KL</given-names></name></person-group>
<year>2007</year>
<article-title>Bnip3 mediates the hypoxia-induced inhibition on mammalian target of rapamycin by interacting with Rheb</article-title>. <source/>J Biol Chem
<volume>282</volume>:<fpage>35803</fpage>–<lpage>35813</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M705231200</pub-id>.<pub-id pub-id-type="pmid">17928295</pub-id></mixed-citation>
</ref>
<ref id="B106">
<label>106.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ekim</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Magnuson</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Acosta-Jaquez</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Keller</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Feener</surname><given-names>EP</given-names></name>, <name name-style="western"><surname>Fingar</surname><given-names>DC</given-names></name></person-group>
<year>2011</year>
<article-title>mTOR kinase domain phosphorylation promotes mTORC1 signaling, cell growth, and cell cycle progression</article-title>. <source/>Mol Cell Biol
<volume>31</volume>:<fpage>2787</fpage>–<lpage>2801</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.05437-11</pub-id>.<pub-id pub-id-type="pmid">21576368</pub-id></mixed-citation>
</ref>
<ref id="B107">
<label>107.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soliman</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Acosta-Jaquez</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Dunlop</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Ekim</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Maj</surname><given-names>NE</given-names></name>, <name name-style="western"><surname>Tee</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Fingar</surname><given-names>DC</given-names></name></person-group>
<year>2010</year>
<article-title>mTOR Ser-2481 autophosphorylation monitors mTORC-specific catalytic activity and clarifies rapamycin mechanism of action</article-title>. <source/>J Biol Chem
<volume>285</volume>:<fpage>7866</fpage>–<lpage>7879</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M109.096222</pub-id>.<pub-id pub-id-type="pmid">20022946</pub-id></mixed-citation>
</ref>
<ref id="B108">
<label>108.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bodur</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Kazyken</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ekim Ustunel</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Siroky</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Tooley</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Gonzalez</surname><given-names>IE</given-names></name>, <name name-style="western"><surname>Foley</surname><given-names>DH</given-names></name>, <name name-style="western"><surname>Acosta-Jaquez</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Barnes</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Steinl</surname><given-names>GK</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>KW</given-names></name>, <name name-style="western"><surname>Lumeng</surname><given-names>CN</given-names></name>, <name name-style="western"><surname>Riddle</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Myers</surname><given-names>MG</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Fingar</surname><given-names>DC</given-names></name></person-group>
<year>2018</year>
<article-title>The IKK-related kinase TBK1 activates mTORC1 directly in response to growth factors and innate immune agonists</article-title>. <source/>EMBO J
<volume>37</volume>:<fpage>19</fpage>–<lpage>38</lpage>. doi:<pub-id pub-id-type="doi">10.15252/embj.201696164</pub-id>.<pub-id pub-id-type="pmid">29150432</pub-id></mixed-citation>
</ref>
<ref id="B109">
<label>109.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Acosta-Jaquez</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Keller</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Foster</surname><given-names>KG</given-names></name>, <name name-style="western"><surname>Ekim</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Soliman</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Feener</surname><given-names>EP</given-names></name>, <name name-style="western"><surname>Ballif</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Fingar</surname><given-names>DC</given-names></name></person-group>
<year>2009</year>
<article-title>Site-specific mTOR phosphorylation promotes mTORC1-mediated signaling and cell growth</article-title>. <source/>Mol Cell Biol
<volume>29</volume>:<fpage>4308</fpage>–<lpage>4324</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.01665-08</pub-id>.<pub-id pub-id-type="pmid">19487463</pub-id></mixed-citation>
</ref>
<ref id="B110">
<label>110.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Foster</surname><given-names>KG</given-names></name>, <name name-style="western"><surname>Acosta-Jaquez</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Romeo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ekim</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Soliman</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Carriere</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Roux</surname><given-names>PP</given-names></name>, <name name-style="western"><surname>Ballif</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Fingar</surname><given-names>DC</given-names></name></person-group>
<year>2010</year>
<article-title>Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation</article-title>. <source/>J Biol Chem
<volume>285</volume>:<fpage>80</fpage>–<lpage>94</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M109.029637</pub-id>.<pub-id pub-id-type="pmid">19864431</pub-id></mixed-citation>
</ref>
<ref id="B111">
<label>111.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deragon</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Bousquet-Antonelli</surname><given-names>C</given-names></name></person-group>
<year>2015</year>
<article-title>The role of LARP1 in translation and beyond</article-title>. <source/>Wiley Interdiscip Rev RNA
<volume>6</volume>:<fpage>399</fpage>–<lpage>417</lpage>. doi:<pub-id pub-id-type="doi">10.1002/wrna.1282</pub-id>.<pub-id pub-id-type="pmid">25892282</pub-id></mixed-citation>
</ref>
<ref id="B112">
<label>112.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meyuhas</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Kahan</surname><given-names>T</given-names></name></person-group>
<year>2015</year>
<article-title>The race to decipher the top secrets of TOP mRNAs</article-title>. <source/>Biochim Biophys Acta
<volume>1849</volume>:<fpage>801</fpage>–<lpage>811</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbagrm.2014.08.015</pub-id>.<pub-id pub-id-type="pmid">25234618</pub-id></mixed-citation>
</ref>
<ref id="B113">
<label>113.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parsyan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Svitkin</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Shahbazian</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Gkogkas</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lasko</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Merrick</surname><given-names>WC</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>
<year>2011</year>
<article-title>mRNA helicases: the tacticians of translational control</article-title>. <source/>Nat Rev Mol Cell Biol
<volume>12</volume>:<fpage>235</fpage>–<lpage>245</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrm3083</pub-id>.<pub-id pub-id-type="pmid">21427765</pub-id></mixed-citation>
</ref>
<ref id="B114">
<label>114.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hershey</surname><given-names>JW</given-names></name></person-group>
<year>2015</year>
<article-title>The role of eIF3 and its individual subunits in cancer</article-title>. <source/>Biochim Biophys Acta
<volume>1849</volume>:<fpage>792</fpage>–<lpage>800</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbagrm.2014.10.005</pub-id>.<pub-id pub-id-type="pmid">25450521</pub-id></mixed-citation>
</ref>
<ref id="B115">
<label>115.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Valasek</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Zeman</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wagner</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Beznoskova</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Pavlikova</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Mohammad</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Hronova</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Herrmannova</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hashem</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Gunisova</surname><given-names>S</given-names></name></person-group>
<year>2017</year>
<article-title>Embraced by eIF3: structural and functional insights into the roles of eIF3 across the translation cycle</article-title>. <source/>Nucleic Acids Res
<volume>45</volume>:<fpage>10948</fpage>–<lpage>10968</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkx805</pub-id>.<pub-id pub-id-type="pmid">28981723</pub-id></mixed-citation>
</ref>
<ref id="B116">
<label>116.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pause</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Belsham</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Gingras</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Donze</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Lawrence</surname><given-names>JC</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>
<year>1994</year>
<article-title>Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function</article-title>. <source/>Nature
<volume>371</volume>:<fpage>762</fpage>–<lpage>767</lpage>. doi:<pub-id pub-id-type="doi">10.1038/371762a0</pub-id>.<pub-id pub-id-type="pmid">7935836</pub-id></mixed-citation>
</ref>
<ref id="B117">
<label>117.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brunn</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Hudson</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Sekulic</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Hosoi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Houghton</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Lawrence</surname><given-names>JC</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Abraham</surname><given-names>RT</given-names></name></person-group>
<year>1997</year>
<article-title>Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin</article-title>. <source/>Science
<volume>277</volume>:<fpage>99</fpage>–<lpage>101</lpage>.<pub-id pub-id-type="pmid">9204908</pub-id></mixed-citation>
</ref>
<ref id="B118">
<label>118.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gingras</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Gygi</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Raught</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Polakiewicz</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Abraham</surname><given-names>RT</given-names></name>, <name name-style="western"><surname>Hoekstra</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Aebersold</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>
<year>1999</year>
<article-title>Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism</article-title>. <source/>Genes Dev
<volume>13</volume>:<fpage>1422</fpage>–<lpage>1437</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gad.13.11.1422</pub-id>.<pub-id pub-id-type="pmid">10364159</pub-id></mixed-citation>
</ref>
<ref id="B119">
<label>119.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gingras</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Raught</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Gygi</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Niedzwiecka</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Miron</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Burley</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Polakiewicz</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Wyslouch-Cieszynska</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Aebersold</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>
<year>2001</year>
<article-title>Hierarchical phosphorylation of the translation inhibitor 4E-BP1</article-title>. <source/>Genes Dev
<volume>15</volume>:<fpage>2852</fpage>–<lpage>2864</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gad.887201</pub-id>.<pub-id pub-id-type="pmid">11691836</pub-id></mixed-citation>
</ref>
<ref id="B120">
<label>120.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dowling</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Topisirovic</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Alain</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Bidinosti</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fonseca</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Petroulakis</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Larsson</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Selvaraj</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kozma</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>
<year>2010</year>
<article-title>mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs</article-title>. <source/>Science
<volume>328</volume>:<fpage>1172</fpage>–<lpage>1176</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1187532</pub-id>.<pub-id pub-id-type="pmid">20508131</pub-id></mixed-citation>
</ref>
<ref id="B121">
<label>121.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ohanna</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sobering</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Lapointe</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Lorenzo</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Praud</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Petroulakis</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kelly</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Sotiropoulos</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pende</surname><given-names>M</given-names></name></person-group>
<year>2005</year>
<article-title>Atrophy of S6K1(−/−) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control</article-title>. <source/>Nat Cell Biol
<volume>7</volume>:<fpage>286</fpage>–<lpage>294</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ncb1231</pub-id>.<pub-id pub-id-type="pmid">15723049</pub-id></mixed-citation>
</ref>
<ref id="B122">
<label>122.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pende</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Um</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Mieulet</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Sticker</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Goss</surname><given-names>VL</given-names></name>, <name name-style="western"><surname>Mestan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mueller</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fumagalli</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kozma</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>G</given-names></name></person-group>
<year>2004</year>
<article-title>S6K1(−/−)/S6K2(−/−) mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway</article-title>. <source/>Mol Cell Biol
<volume>24</volume>:<fpage>3112</fpage>–<lpage>3124</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.24.8.3112-3124.2004</pub-id>.<pub-id pub-id-type="pmid">15060135</pub-id></mixed-citation>
</ref>
<ref id="B123">
<label>123.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miron</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Verdu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lachance</surname><given-names>PE</given-names></name>, <name name-style="western"><surname>Birnbaum</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Lasko</surname><given-names>PF</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>
<year>2001</year>
<article-title>The translational inhibitor 4E-BP is an effector of PI(3)K/Akt signalling and cell growth in Drosophila</article-title>. <source/>Nat Cell Biol
<volume>3</volume>:<fpage>596</fpage>–<lpage>601</lpage>. doi:<pub-id pub-id-type="doi">10.1038/35078571</pub-id>.<pub-id pub-id-type="pmid">11389445</pub-id></mixed-citation>
</ref>
<ref id="B124">
<label>124.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Batool</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Aashaq</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Andrabi</surname><given-names>KI</given-names></name></person-group>
<year>2017</year>
<article-title>Reappraisal to the study of 4E-BP1 as an mTOR substrate—a normative critique</article-title>. <source/>Eur J Cell Biol
<volume>96</volume>:<fpage>325</fpage>–<lpage>336</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ejcb.2017.03.013</pub-id>.<pub-id pub-id-type="pmid">28427795</pub-id></mixed-citation>
</ref>
<ref id="B125">
<label>125.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fox</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Hammerman</surname><given-names>PS</given-names></name>, <name name-style="western"><surname>Cinalli</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Master</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Chodosh</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>CB</given-names></name></person-group>
<year>2003</year>
<article-title>The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor</article-title>. <source/>Genes Dev
<volume>17</volume>:<fpage>1841</fpage>–<lpage>1854</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gad.1105003</pub-id>.<pub-id pub-id-type="pmid">12869584</pub-id></mixed-citation>
</ref>
<ref id="B126">
<label>126.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shin</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wolgamott</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Tcherkezian</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Vallabhapurapu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Roux</surname><given-names>PP</given-names></name>, <name name-style="western"><surname>Yoon</surname><given-names>SO</given-names></name></person-group>
<year>2014</year>
<article-title>Glycogen synthase kinase-3beta positively regulates protein synthesis and cell proliferation through the regulation of translation initiation factor 4E-binding protein 1</article-title>. <source/>Oncogene
<volume>33</volume>:<fpage>1690</fpage>–<lpage>1699</lpage>. doi:<pub-id pub-id-type="doi">10.1038/onc.2013.113</pub-id>.<pub-id pub-id-type="pmid">23584478</pub-id></mixed-citation>
</ref>
<ref id="B127">
<label>127.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shin</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wolgamott</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Roux</surname><given-names>PP</given-names></name>, <name name-style="western"><surname>Yoon</surname><given-names>SO</given-names></name></person-group>
<year>2014</year>
<article-title>Casein kinase 1epsilon promotes cell proliferation by regulating mRNA translation</article-title>. <source/>Cancer Res
<volume>74</volume>:<fpage>201</fpage>–<lpage>211</lpage>. doi:<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-13-1175</pub-id>.<pub-id pub-id-type="pmid">24247720</pub-id></mixed-citation>
</ref>
<ref id="B128">
<label>128.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shuda</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Velasquez</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Cordek</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Kwun</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>PS</given-names></name></person-group>
<year>2015</year>
<article-title>CDK1 substitutes for mTOR kinase to activate mitotic cap-dependent protein translation</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>112</volume>:<fpage>5875</fpage>–<lpage>5882</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1505787112</pub-id>.<pub-id pub-id-type="pmid">25883264</pub-id></mixed-citation>
</ref>
<ref id="B129">
<label>129.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Velasquez</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Shuda</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lee-Oesterreich</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Pogge von Strandmann</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Gritsenko</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Jacobs</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>PS</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>Y</given-names></name></person-group>
<year>2016</year>
<article-title>Mitotic protein kinase CDK1 phosphorylation of mRNA translation regulator 4E-BP1 Ser83 may contribute to cell transformation</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>113</volume>:<fpage>8466</fpage>–<lpage>8471</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1607768113</pub-id>.<pub-id pub-id-type="pmid">27402756</pub-id></mixed-citation>
</ref>
<ref id="B130">
<label>130.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dowling</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Topisirovic</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Fonseca</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>
<year>2010</year>
<article-title>Dissecting the role of mTOR: lessons from mTOR inhibitors</article-title>. <source/>Biochim Biophys Acta
<volume>1804</volume>:<fpage>433</fpage>–<lpage>439</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbapap.2009.12.001</pub-id>.<pub-id pub-id-type="pmid">20005306</pub-id></mixed-citation>
</ref>
<ref id="B131">
<label>131.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Magnuson</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Ekim</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Fingar</surname><given-names>DC</given-names></name></person-group>
<year>2012</year>
<article-title>Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks</article-title>. <source/>Biochem J
<volume>441</volume>:<fpage>1</fpage>–<lpage>21</lpage>. doi:<pub-id pub-id-type="doi">10.1042/BJ20110892</pub-id>.<pub-id pub-id-type="pmid">22168436</pub-id></mixed-citation>
</ref>
<ref id="B132">
<label>132.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fenton</surname><given-names>TR</given-names></name>, <name name-style="western"><surname>Gout</surname><given-names>IT</given-names></name></person-group>
<year>2011</year>
<article-title>Functions and regulation of the 70kDa ribosomal S6 kinases</article-title>. <source/>Int J Biochem Cell Biol
<volume>43</volume>:<fpage>47</fpage>–<lpage>59</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biocel.2010.09.018</pub-id>.<pub-id pub-id-type="pmid">20932932</pub-id></mixed-citation>
</ref>
<ref id="B133">
<label>133.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gout</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Minami</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Hara</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tsujishita</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Filonenko</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Waterfield</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Yonezawa</surname><given-names>K</given-names></name></person-group>
<year>1998</year>
<article-title>Molecular cloning and characterization of a novel p70 S6 kinase, p70 S6 kinase beta containing a proline-rich region</article-title>. <source/>J Biol Chem
<volume>273</volume>:<fpage>30061</fpage>–<lpage>30064</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.273.46.30061</pub-id>.<pub-id pub-id-type="pmid">9804755</pub-id></mixed-citation>
</ref>
<ref id="B134">
<label>134.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grove</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Banerjee</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Balasubramanyam</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Coffer</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Price</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Avruch</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Woodgett</surname><given-names>JR</given-names></name></person-group>
<year>1991</year>
<article-title>Cloning and expression of two human p70 S6 kinase polypeptides differing only at their amino termini</article-title>. <source/>Mol Cell Biol
<volume>11</volume>:<fpage>5541</fpage>–<lpage>5550</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.11.11.5541</pub-id>.<pub-id pub-id-type="pmid">1922062</pub-id></mixed-citation>
</ref>
<ref id="B135">
<label>135.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tavares</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Pavan</surname><given-names>IC</given-names></name>, <name name-style="western"><surname>Amaral</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Meneguello</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Luchessi</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Simabuco</surname><given-names>FM</given-names></name></person-group>
<year>2015</year>
<article-title>The S6K protein family in health and disease</article-title>. <source/>Life Sci
<volume>131</volume>:<fpage>1</fpage>–<lpage>10</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.lfs.2015.03.001</pub-id>.<pub-id pub-id-type="pmid">25818187</pub-id></mixed-citation>
</ref>
<ref id="B136">
<label>136.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ben-Hur</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Denichenko</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Siegfried</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Maimon</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Krainer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Davidson</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Karni</surname><given-names>R</given-names></name></person-group>
<year>2013</year>
<article-title>S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1</article-title>. <source/>Cell Rep
<volume>3</volume>:<fpage>103</fpage>–<lpage>115</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.celrep.2012.11.020</pub-id>.<pub-id pub-id-type="pmid">23273915</pub-id></mixed-citation>
</ref>
<ref id="B137">
<label>137.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Richard</surname><given-names>S</given-names></name></person-group>
<year>2015</year>
<article-title>Sam68 regulates S6K1 alternative splicing during adipogenesis</article-title>. <source/>Mol Cell Biol
<volume>35</volume>:<fpage>1926</fpage>–<lpage>1939</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.01488-14</pub-id>.<pub-id pub-id-type="pmid">25776557</pub-id></mixed-citation>
</ref>
<ref id="B138">
<label>138.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fingar</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Salama</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Tsou</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Harlow</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name></person-group>
<year>2002</year>
<article-title>Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E</article-title>. <source/>Genes Dev
<volume>16</volume>:<fpage>1472</fpage>–<lpage>1487</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gad.995802</pub-id>.<pub-id pub-id-type="pmid">12080086</pub-id></mixed-citation>
</ref>
<ref id="B139">
<label>139.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montagne</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Stewart</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Stocker</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hafen</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Kozma</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>G</given-names></name></person-group>
<year>1999</year>
<article-title>Drosophila S6 kinase: a regulator of cell size</article-title>. <source/>Science
<volume>285</volume>:<fpage>2126</fpage>–<lpage>2129</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.285.5436.2126</pub-id>.<pub-id pub-id-type="pmid">10497130</pub-id></mixed-citation>
</ref>
<ref id="B140">
<label>140.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shima</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Pende</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Fumagalli</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Kozma</surname><given-names>SC</given-names></name></person-group>
<year>1998</year>
<article-title>Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase</article-title>. <source/>EMBO J
<volume>17</volume>:<fpage>6649</fpage>–<lpage>6659</lpage>. doi:<pub-id pub-id-type="doi">10.1093/emboj/17.22.6649</pub-id>.<pub-id pub-id-type="pmid">9822608</pub-id></mixed-citation>
</ref>
<ref id="B141">
<label>141.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goh</surname><given-names>ET</given-names></name>, <name name-style="western"><surname>Pardo</surname><given-names>OE</given-names></name>, <name name-style="western"><surname>Michael</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Niewiarowski</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Totty</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Volkova</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Tsaneva</surname><given-names>IR</given-names></name>, <name name-style="western"><surname>Seckl</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Gout</surname><given-names>I</given-names></name></person-group>
<year>2010</year>
<article-title>Involvement of heterogeneous ribonucleoprotein F in the regulation of cell proliferation via the mammalian target of rapamycin/S6 kinase 2 pathway</article-title>. <source/>J Biol Chem
<volume>285</volume>:<fpage>17065</fpage>–<lpage>17076</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M109.078782</pub-id>.<pub-id pub-id-type="pmid">20308064</pub-id></mixed-citation>
</ref>
<ref id="B142">
<label>142.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Warner</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Bridge</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Hewitson</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Hodgkinson</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Heyam</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Massa</surname><given-names>BC</given-names></name>, <name name-style="western"><surname>Haslam</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Chatzifrangkeskou</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Evans</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Plevin</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Sharp</surname><given-names>TV</given-names></name>, <name name-style="western"><surname>Lagos</surname><given-names>D</given-names></name></person-group>
<year>2016</year>
<article-title>S6K2-mediated regulation of TRBP as a determinant of miRNA expression in human primary lymphatic endothelial cells</article-title>. <source/>Nucleic Acids Res
<volume>44</volume>:<fpage>9942</fpage>–<lpage>9955</lpage>.<pub-id pub-id-type="pmid">27407113</pub-id></mixed-citation>
</ref>
<ref id="B143">
<label>143.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Valovka</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Verdier</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Cramer</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Zhyvoloup</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fenton</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Rebholz</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Gzhegotsky</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lutsyk</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Matsuka</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Filonenko</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Proud</surname><given-names>CG</given-names></name>, <name name-style="western"><surname>Parker</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Gout</surname><given-names>IT</given-names></name></person-group>
<year>2003</year>
<article-title>Protein kinase C phosphorylates ribosomal protein S6 kinase betaII and regulates its subcellular localization</article-title>. <source/>Mol Cell Biol
<volume>23</volume>:<fpage>852</fpage>–<lpage>863</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.23.3.852-863.2003</pub-id>.<pub-id pub-id-type="pmid">12529391</pub-id></mixed-citation>
</ref>
<ref id="B144">
<label>144.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Schalm</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Richardson</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Romanelli</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Keon</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name></person-group>
<year>2001</year>
<article-title>Regulation of ribosomal S6 kinase 2 by effectors of the phosphoinositide 3-kinase pathway</article-title>. <source/>J Biol Chem
<volume>276</volume>:<fpage>7884</fpage>–<lpage>7891</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M006969200</pub-id>.<pub-id pub-id-type="pmid">11108711</pub-id></mixed-citation>
</ref>
<ref id="B145">
<label>145.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Schalm</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Romanelli</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Keon</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name></person-group>
<year>2001</year>
<article-title>Ribosomal S6 kinase 2 inhibition by a potent C-terminal repressor domain is relieved by mitogen-activated protein-extracellular signal-regulated kinase kinase-regulated phosphorylation</article-title>. <source/>J Biol Chem
<volume>276</volume>:<fpage>7892</fpage>–<lpage>7898</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M009972200</pub-id>.<pub-id pub-id-type="pmid">11108720</pub-id></mixed-citation>
</ref>
<ref id="B146">
<label>146.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shin</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wolgamott</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yoon</surname><given-names>SO</given-names></name></person-group>
<year>2011</year>
<article-title>Glycogen synthase kinase (GSK)-3 promotes p70 ribosomal protein S6 kinase (p70S6K) activity and cell proliferation</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>108</volume>:<fpage>1204</fpage>–<lpage>1213</lpage>.</mixed-citation>
</ref>
<ref id="B147">
<label>147.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roux</surname><given-names>PP</given-names></name>, <name name-style="western"><surname>Shahbazian</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Vu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Holz</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Taunton</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name></person-group>
<year>2007</year>
<article-title>RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation</article-title>. <source/>J Biol Chem
<volume>282</volume>:<fpage>14056</fpage>–<lpage>14064</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M700906200</pub-id>.<pub-id pub-id-type="pmid">17360704</pub-id></mixed-citation>
</ref>
<ref id="B148">
<label>148.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruvinsky</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Sharon</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Lerer</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Stolovich-Rain</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nir</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Dor</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zisman</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Meyuhas</surname><given-names>O</given-names></name></person-group>
<year>2005</year>
<article-title>Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis</article-title>. <source/>Genes Dev
<volume>19</volume>:<fpage>2199</fpage>–<lpage>2211</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gad.351605</pub-id>.<pub-id pub-id-type="pmid">16166381</pub-id></mixed-citation>
</ref>
<ref id="B149">
<label>149.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chauvin</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Koka</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Nouschi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mieulet</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Hoareau-Aveilla</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Dreazen</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Cagnard</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Carpentier</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Kiss</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Meyuhas</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Pende</surname><given-names>M</given-names></name></person-group>
<year>2014</year>
<article-title>Ribosomal protein S6 kinase activity controls the ribosome biogenesis transcriptional program</article-title>. <source/>Oncogene
<volume>33</volume>:<fpage>474</fpage>–<lpage>483</lpage>. doi:<pub-id pub-id-type="doi">10.1038/onc.2012.606</pub-id>.<pub-id pub-id-type="pmid">23318442</pub-id></mixed-citation>
</ref>
<ref id="B150">
<label>150.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Terada</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Alessi</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Proud</surname><given-names>CG</given-names></name></person-group>
<year>2001</year>
<article-title>Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase</article-title>. <source/>EMBO J
<volume>20</volume>:<fpage>4370</fpage>–<lpage>4379</lpage>. doi:<pub-id pub-id-type="doi">10.1093/emboj/20.16.4370</pub-id>.<pub-id pub-id-type="pmid">11500364</pub-id></mixed-citation>
</ref>
<ref id="B151">
<label>151.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kenney</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Proud</surname><given-names>CG</given-names></name></person-group>
<year>2014</year>
<article-title>Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple roles</article-title>. <source/>Adv Biol Regul
<volume>55</volume>:<fpage>15</fpage>–<lpage>27</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jbior.2014.04.003</pub-id>.<pub-id pub-id-type="pmid">24853390</pub-id></mixed-citation>
</ref>
<ref id="B152">
<label>152.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bermek</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Matthaei</surname><given-names>H</given-names></name></person-group>
<year>1971</year>
<article-title>Interactions between human translocation factor, guanosine triphosphate, and ribosomes</article-title>. <source/>Biochemistry
<volume>10</volume>:<fpage>4906</fpage>–<lpage>4912</lpage>. doi:<pub-id pub-id-type="doi">10.1021/bi00802a012</pub-id>.<pub-id pub-id-type="pmid">5134535</pub-id></mixed-citation>
</ref>
<ref id="B153">
<label>153.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skogerson</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Moldave</surname><given-names>K</given-names></name></person-group>
<year>1968</year>
<article-title>Characterization of the interaction of aminoacyltransferase II with ribosomes. Binding of transferase II and translocation of peptidyl transfer ribonucleic acid</article-title>. <source/>J Biol Chem
<volume>243</volume>:<fpage>5354</fpage>–<lpage>5360</lpage>.<pub-id pub-id-type="pmid">4883096</pub-id></mixed-citation>
</ref>
<ref id="B154">
<label>154.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Regufe da Mota</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lanucara</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Agarwala</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Pyr Dit Ruys</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Vertommen</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Rider</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Eyers</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Proud</surname><given-names>CG</given-names></name></person-group>
<year>2014</year>
<article-title>Eukaryotic elongation factor 2 kinase activity is controlled by multiple inputs from oncogenic signaling</article-title>. <source/>Mol Cell Biol
<volume>34</volume>:<fpage>4088</fpage>–<lpage>4103</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.01035-14</pub-id>.<pub-id pub-id-type="pmid">25182533</pub-id></mixed-citation>
</ref>
<ref id="B155">
<label>155.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knebel</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Morrice</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>P</given-names></name></person-group>
<year>2001</year>
<article-title>A novel method to identify protein kinase substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4/p38delta</article-title>. <source/>EMBO J
<volume>20</volume>:<fpage>4360</fpage>–<lpage>4369</lpage>. doi:<pub-id pub-id-type="doi">10.1093/emboj/20.16.4360</pub-id>.<pub-id pub-id-type="pmid">11500363</pub-id></mixed-citation>
</ref>
<ref id="B156">
<label>156.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Inoki</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Guan</surname><given-names>KL</given-names></name></person-group>
<year>2003</year>
<article-title>TSC2 mediates cellular energy response to control cell growth and survival</article-title>. <source/>Cell
<volume>115</volume>:<fpage>577</fpage>–<lpage>590</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0092-8674(03)00929-2</pub-id>.<pub-id pub-id-type="pmid">14651849</pub-id></mixed-citation>
</ref>
<ref id="B157">
<label>157.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Browne</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Finn</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Proud</surname><given-names>CG</given-names></name></person-group>
<year>2004</year>
<article-title>Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398</article-title>. <source/>J Biol Chem
<volume>279</volume>:<fpage>12220</fpage>–<lpage>12231</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M309773200</pub-id>.<pub-id pub-id-type="pmid">14709557</pub-id></mixed-citation>
</ref>
<ref id="B158">
<label>158.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faller</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Jackson</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Knight</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Ridgway</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Jamieson</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Karim</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Radulescu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Huels</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Myant</surname><given-names>KB</given-names></name>, <name name-style="western"><surname>Dudek</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Casey</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Scopelliti</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Cordero</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Vidal</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pende</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ryazanov</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Meyuhas</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>MN</given-names></name>, <name name-style="western"><surname>Bushell</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Willis</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Sansom</surname><given-names>OJ</given-names></name></person-group>
<year>2015</year>
<article-title>mTORC1-mediated translational elongation limits intestinal tumour initiation and growth</article-title>. <source/>Nature
<volume>517</volume>:<fpage>497</fpage>–<lpage>500</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature13896</pub-id>.<pub-id pub-id-type="pmid">25383520</pub-id></mixed-citation>
</ref>
<ref id="B159">
<label>159.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leprivier</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Rotblat</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Khan</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Jan</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Sorensen</surname><given-names>PH</given-names></name></person-group>
<year>2015</year>
<article-title>Stress-mediated translational control in cancer cells</article-title>. <source/>Biochim Biophys Acta
<volume>1849</volume>:<fpage>845</fpage>–<lpage>860</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbagrm.2014.11.002</pub-id>.<pub-id pub-id-type="pmid">25464034</pub-id></mixed-citation>
</ref>
<ref id="B160">
<label>160.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goke</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Goke</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Knolle</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Trusheim</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Schmidt</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wilmen</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Carmody</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Goke</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>YH</given-names></name></person-group>
<year>2002</year>
<article-title>DUG is a novel homologue of translation initiation factor 4G that binds eIF4A</article-title>. <source/>Biochem Biophys Res Commun
<volume>297</volume>:<fpage>78</fpage>–<lpage>82</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0006-291X(02)02129-0</pub-id>.<pub-id pub-id-type="pmid">12220511</pub-id></mixed-citation>
</ref>
<ref id="B161">
<label>161.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Jansen</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Komar</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Merrick</surname><given-names>WC</given-names></name>, <name name-style="western"><surname>Costes</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lockett</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Colburn</surname><given-names>NH</given-names></name></person-group>
<year>2003</year>
<article-title>The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation</article-title>. <source/>Mol Cell Biol
<volume>23</volume>:<fpage>26</fpage>–<lpage>37</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.23.1.26-37.2003</pub-id>.<pub-id pub-id-type="pmid">12482958</pub-id></mixed-citation>
</ref>
<ref id="B162">
<label>162.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Zakowicz</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hegamyer</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Colburn</surname><given-names>NH</given-names></name></person-group>
<year>2004</year>
<article-title>A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A</article-title>. <source/>Mol Cell Biol
<volume>24</volume>:<fpage>3894</fpage>–<lpage>3906</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.24.9.3894-3906.2004</pub-id>.<pub-id pub-id-type="pmid">15082783</pub-id></mixed-citation>
</ref>
<ref id="B163">
<label>163.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dorrello</surname><given-names>NV</given-names></name>, <name name-style="western"><surname>Peschiaroli</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Guardavaccaro</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Colburn</surname><given-names>NH</given-names></name>, <name name-style="western"><surname>Sherman</surname><given-names>NE</given-names></name>, <name name-style="western"><surname>Pagano</surname><given-names>M</given-names></name></person-group>
<year>2006</year>
<article-title>S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth</article-title>. <source/>Science
<volume>314</volume>:<fpage>467</fpage>–<lpage>471</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1130276</pub-id>.<pub-id pub-id-type="pmid">17053147</pub-id></mixed-citation>
</ref>
<ref id="B164">
<label>164.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galan</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Geraghty</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Lavoie</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Kanshin</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Tcherkezian</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Calabrese</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Jeschke</surname><given-names>GR</given-names></name>, <name name-style="western"><surname>Turk</surname><given-names>BE</given-names></name>, <name name-style="western"><surname>Ballif</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Thibault</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Roux</surname><given-names>PP</given-names></name></person-group>
<year>2014</year>
<article-title>Phosphoproteomic analysis identifies the tumor suppressor PDCD4 as a RSK substrate negatively regulated by 14-3-3</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>111</volume>:<fpage>E2918</fpage>–<lpage>E2927</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1405601111</pub-id>.<pub-id pub-id-type="pmid">25002506</pub-id></mixed-citation>
</ref>
<ref id="B165">
<label>165.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palamarchuk</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Efanov</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Maximov</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Aqeilan</surname><given-names>RI</given-names></name>, <name name-style="western"><surname>Croce</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Pekarsky</surname><given-names>Y</given-names></name></person-group>
<year>2005</year>
<article-title>Akt phosphorylates and regulates Pdcd4 tumor suppressor protein</article-title>. <source/>Cancer Res
<volume>65</volume>:<fpage>11282</fpage>–<lpage>11286</lpage>. doi:<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-3469</pub-id>.<pub-id pub-id-type="pmid">16357133</pub-id></mixed-citation>
</ref>
<ref id="B166">
<label>166.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grifo</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Abramson</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Satler</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Merrick</surname><given-names>WC</given-names></name></person-group>
<year>1984</year>
<article-title>RNA-stimulated ATPase activity of eukaryotic initiation factors</article-title>. <source/>J Biol Chem
<volume>259</volume>:<fpage>8648</fpage>–<lpage>8654</lpage>.<pub-id pub-id-type="pmid">6145716</pub-id></mixed-citation>
</ref>
<ref id="B167">
<label>167.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richter-Cook</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Dever</surname><given-names>TE</given-names></name>, <name name-style="western"><surname>Hensold</surname><given-names>JO</given-names></name>, <name name-style="western"><surname>Merrick</surname><given-names>WC</given-names></name></person-group>
<year>1998</year>
<article-title>Purification and characterization of a new eukaryotic protein translation factor. Eukaryotic initiation factor 4H</article-title>. <source/>J Biol Chem
<volume>273</volume>:<fpage>7579</fpage>–<lpage>7587</lpage>.<pub-id pub-id-type="pmid">9516461</pub-id></mixed-citation>
</ref>
<ref id="B168">
<label>168.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rogers</surname><given-names>GW</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Richter</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Lima</surname><given-names>WF</given-names></name>, <name name-style="western"><surname>Merrick</surname><given-names>WC</given-names></name></person-group>
<year>2001</year>
<article-title>Modulation of the helicase activity of eIF4A by eIF4B, eIF4H, and eIF4F</article-title>. <source/>J Biol Chem
<volume>276</volume>:<fpage>30914</fpage>–<lpage>30922</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M100157200</pub-id>.<pub-id pub-id-type="pmid">11418588</pub-id></mixed-citation>
</ref>
<ref id="B169">
<label>169.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rozen</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Edery</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Meerovitch</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Dever</surname><given-names>TE</given-names></name>, <name name-style="western"><surname>Merrick</surname><given-names>WC</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>
<year>1990</year>
<article-title>Bidirectional RNA helicase activity of eucaryotic translation initiation factors 4A and 4F</article-title>. <source/>Mol Cell Biol
<volume>10</volume>:<fpage>1134</fpage>–<lpage>1144</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.10.3.1134</pub-id>.<pub-id pub-id-type="pmid">2304461</pub-id></mixed-citation>
</ref>
<ref id="B170">
<label>170.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raught</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Peiretti</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Gingras</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Livingstone</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Shahbazian</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Mayeur</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Polakiewicz</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Hershey</surname><given-names>JW</given-names></name></person-group>
<year>2004</year>
<article-title>Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases</article-title>. <source/>EMBO J
<volume>23</volume>:<fpage>1761</fpage>–<lpage>1769</lpage>. doi:<pub-id pub-id-type="doi">10.1038/sj.emboj.7600193</pub-id>.<pub-id pub-id-type="pmid">15071500</pub-id></mixed-citation>
</ref>
<ref id="B171">
<label>171.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shahbazian</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Roux</surname><given-names>PP</given-names></name>, <name name-style="western"><surname>Mieulet</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Raught</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Taunton</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hershey</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Pende</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>
<year>2006</year>
<article-title>The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity</article-title>. <source/>EMBO J
<volume>25</volume>:<fpage>2781</fpage>–<lpage>2791</lpage>. doi:<pub-id pub-id-type="doi">10.1038/sj.emboj.7601166</pub-id>.<pub-id pub-id-type="pmid">16763566</pub-id></mixed-citation>
</ref>
<ref id="B172">
<label>172.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Gorp</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>van der Vos</surname><given-names>KE</given-names></name>, <name name-style="western"><surname>Brenkman</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Bremer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>van den Broek</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Zwartkruis</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Hershey</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Burgering</surname><given-names>BM</given-names></name>, <name name-style="western"><surname>Calkhoven</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>Coffer</surname><given-names>PJ</given-names></name></person-group>
<year>2009</year>
<article-title>AGC kinases regulate phosphorylation and activation of eukaryotic translation initiation factor 4B</article-title>. <source/>Oncogene
<volume>28</volume>:<fpage>95</fpage>–<lpage>106</lpage>. doi:<pub-id pub-id-type="doi">10.1038/onc.2008.367</pub-id>.<pub-id pub-id-type="pmid">18836482</pub-id></mixed-citation>
</ref>
<ref id="B173">
<label>173.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holz</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Ballif</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Gygi</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name></person-group>
<year>2005</year>
<article-title>mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events</article-title>. <source/>Cell
<volume>123</volume>:<fpage>569</fpage>–<lpage>580</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2005.10.024</pub-id>.<pub-id pub-id-type="pmid">16286006</pub-id></mixed-citation>
</ref>
<ref id="B174">
<label>174.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martineau</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Derry</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Yanagiya</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Berlanga</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Shyu</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Imataka</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Gehring</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>
<year>2008</year>
<article-title>Poly(A)-binding protein-interacting protein 1 binds to eukaryotic translation initiation factor 3 to stimulate translation</article-title>. <source/>Mol Cell Biol
<volume>28</volume>:<fpage>6658</fpage>–<lpage>6667</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.00738-08</pub-id>.<pub-id pub-id-type="pmid">18725400</pub-id></mixed-citation>
</ref>
<ref id="B175">
<label>175.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martineau</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Alain</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Petroulakis</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Shahbazian</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Fabre</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Bousquet-Dubouch</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Monsarrat</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Pyronnet</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>
<year>2014</year>
<article-title>Control of Paip1-eukayrotic translation initiation factor 3 interaction by amino acids through S6 kinase</article-title>. <source/>Mol Cell Biol
<volume>34</volume>:<fpage>1046</fpage>–<lpage>1053</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.01079-13</pub-id>.<pub-id pub-id-type="pmid">24396066</pub-id></mixed-citation>
</ref>
<ref id="B176">
<label>176.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richardson</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Broenstrup</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fingar</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Julich</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ballif</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Gygi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name></person-group>
<year>2004</year>
<article-title>SKAR is a specific target of S6 kinase 1 in cell growth control</article-title>. <source/>Curr Biol
<volume>14</volume>:<fpage>1540</fpage>–<lpage>1549</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cub.2004.08.061</pub-id>.<pub-id pub-id-type="pmid">15341740</pub-id></mixed-citation>
</ref>
<ref id="B177">
<label>177.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>XM</given-names></name>, <name name-style="western"><surname>Yoon</surname><given-names>SO</given-names></name>, <name name-style="western"><surname>Richardson</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Julich</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name></person-group>
<year>2008</year>
<article-title>SKAR links pre-mRNA splicing to mTOR/S6K1-mediated enhanced translation efficiency of spliced mRNAs</article-title>. <source/>Cell
<volume>133</volume>:<fpage>303</fpage>–<lpage>313</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2008.02.031</pub-id>.<pub-id pub-id-type="pmid">18423201</pub-id></mixed-citation>
</ref>
<ref id="B178">
<label>178.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fonseca</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Zakaria</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Jia</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Graber</surname><given-names>TE</given-names></name>, <name name-style="western"><surname>Svitkin</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Tahmasebi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Healy</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Hoang</surname><given-names>HD</given-names></name>, <name name-style="western"><surname>Jensen</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Diao</surname><given-names>IT</given-names></name>, <name name-style="western"><surname>Lussier</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dajadian</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Padmanabhan</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Matta-Camacho</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Hearnden</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Tsukumo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yanagiya</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Morita</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Petroulakis</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Gonzalez</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Hernandez</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Alain</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Damgaard</surname><given-names>CK</given-names></name></person-group>
<year>2015</year>
<article-title>La-related protein 1 (LARP1) represses terminal oligopyrimidine (TOP) mRNA translation downstream of mTOR complex 1 (mTORC1)</article-title>. <source/>J Biol Chem
<volume>290</volume>:<fpage>15996</fpage>–<lpage>16020</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M114.621730</pub-id>.<pub-id pub-id-type="pmid">25940091</pub-id></mixed-citation>
</ref>
<ref id="B179">
<label>179.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aoki</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Adachi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Homoto</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kusano</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Koike</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Natsume</surname><given-names>T</given-names></name></person-group>
<year>2013</year>
<article-title>LARP1 specifically recognizes the 3′ terminus of poly(A) mRNA</article-title>. <source/>FEBS Lett
<volume>587</volume>:<fpage>2173</fpage>–<lpage>2178</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.febslet.2013.05.035</pub-id>.<pub-id pub-id-type="pmid">23711370</pub-id></mixed-citation>
</ref>
<ref id="B180">
<label>180.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lahr</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Mack</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Heroux</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Blagden</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Bousquet-Antonelli</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Deragon</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Berman</surname><given-names>AJ</given-names></name></person-group>
<year>2015</year>
<article-title>The La-related protein 1-specific domain repurposes HEAT-like repeats to directly bind a 5′TOP sequence</article-title>. <source/>Nucleic Acids Res
<volume>43</volume>:<fpage>8077</fpage>–<lpage>8088</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkv748</pub-id>.<pub-id pub-id-type="pmid">26206669</pub-id></mixed-citation>
</ref>
<ref id="B181">
<label>181.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lahr</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Fonseca</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Ciotti</surname><given-names>GE</given-names></name>, <name name-style="western"><surname>Al-Ashtal</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Jia</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Niklaus</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Blagden</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Alain</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Berman</surname><given-names>AJ</given-names></name></person-group>
<year>2017</year>
<article-title>La-related protein 1 (LARP1) binds the mRNA cap, blocking eIF4F assembly on TOP mRNAs</article-title>. <source/>Elife
<volume>6</volume>:<elocation-id>e24146</elocation-id>. doi:<pub-id pub-id-type="doi">10.7554/eLife.24146</pub-id>.<pub-id pub-id-type="pmid">28379136</pub-id></mixed-citation>
</ref>
<ref id="B182">
<label>182.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Philippe</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Vasseur</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Debart</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Thoreen</surname><given-names>CC</given-names></name></person-group>
<year>2017</year>
<article-title>La-related protein 1 (LARP1) repression of TOP mRNA translation is mediated through its cap-binding domain and controlled by an adjacent regulatory region</article-title>. <source/>Nucleic Acids Res
<volume>46</volume>:<fpage>1457</fpage>–<lpage>1469</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkx1237</pub-id>.</mixed-citation>
</ref>
<ref id="B183">
<label>183.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gentilella</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Moron-Duran</surname><given-names>FD</given-names></name>, <name name-style="western"><surname>Fuentes</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Zweig-Rocha</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Riano-Canalias</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Pelletier</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ruiz</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Turon</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Castano</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Tauler</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bueno</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Menendez</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Kozma</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>G</given-names></name></person-group>
<year>2017</year>
<article-title>Autogenous control of 5′TOP mRNA stability by 40S ribosomes</article-title>. <source/>Mol Cell
<volume>67</volume>:<fpage>55</fpage>–<lpage>70.e54</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molcel.2017.06.005</pub-id>.<pub-id pub-id-type="pmid">28673543</pub-id></mixed-citation>
</ref>
<ref id="B184">
<label>184.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raught</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Gingras</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Gygi</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Imataka</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Morino</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gradi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Aebersold</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>
<year>2000</year>
<article-title>Serum-stimulated, rapamycin-sensitive phosphorylation sites in the eukaryotic translation initiation factor 4GI</article-title>. <source/>EMBO J
<volume>19</volume>:<fpage>434</fpage>–<lpage>444</lpage>. doi:<pub-id pub-id-type="doi">10.1093/emboj/19.3.434</pub-id>.<pub-id pub-id-type="pmid">10654941</pub-id></mixed-citation>
</ref>
<ref id="B185">
<label>185.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mayer</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yuan</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Grummt</surname><given-names>I</given-names></name></person-group>
<year>2004</year>
<article-title>mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability</article-title>. <source/>Genes Dev
<volume>18</volume>:<fpage>423</fpage>–<lpage>434</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gad.285504</pub-id>.<pub-id pub-id-type="pmid">15004009</pub-id></mixed-citation>
</ref>
<ref id="B186">
<label>186.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kantidakis</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ramsbottom</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Birch</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Dowding</surname><given-names>SN</given-names></name>, <name name-style="western"><surname>White</surname><given-names>RJ</given-names></name></person-group>
<year>2010</year>
<article-title>mTOR associates with TFIIIC, is found at tRNA and 5S rRNA genes, and targets their repressor Maf1</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>107</volume>:<fpage>11823</fpage>–<lpage>11828</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1005188107</pub-id>.<pub-id pub-id-type="pmid">20543138</pub-id></mixed-citation>
</ref>
<ref id="B187">
<label>187.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Michels</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Robitaille</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Buczynski-Ruchonnet</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Hodroj</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Reina</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>MN</given-names></name>, <name name-style="western"><surname>Hernandez</surname><given-names>N</given-names></name></person-group>
<year>2010</year>
<article-title>mTORC1 directly phosphorylates and regulates human MAF1</article-title>. <source/>Mol Cell Biol
<volume>30</volume>:<fpage>3749</fpage>–<lpage>3757</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.00319-10</pub-id>.<pub-id pub-id-type="pmid">20516213</pub-id></mixed-citation>
</ref>
<ref id="B188">
<label>188.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shor</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Shakey</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Toral-Barza</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Follettie</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>K</given-names></name></person-group>
<year>2010</year>
<article-title>Requirement of the mTOR kinase for the regulation of Maf1 phosphorylation and control of RNA polymerase III-dependent transcription in cancer cells</article-title>. <source/>J Biol Chem
<volume>285</volume>:<fpage>15380</fpage>–<lpage>15392</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M109.071639</pub-id>.<pub-id pub-id-type="pmid">20233713</pub-id></mixed-citation>
</ref>
<ref id="B189">
<label>189.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Tsang</surname><given-names>CK</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>XF</given-names></name></person-group>
<year>2009</year>
<article-title>Mechanisms of regulation of RNA polymerase III-dependent transcription by TORC1</article-title>. <source/>EMBO J
<volume>28</volume>:<fpage>2220</fpage>–<lpage>2230</lpage>. doi:<pub-id pub-id-type="doi">10.1038/emboj.2009.179</pub-id>.<pub-id pub-id-type="pmid">19574957</pub-id></mixed-citation>
</ref>
<ref id="B190">
<label>190.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kraft</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Deplazes</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sohrmann</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Peter</surname><given-names>M</given-names></name></person-group>
<year>2008</year>
<article-title>Mature ribosomes are selectively degraded upon starvation by an autophagy pathway requiring the Ubp3p/Bre5p ubiquitin protease</article-title>. <source/>Nat Cell Biol
<volume>10</volume>:<fpage>602</fpage>–<lpage>610</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ncb1723</pub-id>.<pub-id pub-id-type="pmid">18391941</pub-id></mixed-citation>
</ref>
<ref id="B191">
<label>191.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ossareh-Nazari</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Nino</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Bengtson</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Joazeiro</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Dargemont</surname><given-names>C</given-names></name></person-group>
<year>2014</year>
<article-title>Ubiquitylation by the Ltn1 E3 ligase protects 60S ribosomes from starvation-induced selective autophagy</article-title>. <source/>J Cell Biol
<volume>204</volume>:<fpage>909</fpage>–<lpage>917</lpage>. doi:<pub-id pub-id-type="doi">10.1083/jcb.201308139</pub-id>.<pub-id pub-id-type="pmid">24616224</pub-id></mixed-citation>
</ref>
<ref id="B192">
<label>192.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>An</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Harper</surname><given-names>JW</given-names></name></person-group>
<year>2018</year>
<article-title>Systematic analysis of ribophagy in human cells reveals bystander flux during selective autophagy</article-title>. <source/>Nat Cell Biol
<volume>20</volume>:<fpage>135</fpage>–<lpage>143</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41556-017-0007-x</pub-id>.<pub-id pub-id-type="pmid">29230017</pub-id></mixed-citation>
</ref>
<ref id="B193">
<label>193.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lodish</surname><given-names>HF</given-names></name></person-group>
<year>1971</year>
<article-title>Alpha and beta globin messenger ribonucleic acid. Different amounts and rates of initiation of translation</article-title>. <source/>J Biol Chem
<volume>246</volume>:<fpage>7131</fpage>–<lpage>7138</lpage>.<pub-id pub-id-type="pmid">5167019</pub-id></mixed-citation>
</ref>
<ref id="B194">
<label>194.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gandin</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Sikstrom</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Alain</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Morita</surname><given-names>M</given-names></name>, <name name-style="western"><surname>McLaughlan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Larsson</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Topisirovic</surname><given-names>I</given-names></name></person-group>
<year>2014</year>
<article-title>Polysome fractionation and analysis of mammalian translatomes on a genome-wide scale</article-title>. <source/>J Vis Exp doi:<pub-id pub-id-type="doi">10.3791/51455</pub-id>.</mixed-citation>
</ref>
<ref id="B195">
<label>195.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ingolia</surname><given-names>NT</given-names></name>, <name name-style="western"><surname>Ghaemmaghami</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Newman</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Weissman</surname><given-names>JS</given-names></name></person-group>
<year>2009</year>
<article-title>Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling</article-title>. <source/>Science
<volume>324</volume>:<fpage>218</fpage>–<lpage>223</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1168978</pub-id>.<pub-id pub-id-type="pmid">19213877</pub-id></mixed-citation>
</ref>
<ref id="B196">
<label>196.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kawasome</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Papst</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Webb</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Keller</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Gelfand</surname><given-names>EW</given-names></name>, <name name-style="western"><surname>Terada</surname><given-names>N</given-names></name></person-group>
<year>1998</year>
<article-title>Targeted disruption of p70(s6k) defines its role in protein synthesis and rapamycin sensitivity</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>95</volume>:<fpage>5033</fpage>–<lpage>5038</lpage>.<pub-id pub-id-type="pmid">9560223</pub-id></mixed-citation>
</ref>
<ref id="B197">
<label>197.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Loreni</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Amaldi</surname><given-names>F</given-names></name></person-group>
<year>2000</year>
<article-title>Transcription inhibitors stimulate translation of 5′ TOP mRNAs through activation of S6 kinase and the mTOR/FRAP signalling pathway</article-title>. <source/>Eur J Biochem
<volume>267</volume>:<fpage>6594</fpage>–<lpage>6601</lpage>. doi:<pub-id pub-id-type="doi">10.1046/j.1432-1327.2000.01753.x</pub-id>.<pub-id pub-id-type="pmid">11054111</pub-id></mixed-citation>
</ref>
<ref id="B198">
<label>198.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hornstein</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Stolovich</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Levy</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Livingstone</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Templeton</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Avruch</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Meyuhas</surname><given-names>O</given-names></name></person-group>
<year>2001</year>
<article-title>Amino acid-induced translation of TOP mRNAs is fully dependent on phosphatidylinositol 3-kinase-mediated signaling, is partially inhibited by rapamycin, and is independent of S6K1 and rpS6 phosphorylation</article-title>. <source/>Mol Cell Biol
<volume>21</volume>:<fpage>8671</fpage>–<lpage>8683</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.21.24.8671-8683.2001</pub-id>.<pub-id pub-id-type="pmid">11713299</pub-id></mixed-citation>
</ref>
<ref id="B199">
<label>199.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thoreen</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Chantranupong</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Keys</surname><given-names>HR</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Gray</surname><given-names>NS</given-names></name>, <name name-style="western"><surname>Sabatini</surname><given-names>DM</given-names></name></person-group>
<year>2012</year>
<article-title>A unifying model for mTORC1-mediated regulation of mRNA translation</article-title>. <source/>Nature
<volume>485</volume>:<fpage>109</fpage>–<lpage>113</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature11083</pub-id>.<pub-id pub-id-type="pmid">22552098</pub-id></mixed-citation>
</ref>
<ref id="B200">
<label>200.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shama</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Avni</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Frederickson</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Meyuhas</surname><given-names>O</given-names></name></person-group>
<year>1995</year>
<article-title>Overexpression of initiation factor eIF-4E does not relieve the translational repression of ribosomal protein mRNAs in quiescent cells</article-title>. <source/>Gene Expr
<volume>4</volume>:<fpage>241</fpage>–<lpage>252</lpage>.<pub-id pub-id-type="pmid">7787416</pub-id></mixed-citation>
</ref>
<ref id="B201">
<label>201.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miloslavski</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Avraham</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Iluz</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Hayouka</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Kasir</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mudhasani</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>SN</given-names></name>, <name name-style="western"><surname>Cybulski</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Ruegg</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Larsson</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Gandin</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Rajakumar</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Topisirovic</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Meyuhas</surname><given-names>O</given-names></name></person-group>
<year>2014</year>
<article-title>Oxygen sufficiency controls TOP mRNA translation via the TSC-Rheb-mTOR pathway in a 4E-BP-independent manner</article-title>. <source/>J Mol Cell Biol
<volume>6</volume>:<fpage>255</fpage>–<lpage>266</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jmcb/mju008</pub-id>.<pub-id pub-id-type="pmid">24627160</pub-id></mixed-citation>
</ref>
<ref id="B202">
<label>202.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Damgaard</surname><given-names>CK</given-names></name>, <name name-style="western"><surname>Lykke-Andersen</surname><given-names>J</given-names></name></person-group>
<year>2011</year>
<article-title>Translational coregulation of 5′TOP mRNAs by TIA-1 and TIAR</article-title>. <source/>Genes Dev
<volume>25</volume>:<fpage>2057</fpage>–<lpage>2068</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gad.17355911</pub-id>.<pub-id pub-id-type="pmid">21979918</pub-id></mixed-citation>
</ref>
<ref id="B203">
<label>203.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Panas</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Ivanov</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>P</given-names></name></person-group>
<year>2016</year>
<article-title>Mechanistic insights into mammalian stress granule dynamics</article-title>. <source/>J Cell Biol
<volume>215</volume>:<fpage>313</fpage>–<lpage>323</lpage>. doi:<pub-id pub-id-type="doi">10.1083/jcb.201609081</pub-id>.<pub-id pub-id-type="pmid">27821493</pub-id></mixed-citation>
</ref>
<ref id="B204">
<label>204.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patursky-Polischuk</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Kasir</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Miloslavski</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hayouka</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Hausner-Hanochi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Stolovich-Rain</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tsukerman</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Biton</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mudhasani</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>SN</given-names></name>, <name name-style="western"><surname>Meyuhas</surname><given-names>O</given-names></name></person-group>
<year>2014</year>
<article-title>Reassessment of the role of TSC, mTORC1 and microRNAs in amino acids-meditated translational control of TOP mRNAs</article-title>. <source/>PLoS One
<volume>9</volume>:<elocation-id>e109410</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0109410</pub-id>.<pub-id pub-id-type="pmid">25338081</pub-id></mixed-citation>
</ref>
<ref id="B205">
<label>205.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patursky-Polischuk</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Stolovich-Rain</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hausner-Hanochi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kasir</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cybulski</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Avruch</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ruegg</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>MN</given-names></name>, <name name-style="western"><surname>Meyuhas</surname><given-names>O</given-names></name></person-group>
<year>2009</year>
<article-title>The TSC-mTOR pathway mediates translational activation of TOP mRNAs by insulin largely in a raptor- or rictor-independent manner</article-title>. <source/>Mol Cell Biol
<volume>29</volume>:<fpage>640</fpage>–<lpage>649</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.00980-08</pub-id>.<pub-id pub-id-type="pmid">19047368</pub-id></mixed-citation>
</ref>
<ref id="B206">
<label>206.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsieh</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Edlind</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Ingolia</surname><given-names>NT</given-names></name>, <name name-style="western"><surname>Janes</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Sher</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>EY</given-names></name>, <name name-style="western"><surname>Stumpf</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Christensen</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bonham</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ren</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Jessen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Feldman</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Weissman</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Shokat</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Rommel</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ruggero</surname><given-names>D</given-names></name></person-group>
<year>2012</year>
<article-title>The translational landscape of mTOR signalling steers cancer initiation and metastasis</article-title>. <source/>Nature
<volume>485</volume>:<fpage>55</fpage>–<lpage>61</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature10912</pub-id>.<pub-id pub-id-type="pmid">22367541</pub-id></mixed-citation>
</ref>
<ref id="B207">
<label>207.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eliseeva</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Vorontsov</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Babeyev</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Buyanova</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sysoeva</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kondrashov</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Kulakovskiy</surname><given-names>I</given-names></name></person-group>
<year>2013</year>
<article-title>In silico motif analysis suggests an interplay of transcriptional and translational control in mTOR response</article-title>. <source/>Translation (Austin)
<volume>1</volume>:<fpage>e27469</fpage>.<pub-id pub-id-type="pmid">26955507</pub-id></mixed-citation>
</ref>
<ref id="B208">
<label>208.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Larsson</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Morita</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Topisirovic</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Alain</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Blouin</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Pollak</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>
<year>2012</year>
<article-title>Distinct perturbation of the translatome by the antidiabetic drug metformin</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>109</volume>:<fpage>8977</fpage>–<lpage>8982</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1201689109</pub-id>.<pub-id pub-id-type="pmid">22611195</pub-id></mixed-citation>
</ref>
<ref id="B209">
<label>209.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Benedetti</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Graff</surname><given-names>JR</given-names></name></person-group>
<year>2004</year>
<article-title>eIF-4E expression and its role in malignancies and metastases</article-title>. <source/>Oncogene
<volume>23</volume>:<fpage>3189</fpage>–<lpage>3199</lpage>. doi:<pub-id pub-id-type="doi">10.1038/sj.onc.1207545</pub-id>.<pub-id pub-id-type="pmid">15094768</pub-id></mixed-citation>
</ref>
<ref id="B210">
<label>210.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Graff</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Konicek</surname><given-names>BW</given-names></name>, <name name-style="western"><surname>Carter</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Marcusson</surname><given-names>EG</given-names></name></person-group>
<year>2008</year>
<article-title>Targeting the eukaryotic translation initiation factor 4E for cancer therapy</article-title>. <source/>Cancer Res
<volume>68</volume>:<fpage>631</fpage>–<lpage>634</lpage>. doi:<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-5635</pub-id>.<pub-id pub-id-type="pmid">18245460</pub-id></mixed-citation>
</ref>
<ref id="B211">
<label>211.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Colina</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Costa-Mattioli</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Dowling</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Jaramillo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tai</surname><given-names>LH</given-names></name>, <name name-style="western"><surname>Breitbach</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Martineau</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Larsson</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Rong</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Svitkin</surname><given-names>YV</given-names></name>, <name name-style="western"><surname>Makrigiannis</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Bell</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>
<year>2008</year>
<article-title>Translational control of the innate immune response through IRF-7</article-title>. <source/>Nature
<volume>452</volume>:<fpage>323</fpage>–<lpage>328</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature06730</pub-id>.<pub-id pub-id-type="pmid">18272964</pub-id></mixed-citation>
</ref>
<ref id="B212">
<label>212.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lynch</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fitzgerald</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Johnston</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Schmidt</surname><given-names>EV</given-names></name></person-group>
<year>2004</year>
<article-title>Activated eIF4E-binding protein slows G1 progression and blocks transformation by c-myc without inhibiting cell growth</article-title>. <source/>J Biol Chem
<volume>279</volume>:<fpage>3327</fpage>–<lpage>3339</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M310872200</pub-id>.<pub-id pub-id-type="pmid">14607835</pub-id></mixed-citation>
</ref>
<ref id="B213">
<label>213.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petroulakis</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Parsyan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dowling</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>LeBacquer</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Martineau</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Bidinosti</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Larsson</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Alain</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Rong</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Mamane</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Paquet</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Furic</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Topisirovic</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Shahbazian</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Livingstone</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Costa-Mattioli</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Teodoro</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>
<year>2009</year>
<article-title>p53-dependent translational control of senescence and transformation via 4E-BPs</article-title>. <source/>Cancer Cell
<volume>16</volume>:<fpage>439</fpage>–<lpage>446</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ccr.2009.09.025</pub-id>.<pub-id pub-id-type="pmid">19878875</pub-id></mixed-citation>
</ref>
<ref id="B214">
<label>214.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Graff</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Zimmer</surname><given-names>SG</given-names></name></person-group>
<year>2003</year>
<article-title>Translational control and metastatic progression: enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs</article-title>. <source/>Clin Exp Metastasis
<volume>20</volume>:<fpage>265</fpage>–<lpage>273</lpage>. doi:<pub-id pub-id-type="doi">10.1023/A:1022943419011</pub-id>.<pub-id pub-id-type="pmid">12741684</pub-id></mixed-citation>
</ref>
<ref id="B215">
<label>215.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koromilas</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Lazaris-Karatzas</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>
<year>1992</year>
<article-title>mRNAs containing extensive secondary structure in their 5′ non-coding region translate efficiently in cells overexpressing initiation factor eIF-4E</article-title>. <source/>EMBO J
<volume>11</volume>:<fpage>4153</fpage>–<lpage>4158</lpage>.<pub-id pub-id-type="pmid">1396596</pub-id></mixed-citation>
</ref>
<ref id="B216">
<label>216.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>
<year>2008</year>
<article-title>eIF4E, the mRNA cap-binding protein: from basic discovery to translational research</article-title>. <source/>Biochem Cell Biol
<volume>86</volume>:<fpage>178</fpage>–<lpage>183</lpage>. doi:<pub-id pub-id-type="doi">10.1139/O08-034</pub-id>.<pub-id pub-id-type="pmid">18443631</pub-id></mixed-citation>
</ref>
<ref id="B217">
<label>217.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Svitkin</surname><given-names>YV</given-names></name>, <name name-style="western"><surname>Pause</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Haghighat</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pyronnet</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Witherell</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Belsham</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>
<year>2001</year>
<article-title>The requirement for eukaryotic initiation factor 4A (elF4A) in translation is in direct proportion to the degree of mRNA 5′ secondary structure</article-title>. <source/>RNA
<volume>7</volume>:<fpage>382</fpage>–<lpage>394</lpage>. doi:<pub-id pub-id-type="doi">10.1017/S135583820100108X</pub-id>.<pub-id pub-id-type="pmid">11333019</pub-id></mixed-citation>
</ref>
<ref id="B218">
<label>218.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feoktistova</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tuvshintogs</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Do</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fraser</surname><given-names>CS</given-names></name></person-group>
<year>2013</year>
<article-title>Human eIF4E promotes mRNA restructuring by stimulating eIF4A helicase activity</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>110</volume>:<fpage>13339</fpage>–<lpage>13344</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1303781110</pub-id>.<pub-id pub-id-type="pmid">23901100</pub-id></mixed-citation>
</ref>
<ref id="B219">
<label>219.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garcia-Garcia</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Frieda</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Feoktistova</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Fraser</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Block</surname><given-names>SM</given-names></name></person-group>
<year>2015</year>
<article-title>Factor-dependent processivity in human eIF4A DEAD-box helicase</article-title>. <source/>Science
<volume>348</volume>:<fpage>1486</fpage>–<lpage>1488</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.aaa5089</pub-id>.<pub-id pub-id-type="pmid">26113725</pub-id></mixed-citation>
</ref>
<ref id="B220">
<label>220.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kozak</surname><given-names>M</given-names></name></person-group>
<year>1987</year>
<article-title>An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs</article-title>. <source/>Nucleic Acids Res
<volume>15</volume>:<fpage>8125</fpage>–<lpage>8148</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/15.20.8125</pub-id>.<pub-id pub-id-type="pmid">3313277</pub-id></mixed-citation>
</ref>
<ref id="B221">
<label>221.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Masvidal</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Hulea</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Furic</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Topisirovic</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Larsson</surname><given-names>O</given-names></name></person-group>
<year>2017</year>
<article-title>mTOR-sensitive translation: cleared fog reveals more trees</article-title>. <source/>RNA Biol
<volume>14</volume>:<fpage>1299</fpage>–<lpage>1305</lpage>. doi:<pub-id pub-id-type="doi">10.1080/15476286.2017.1290041</pub-id>.<pub-id pub-id-type="pmid">28277937</pub-id></mixed-citation>
</ref>
<ref id="B222">
<label>222.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gandin</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Masvidal</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Hulea</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Gravel</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Cargnello</surname><given-names>M</given-names></name>, <name name-style="western"><surname>McLaughlan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cai</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Balanathan</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Morita</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rajakumar</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Furic</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Pollak</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Porco</surname><given-names>JA</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>St-Pierre</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Pelletier</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Larsson</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Topisirovic</surname><given-names>I</given-names></name></person-group>
<year>2016</year>
<article-title>nanoCAGE reveals 5′ UTR features that define specific modes of translation of functionally related MTOR-sensitive mRNAs</article-title>. <source/>Genome Res
<volume>26</volume>:<fpage>636</fpage>–<lpage>648</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gr.197566.115</pub-id>.<pub-id pub-id-type="pmid">26984228</pub-id></mixed-citation>
</ref>
<ref id="B223">
<label>223.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elfakess</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Sinvani</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Haimov</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Svitkin</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Dikstein</surname><given-names>R</given-names></name></person-group>
<year>2011</year>
<article-title>Unique translation initiation of mRNAs-containing TISU element</article-title>. <source/>Nucleic Acids Res
<volume>39</volume>:<fpage>7598</fpage>–<lpage>7609</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkr484</pub-id>.<pub-id pub-id-type="pmid">21705780</pub-id></mixed-citation>
</ref>
<ref id="B224">
<label>224.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sinvani</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Haimov</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Svitkin</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Tamarkin-Ben-Harush</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Viollet</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Dikstein</surname><given-names>R</given-names></name></person-group>
<year>2015</year>
<article-title>Translational tolerance of mitochondrial genes to metabolic energy stress involves TISU and eIF1-eIF4GI cooperation in start codon selection</article-title>. <source/>Cell Metab
<volume>21</volume>:<fpage>479</fpage>–<lpage>492</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cmet.2015.02.010</pub-id>.<pub-id pub-id-type="pmid">25738462</pub-id></mixed-citation>
</ref>
<ref id="B225">
<label>225.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haimov</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Sinvani</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ulitsky</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Emmanuel</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Tamarkin-Ben-Harush</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Vardy</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dikstein</surname><given-names>R</given-names></name></person-group>
<year>2017</year>
<article-title>Efficient and accurate translation initiation directed by TISU involves RPS3 and RPS10e binding and differential eukaryotic initiation factor 1A regulation</article-title>. <source/>Mol Cell Biol
<volume>37</volume>:<elocation-id>e00150-17</elocation-id>. doi:<pub-id pub-id-type="doi">10.1128/MCB.00150-17</pub-id>.<pub-id pub-id-type="pmid">28584194</pub-id></mixed-citation>
</ref>
<ref id="B226">
<label>226.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Modelska</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Turro</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Russell</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Beaton</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sbarrato</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Spriggs</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Graf</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Provenzano</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Blows</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Pharoah</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Caldas</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Le Quesne</surname><given-names>J</given-names></name></person-group>
<year>2015</year>
<article-title>The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape</article-title>. <source/>Cell Death Dis
<volume>6</volume>:<fpage>e1603</fpage>. doi:<pub-id pub-id-type="doi">10.1038/cddis.2014.542</pub-id>.<pub-id pub-id-type="pmid">25611378</pub-id></mixed-citation>
</ref>
<ref id="B227">
<label>227.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramirez-Valle</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Braunstein</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zavadil</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Formenti</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>RJ</given-names></name></person-group>
<year>2008</year>
<article-title>eIF4GI links nutrient sensing by mTOR to cell proliferation and inhibition of autophagy</article-title>. <source/>J Cell Biol
<volume>181</volume>:<fpage>293</fpage>–<lpage>307</lpage>. doi:<pub-id pub-id-type="doi">10.1083/jcb.200710215</pub-id>.<pub-id pub-id-type="pmid">18426977</pub-id></mixed-citation>
</ref>
<ref id="B228">
<label>228.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rubio</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Weisburd</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Holderfield</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Arias</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Fang</surname><given-names>E</given-names></name>, <name name-style="western"><surname>DeRisi</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Fanidi</surname><given-names>A</given-names></name></person-group>
<year>2014</year>
<article-title>Transcriptome-wide characterization of the eIF4A signature highlights plasticity in translation regulation</article-title>. <source/>Genome Biol
<volume>15</volume>:<fpage>476</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13059-014-0476-1</pub-id>.<pub-id pub-id-type="pmid">25273840</pub-id></mixed-citation>
</ref>
<ref id="B229">
<label>229.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolfe</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Zhong</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Drewe</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Rajasekhar</surname><given-names>VK</given-names></name>, <name name-style="western"><surname>Sanghvi</surname><given-names>VR</given-names></name>, <name name-style="western"><surname>Mavrakis</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Roderick</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Van der Meulen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Schatz</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Rodrigo</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Rondou</surname><given-names>P</given-names></name>, <name name-style="western"><surname>de Stanchina</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Teruya-Feldstein</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kelliher</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Speleman</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Porco</surname><given-names>JA</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Pelletier</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ratsch</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Wendel</surname><given-names>HG</given-names></name></person-group>
<year>2014</year>
<article-title>RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer</article-title>. <source/>Nature
<volume>513</volume>:<fpage>65</fpage>–<lpage>70</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature13485</pub-id>.<pub-id pub-id-type="pmid">25079319</pub-id></mixed-citation>
</ref>
<ref id="B230">
<label>230.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Csibi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Yoon</surname><given-names>SO</given-names></name>, <name name-style="western"><surname>Tong</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ilter</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Elia</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Fendt</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Roberts</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name></person-group>
<year>2014</year>
<article-title>The mTORC1/S6K1 pathway regulates glutamine metabolism through the eIF4B-dependent control of c-Myc translation</article-title>. <source/>Curr Biol
<volume>24</volume>:<fpage>2274</fpage>–<lpage>2280</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cub.2014.08.007</pub-id>.<pub-id pub-id-type="pmid">25220053</pub-id></mixed-citation>
</ref>
<ref id="B231">
<label>231.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shahbazian</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Parsyan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Petroulakis</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Topisirovic</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Martineau</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Gibbs</surname><given-names>BF</given-names></name>, <name name-style="western"><surname>Svitkin</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>
<year>2010</year>
<article-title>Control of cell survival and proliferation by mammalian eukaryotic initiation factor 4B</article-title>. <source/>Mol Cell Biol
<volume>30</volume>:<fpage>1478</fpage>–<lpage>1485</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.01218-09</pub-id>.<pub-id pub-id-type="pmid">20086100</pub-id></mixed-citation>
</ref>
<ref id="B232">
<label>232.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gandin</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Masvidal</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Cargnello</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gyenis</surname><given-names>L</given-names></name>, <name name-style="western"><surname>McLaughlan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cai</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Tenkerian</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Morita</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Balanathan</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Jean-Jean</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Stambolic</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Trost</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Furic</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Larose</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Koromilas</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Asano</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Litchfield</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Larsson</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Topisirovic</surname><given-names>I</given-names></name></person-group>
<year>2016</year>
<article-title>mTORC1 and CK2 coordinate ternary and eIF4F complex assembly</article-title>. <source/>Nat Commun
<volume>7</volume>:<fpage>11127</fpage>. doi:<pub-id pub-id-type="doi">10.1038/ncomms11127</pub-id>.<pub-id pub-id-type="pmid">27040916</pub-id></mixed-citation>
</ref>
<ref id="B233">
<label>233.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Widmann</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Gibson</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Jarpe</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>GL</given-names></name></person-group>
<year>1999</year>
<article-title>Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human</article-title>. <source/>Physiol Rev
<volume>79</volume>:<fpage>143</fpage>–<lpage>180</lpage>. doi:<pub-id pub-id-type="doi">10.1152/physrev.1999.79.1.143</pub-id>.<pub-id pub-id-type="pmid">9922370</pub-id></mixed-citation>
</ref>
<ref id="B234">
<label>234.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Gibson</surname><given-names>TB</given-names></name>, <name name-style="western"><surname>Robinson</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Silvestro</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Pearson</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Wright</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Vanderbilt</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cobb</surname><given-names>MH</given-names></name></person-group>
<year>2001</year>
<article-title>MAP kinases</article-title>. <source/>Chem Rev
<volume>101</volume>:<fpage>2449</fpage>–<lpage>2476</lpage>. doi:<pub-id pub-id-type="doi">10.1021/cr000241p</pub-id>.<pub-id pub-id-type="pmid">11749383</pub-id></mixed-citation>
</ref>
<ref id="B235">
<label>235.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kyriakis</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Avruch</surname><given-names>J</given-names></name></person-group>
<year>2001</year>
<article-title>Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation</article-title>. <source/>Physiol Rev
<volume>81</volume>:<fpage>807</fpage>–<lpage>869</lpage>. doi:<pub-id pub-id-type="doi">10.1152/physrev.2001.81.2.807</pub-id>.<pub-id pub-id-type="pmid">11274345</pub-id></mixed-citation>
</ref>
<ref id="B236">
<label>236.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pearson</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Robinson</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Beers Gibson</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>BE</given-names></name>, <name name-style="western"><surname>Karandikar</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Berman</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Cobb</surname><given-names>MH</given-names></name></person-group>
<year>2001</year>
<article-title>Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions</article-title>. <source/>Endocr Rev
<volume>22</volume>:<fpage>153</fpage>–<lpage>183</lpage>.<pub-id pub-id-type="pmid">11294822</pub-id></mixed-citation>
</ref>
<ref id="B237">
<label>237.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roux</surname><given-names>PP</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name></person-group>
<year>2004</year>
<article-title>ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions</article-title>. <source/>Microbiol Mol Biol Rev
<volume>68</volume>:<fpage>320</fpage>–<lpage>344</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MMBR.68.2.320-344.2004</pub-id>.<pub-id pub-id-type="pmid">15187187</pub-id></mixed-citation>
</ref>
<ref id="B238">
<label>238.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cargnello</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Roux</surname><given-names>PP</given-names></name></person-group>
<year>2011</year>
<article-title>Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases</article-title>. <source/>Microbiol Mol Biol Rev
<volume>75</volume>:<fpage>50</fpage>–<lpage>83</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MMBR.00031-10</pub-id>.<pub-id pub-id-type="pmid">21372320</pub-id></mixed-citation>
</ref>
<ref id="B239">
<label>239.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gaestel</surname><given-names>M</given-names></name></person-group>
<year>2006</year>
<article-title>MAPKAP kinases—MKs—two's company, three's a crowd</article-title>. <source/>Nat Rev Mol Cell Biol
<volume>7</volume>:<fpage>120</fpage>–<lpage>130</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrm1834</pub-id>.<pub-id pub-id-type="pmid">16421520</pub-id></mixed-citation>
</ref>
<ref id="B240">
<label>240.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buxade</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Parra-Palau</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Proud</surname><given-names>CG</given-names></name></person-group>
<year>2008</year>
<article-title>The Mnks: MAP kinase-interacting kinases (MAP kinase signal-integrating kinases)</article-title>. <source/>Front Biosci
<volume>13</volume>:<fpage>5359</fpage>–<lpage>5373</lpage>. doi:<pub-id pub-id-type="doi">10.2741/3086</pub-id>.<pub-id pub-id-type="pmid">18508592</pub-id></mixed-citation>
</ref>
<ref id="B241">
<label>241.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carriere</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ray</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Roux</surname><given-names>PP</given-names></name></person-group>
<year>2008</year>
<article-title>The RSK factors of activating the Ras/MAPK signaling cascade</article-title>. <source/>Front Biosci
<volume>13</volume>:<fpage>4258</fpage>–<lpage>4275</lpage>. doi:<pub-id pub-id-type="doi">10.2741/3003</pub-id>.<pub-id pub-id-type="pmid">18508509</pub-id></mixed-citation>
</ref>
<ref id="B242">
<label>242.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Flynn</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Proud</surname><given-names>CG</given-names></name></person-group>
<year>1995</year>
<article-title>Serine 209, not serine 53, is the major site of phosphorylation in initiation factor eIF-4E in serum-treated Chinese hamster ovary cells</article-title>. <source/>J Biol Chem
<volume>270</volume>:<fpage>21684</fpage>–<lpage>21688</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.270.37.21684</pub-id>.<pub-id pub-id-type="pmid">7665584</pub-id></mixed-citation>
</ref>
<ref id="B243">
<label>243.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Joshi</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Cai</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Keiper</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Minich</surname><given-names>WB</given-names></name>, <name name-style="western"><surname>Mendez</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Beach</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Stepinski</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Stolarski</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Darzynkiewicz</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Rhoads</surname><given-names>RE</given-names></name></person-group>
<year>1995</year>
<article-title>Phosphorylation of eukaryotic protein synthesis initiation factor 4E at Ser-209</article-title>. <source/>J Biol Chem
<volume>270</volume>:<fpage>14597</fpage>–<lpage>14603</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.270.24.14597</pub-id>.<pub-id pub-id-type="pmid">7782323</pub-id></mixed-citation>
</ref>
<ref id="B244">
<label>244.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fukunaga</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hunter</surname><given-names>T</given-names></name></person-group>
<year>1997</year>
<article-title>MNK1, a new MAP kinase-activate protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates</article-title>. <source/>EMBO J
<volume>16</volume>:<fpage>1921</fpage>–<lpage>1997</lpage>. doi:<pub-id pub-id-type="doi">10.1093/emboj/16.8.1921</pub-id>.<pub-id pub-id-type="pmid">9155018</pub-id></mixed-citation>
</ref>
<ref id="B245">
<label>245.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Waskiewicz</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Flynn</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Proud</surname><given-names>CG</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>JA</given-names></name></person-group>
<year>1997</year>
<article-title>Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2</article-title>. <source/>EMBO J
<volume>16</volume>:<fpage>1909</fpage>–<lpage>1920</lpage>. doi:<pub-id pub-id-type="doi">10.1093/emboj/16.8.1909</pub-id>.<pub-id pub-id-type="pmid">9155017</pub-id></mixed-citation>
</ref>
<ref id="B246">
<label>246.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O'Loghlen</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gonzalez</surname><given-names>VM</given-names></name>, <name name-style="western"><surname>Pineiro</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Perez-Morgado</surname><given-names>MI</given-names></name>, <name name-style="western"><surname>Salinas</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>ME</given-names></name></person-group>
<year>2004</year>
<article-title>Identification and molecular characterization of Mnk1b, a splice variant of human MAP kinase-interacting kinase Mnk1</article-title>. <source/>Exp Cell Res
<volume>299</volume>:<fpage>343</fpage>–<lpage>355</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.yexcr.2004.06.006</pub-id>.<pub-id pub-id-type="pmid">15350534</pub-id></mixed-citation>
</ref>
<ref id="B247">
<label>247.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scheper</surname><given-names>GC</given-names></name>, <name name-style="western"><surname>Parra</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Wilson</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Van Kollenburg</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Vertegaal</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>ZG</given-names></name>, <name name-style="western"><surname>Proud</surname><given-names>CG</given-names></name></person-group>
<year>2003</year>
<article-title>The N and C termini of the splice variants of the human mitogen-activated protein kinase-interacting kinase Mnk2 determine activity and localization</article-title>. <source/>Mol Cell Biol
<volume>23</volume>:<fpage>5692</fpage>–<lpage>5705</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.23.16.5692-5705.2003</pub-id>.<pub-id pub-id-type="pmid">12897141</pub-id></mixed-citation>
</ref>
<ref id="B248">
<label>248.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scheper</surname><given-names>GC</given-names></name>, <name name-style="western"><surname>Morrice</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Kleijn</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Proud</surname><given-names>CG</given-names></name></person-group>
<year>2001</year>
<article-title>The mitogen-activated protein kinase signal-integrating kinase Mnk2 is a eukaryotic initiation factor 4E kinase with high levels of basal activity in mammalian cells</article-title>. <source/>Mol Cell Biol
<volume>21</volume>:<fpage>743</fpage>–<lpage>754</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.21.3.743-754.2001</pub-id>.<pub-id pub-id-type="pmid">11154262</pub-id></mixed-citation>
</ref>
<ref id="B249">
<label>249.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goto</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Yao</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Proud</surname><given-names>CG</given-names></name></person-group>
<year>2009</year>
<article-title>The C-terminal domain of Mnk1a plays a dual role in tightly regulating its activity</article-title>. <source/>Biochem J
<volume>423</volume>:<fpage>279</fpage>–<lpage>290</lpage>. doi:<pub-id pub-id-type="doi">10.1042/BJ20090228</pub-id>.<pub-id pub-id-type="pmid">19650764</pub-id></mixed-citation>
</ref>
<ref id="B250">
<label>250.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pyronnet</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Imataka</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Gingras</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Fukunaga</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hunter</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>
<year>1999</year>
<article-title>Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E</article-title>. <source/>EMBO J
<volume>18</volume>:<fpage>270</fpage>–<lpage>279</lpage>. doi:<pub-id pub-id-type="doi">10.1093/emboj/18.1.270</pub-id>.<pub-id pub-id-type="pmid">9878069</pub-id></mixed-citation>
</ref>
<ref id="B251">
<label>251.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lachance</surname><given-names>PE</given-names></name>, <name name-style="western"><surname>Miron</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Raught</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Lasko</surname><given-names>P</given-names></name></person-group>
<year>2002</year>
<article-title>Phosphorylation of eukaryotic translation initiation factor 4E is critical for growth</article-title>. <source/>Mol Cell Biol
<volume>22</volume>:<fpage>1656</fpage>–<lpage>1663</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.22.6.1656-1663.2002</pub-id>.<pub-id pub-id-type="pmid">11865045</pub-id></mixed-citation>
</ref>
<ref id="B252">
<label>252.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Furic</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Rong</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Larsson</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Koumakpayi</surname><given-names>IH</given-names></name>, <name name-style="western"><surname>Yoshida</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Brueschke</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Petroulakis</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Robichaud</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Pollak</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gaboury</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Pandolfi</surname><given-names>PP</given-names></name>, <name name-style="western"><surname>Saad</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>
<year>2010</year>
<article-title>eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>107</volume>:<fpage>14134</fpage>–<lpage>14139</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1005320107</pub-id>.<pub-id pub-id-type="pmid">20679199</pub-id></mixed-citation>
</ref>
<ref id="B253">
<label>253.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ueda</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Watanabe-Fukunaga</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Fukuyama</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Nagata</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fukunaga</surname><given-names>R</given-names></name></person-group>
<year>2004</year>
<article-title>Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development</article-title>. <source/>Mol Cell Biol
<volume>24</volume>:<fpage>6539</fpage>–<lpage>6549</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.24.15.6539-6549.2004</pub-id>.<pub-id pub-id-type="pmid">15254222</pub-id></mixed-citation>
</ref>
<ref id="B254">
<label>254.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Proud</surname><given-names>CG</given-names></name></person-group>
<year>2015</year>
<article-title>Mnks, eIF4E phosphorylation and cancer</article-title>. <source/>Biochim Biophys Acta
<volume>1849</volume>:<fpage>766</fpage>–<lpage>773</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbagrm.2014.10.003</pub-id>.<pub-id pub-id-type="pmid">25450520</pub-id></mixed-citation>
</ref>
<ref id="B255">
<label>255.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Topisirovic</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Ruiz-Gutierrez</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Borden</surname><given-names>KL</given-names></name></person-group>
<year>2004</year>
<article-title>Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities</article-title>. <source/>Cancer Res
<volume>64</volume>:<fpage>8639</fpage>–<lpage>8642</lpage>. doi:<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-2677</pub-id>.<pub-id pub-id-type="pmid">15574771</pub-id></mixed-citation>
</ref>
<ref id="B256">
<label>256.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wendel</surname><given-names>HG</given-names></name>, <name name-style="western"><surname>Silva</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Malina</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mills</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ueda</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Watanabe-Fukunaga</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Fukunaga</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Teruya-Feldstein</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Pelletier</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lowe</surname><given-names>SW</given-names></name></person-group>
<year>2007</year>
<article-title>Dissecting eIF4E action in tumorigenesis</article-title>. <source/>Genes Dev
<volume>21</volume>:<fpage>3232</fpage>–<lpage>3237</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gad.1604407</pub-id>.<pub-id pub-id-type="pmid">18055695</pub-id></mixed-citation>
</ref>
<ref id="B257">
<label>257.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ueda</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sasaki</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Elia</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Chio</surname><given-names>II</given-names></name>, <name name-style="western"><surname>Hamada</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Fukunaga</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Mak</surname><given-names>TW</given-names></name></person-group>
<year>2010</year>
<article-title>Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>107</volume>:<fpage>13984</fpage>–<lpage>13990</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1008136107</pub-id>.<pub-id pub-id-type="pmid">20679220</pub-id></mixed-citation>
</ref>
<ref id="B258">
<label>258.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marcotrigiano</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Gingras</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Burley</surname><given-names>SK</given-names></name></person-group>
<year>1997</year>
<article-title>Cocrystal structure of the messenger RNA 5′ cap-binding protein (eIF4E) bound to 7-methyl-GDP</article-title>. <source/>Cell
<volume>89</volume>:<fpage>951</fpage>–<lpage>961</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0092-8674(00)80280-9</pub-id>.<pub-id pub-id-type="pmid">9200613</pub-id></mixed-citation>
</ref>
<ref id="B259">
<label>259.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matsuo</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>H</given-names></name>, <name name-style="western"><surname>McGuire</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Fletcher</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Gingras</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Wagner</surname><given-names>G</given-names></name></person-group>
<year>1997</year>
<article-title>Structure of translation factor eIF4E bound to m7GDP and interaction with 4E-binding protein</article-title>. <source/>Nat Struct Biol
<volume>4</volume>:<fpage>717</fpage>–<lpage>724</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nsb0997-717</pub-id>.<pub-id pub-id-type="pmid">9302999</pub-id></mixed-citation>
</ref>
<ref id="B260">
<label>260.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scheper</surname><given-names>GC</given-names></name>, <name name-style="western"><surname>van Kollenburg</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Goss</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Proud</surname><given-names>CG</given-names></name></person-group>
<year>2002</year>
<article-title>Phosphorylation of eukaryotic initiation factor 4E markedly reduces its affinity for capped mRNA</article-title>. <source/>J Biol Chem
<volume>277</volume>:<fpage>3303</fpage>–<lpage>3309</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M103607200</pub-id>.<pub-id pub-id-type="pmid">11723111</pub-id></mixed-citation>
</ref>
<ref id="B261">
<label>261.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Slepenkov</surname><given-names>SV</given-names></name>, <name name-style="western"><surname>Darzynkiewicz</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Rhoads</surname><given-names>RE</given-names></name></person-group>
<year>2006</year>
<article-title>Stopped-flow kinetic analysis of eIF4E and phosphorylated eIF4E binding to cap analogs and capped oligoribonucleotides: evidence for a one-step binding mechanism</article-title>. <source/>J Biol Chem
<volume>281</volume>:<fpage>14927</fpage>–<lpage>14938</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M601653200</pub-id>.<pub-id pub-id-type="pmid">16540463</pub-id></mixed-citation>
</ref>
<ref id="B262">
<label>262.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaspar</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Rychlik</surname><given-names>W</given-names></name>, <name name-style="western"><surname>White</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Rhoads</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Morris</surname><given-names>DR</given-names></name></person-group>
<year>1990</year>
<article-title>Simultaneous cytoplasmic redistribution of ribosomal protein L32 mRNA and phosphorylation of eukaryotic initiation factor 4E after mitogenic stimulation of Swiss 3T3 cells</article-title>. <source/>J Biol Chem
<volume>265</volume>:<fpage>3619</fpage>–<lpage>3622</lpage>.<pub-id pub-id-type="pmid">2303467</pub-id></mixed-citation>
</ref>
<ref id="B263">
<label>263.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manzella</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Rychlik</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Rhoads</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Hershey</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Blackshear</surname><given-names>PJ</given-names></name></person-group>
<year>1991</year>
<article-title>Insulin induction of ornithine decarboxylase. Importance of mRNA secondary structure and phosphorylation of eucaryotic initiation factors eIF-4B and eIF-4E</article-title>. <source/>J Biol Chem
<volume>266</volume>:<fpage>2383</fpage>–<lpage>2389</lpage>.<pub-id pub-id-type="pmid">1989989</pub-id></mixed-citation>
</ref>
<ref id="B264">
<label>264.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walsh</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Mohr</surname><given-names>I</given-names></name></person-group>
<year>2004</year>
<article-title>Phosphorylation of eIF4E by Mnk-1 enhances HSV-1 translation and replication in quiescent cells</article-title>. <source/>Genes Dev
<volume>18</volume>:<fpage>660</fpage>–<lpage>672</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gad.1185304</pub-id>.<pub-id pub-id-type="pmid">15075293</pub-id></mixed-citation>
</ref>
<ref id="B265">
<label>265.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Worch</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Tickenbrock</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Schwable</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Steffen</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Cauvet</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Mlody</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Buerger</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Koeffler</surname><given-names>HP</given-names></name>, <name name-style="western"><surname>Berdel</surname><given-names>WE</given-names></name>, <name name-style="western"><surname>Serve</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Muller-Tidow</surname><given-names>C</given-names></name></person-group>
<year>2004</year>
<article-title>The serine-threonine kinase MNK1 is post-translationally stabilized by PML-RARalpha and regulates differentiation of hematopoietic cells</article-title>. <source/>Oncogene
<volume>23</volume>:<fpage>9162</fpage>–<lpage>9172</lpage>. doi:<pub-id pub-id-type="doi">10.1038/sj.onc.1208164</pub-id>.<pub-id pub-id-type="pmid">15516979</pub-id></mixed-citation>
</ref>
<ref id="B266">
<label>266.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knauf</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Tschopp</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Gram</surname><given-names>H</given-names></name></person-group>
<year>2001</year>
<article-title>Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2</article-title>. <source/>Mol Cell Biol
<volume>21</volume>:<fpage>5500</fpage>–<lpage>5511</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.21.16.5500-5511.2001</pub-id>.<pub-id pub-id-type="pmid">11463832</pub-id></mixed-citation>
</ref>
<ref id="B267">
<label>267.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morley</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Naegele</surname><given-names>S</given-names></name></person-group>
<year>2002</year>
<article-title>Phosphorylation of eukaryotic initiation factor (eIF) 4E is not required for de novo protein synthesis following recovery from hypertonic stress in human kidney cells</article-title>. <source/>J Biol Chem
<volume>277</volume>:<fpage>32855</fpage>–<lpage>32859</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.C200376200</pub-id>.<pub-id pub-id-type="pmid">12138083</pub-id></mixed-citation>
</ref>
<ref id="B268">
<label>268.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naegele</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Morley</surname><given-names>SJ</given-names></name></person-group>
<year>2004</year>
<article-title>Molecular cross-talk between MEK1/2 and mTOR signaling during recovery of 293 cells from hypertonic stress</article-title>. <source/>J Biol Chem
<volume>279</volume>:<fpage>46023</fpage>–<lpage>46034</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M404945200</pub-id>.<pub-id pub-id-type="pmid">15292274</pub-id></mixed-citation>
</ref>
<ref id="B269">
<label>269.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beggs</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Tian</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>GG</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Iadevaia</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Jenei</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Proud</surname><given-names>CG</given-names></name></person-group>
<year>2015</year>
<article-title>The MAP kinase-interacting kinases regulate cell migration, vimentin expression and eIF4E/CYFIP1 binding</article-title>. <source/>Biochem J
<volume>467</volume>:<fpage>63</fpage>–<lpage>76</lpage>. doi:<pub-id pub-id-type="doi">10.1042/BJ20141066</pub-id>.<pub-id pub-id-type="pmid">25588502</pub-id></mixed-citation>
</ref>
<ref id="B270">
<label>270.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Robichaud</surname><given-names>N</given-names></name>, <name name-style="western"><surname>del Rincon</surname><given-names>SV</given-names></name>, <name name-style="western"><surname>Huor</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Alain</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Petruccelli</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Hearnden</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Goncalves</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Grotegut</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Spruck</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Furic</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Larsson</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Muller</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name></person-group>
<year>2015</year>
<article-title>Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3</article-title>. <source/>Oncogene
<volume>34</volume>:<fpage>2032</fpage>–<lpage>2042</lpage>. doi:<pub-id pub-id-type="doi">10.1038/onc.2014.146</pub-id>.<pub-id pub-id-type="pmid">24909168</pub-id></mixed-citation>
</ref>
<ref id="B271">
<label>271.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hou</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lam</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Proud</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>S</given-names></name></person-group>
<year>2012</year>
<article-title>Targeting Mnks for cancer therapy</article-title>. <source/>Oncotarget
<volume>3</volume>:<fpage>118</fpage>–<lpage>131</lpage>. doi:<pub-id pub-id-type="doi">10.18632/oncotarget.453</pub-id>.<pub-id pub-id-type="pmid">22392765</pub-id></mixed-citation>
</ref>
<ref id="B272">
<label>272.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dreas</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mikulski</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Milik</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fabritius</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Brzozka</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Rzymski</surname><given-names>T</given-names></name></person-group>
<year>2017</year>
<article-title>Mitogen-activated protein kinase (MAPK) interacting kinases 1 and 2 (MNK1 and MNK2) as targets for cancer therapy: recent progress in the development of MNK inhibitors</article-title>. <source/>Curr Med Chem
<volume>24</volume>:<fpage>3025</fpage>–<lpage>3053</lpage>. doi:<pub-id pub-id-type="doi">10.2174/0929867324666170203123427</pub-id>.<pub-id pub-id-type="pmid">28164761</pub-id></mixed-citation>
</ref>
<ref id="B273">
<label>273.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Romeo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Roux</surname><given-names>PP</given-names></name></person-group>
<year>2012</year>
<article-title>Regulation and function of the RSK family of protein kinases</article-title>. <source/>Biochem J
<volume>441</volume>:<fpage>553</fpage>–<lpage>569</lpage>. doi:<pub-id pub-id-type="doi">10.1042/BJ20110289</pub-id>.<pub-id pub-id-type="pmid">22187936</pub-id></mixed-citation>
</ref>
<ref id="B274">
<label>274.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tanoue</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nishida</surname><given-names>E</given-names></name></person-group>
<year>2003</year>
<article-title>Molecular recognitions in the MAP kinase cascades</article-title>. <source/>Cell Signal
<volume>15</volume>:<fpage>455</fpage>–<lpage>462</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0898-6568(02)00112-2</pub-id>.<pub-id pub-id-type="pmid">12639708</pub-id></mixed-citation>
</ref>
<ref id="B275">
<label>275.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zeniou</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ding</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Trivier</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Hanauer</surname><given-names>A</given-names></name></person-group>
<year>2002</year>
<article-title>Expression analysis of RSK gene family members: the RSK2 gene, mutated in Coffin-Lowry syndrome, is prominently expressed in brain structures essential for cognitive function and learning</article-title>. <source/>Hum Mol Genet
<volume>11</volume>:<fpage>2929</fpage>–<lpage>2940</lpage>. doi:<pub-id pub-id-type="doi">10.1093/hmg/11.23.2929</pub-id>.<pub-id pub-id-type="pmid">12393804</pub-id></mixed-citation>
</ref>
<ref id="B276">
<label>276.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>RH</given-names></name>, <name name-style="western"><surname>Sarnecki</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name></person-group>
<year>1992</year>
<article-title>Nuclear localization and regulation of erk- and rsk-encoded protein kinases</article-title>. <source/>Mol Cell Biol
<volume>12</volume>:<fpage>915</fpage>–<lpage>927</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.12.3.915</pub-id>.<pub-id pub-id-type="pmid">1545823</pub-id></mixed-citation>
</ref>
<ref id="B277">
<label>277.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lara</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Seckl</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Pardo</surname><given-names>OE</given-names></name></person-group>
<year>2013</year>
<article-title>The p90 RSK family members: common functions and isoform specificity</article-title>. <source/>Cancer Res
<volume>73</volume>:<fpage>5301</fpage>–<lpage>5308</lpage>. doi:<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-12-4448</pub-id>.<pub-id pub-id-type="pmid">23970478</pub-id></mixed-citation>
</ref>
<ref id="B278">
<label>278.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dummler</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Hauge</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Silber</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yntema</surname><given-names>HG</given-names></name>, <name name-style="western"><surname>Kruse</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Kofoed</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Hemmings</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Alessi</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Frodin</surname><given-names>M</given-names></name></person-group>
<year>2005</year>
<article-title>Functional characterization of human RSK4, a new 90-kDa ribosomal S6 kinase, reveals constitutive activation in most cell types</article-title>. <source/>J Biol Chem
<volume>280</volume>:<fpage>13304</fpage>–<lpage>13314</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M408194200</pub-id>.<pub-id pub-id-type="pmid">15632195</pub-id></mixed-citation>
</ref>
<ref id="B279">
<label>279.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fisher</surname><given-names>TL</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name></person-group>
<year>1996</year>
<article-title>Evidence for two catalytically active kinase domains in pp90rsk</article-title>. <source/>Mol Cell Biol
<volume>16</volume>:<fpage>1212</fpage>–<lpage>1219</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.16.3.1212</pub-id>.<pub-id pub-id-type="pmid">8622665</pub-id></mixed-citation>
</ref>
<ref id="B280">
<label>280.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Erikson</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Maller</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Erikson</surname><given-names>RL</given-names></name></person-group>
<year>1988</year>
<article-title>A Xenopus ribosomal protein S6 kinase has two apparent kinase domains that are each similar to distinct protein kinases</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>85</volume>:<fpage>3377</fpage>–<lpage>3381</lpage>.<pub-id pub-id-type="pmid">3368449</pub-id></mixed-citation>
</ref>
<ref id="B281">
<label>281.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erikson</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Maller</surname><given-names>JL</given-names></name></person-group>
<year>1985</year>
<article-title>A protein kinase from Xenopus eggs specific for ribosomal protein S6</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>82</volume>:<fpage>742</fpage>–<lpage>746</lpage>.<pub-id pub-id-type="pmid">3856226</pub-id></mixed-citation>
</ref>
<ref id="B282">
<label>282.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Chung</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Erikson</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Alcorta</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Erikson</surname><given-names>RL</given-names></name></person-group>
<year>1991</year>
<article-title>Distinct mechanisms for the activation of the RSK kinases/MAP2 kinase/pp90rsk and pp70-S6 kinase signaling systems are indicated by inhibition of protein synthesis</article-title>. <source/>Cell Growth Differ
<volume>2</volume>:<fpage>279</fpage>–<lpage>285</lpage>.<pub-id pub-id-type="pmid">1648378</pub-id></mixed-citation>
</ref>
<ref id="B283">
<label>283.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kuo</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Crabtree</surname><given-names>GR</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name></person-group>
<year>1992</year>
<article-title>Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases</article-title>. <source/>Cell
<volume>69</volume>:<fpage>1227</fpage>–<lpage>1236</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0092-8674(92)90643-Q</pub-id>.<pub-id pub-id-type="pmid">1377606</pub-id></mixed-citation>
</ref>
<ref id="B284">
<label>284.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meyuhas</surname><given-names>O</given-names></name></person-group>
<year>2008</year>
<article-title>Physiological roles of ribosomal protein S6: one of its kind</article-title>. <source/>Int Rev Cell Mol Biol
<volume>268</volume>:<fpage>1</fpage>–<lpage>37</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1937-6448(08)00801-0</pub-id>.<pub-id pub-id-type="pmid">18703402</pub-id></mixed-citation>
</ref>
<ref id="B285">
<label>285.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cohen</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Frame</surname><given-names>S</given-names></name></person-group>
<year>2001</year>
<article-title>The renaissance of GSK3</article-title>. <source/>Nat Rev Mol Cell Biol
<volume>2</volume>:<fpage>769</fpage>–<lpage>776</lpage>. doi:<pub-id pub-id-type="doi">10.1038/35096075</pub-id>.<pub-id pub-id-type="pmid">11584304</pub-id></mixed-citation>
</ref>
<ref id="B286">
<label>286.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sutherland</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Leighton</surname><given-names>IA</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>P</given-names></name></person-group>
<year>1993</year>
<article-title>Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling</article-title>. <source/>Biochem J
<volume>296</volume>:<fpage>15</fpage>–<lpage>19</lpage>. doi:<pub-id pub-id-type="doi">10.1042/bj2960015</pub-id>.<pub-id pub-id-type="pmid">8250835</pub-id></mixed-citation>
</ref>
<ref id="B287">
<label>287.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wortham</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>Proud</surname><given-names>CG</given-names></name></person-group>
<year>2015</year>
<article-title>eIF2B: recent structural and functional insights into a key regulator of translation</article-title>. <source/>Biochem Soc Trans
<volume>43</volume>:<fpage>1234</fpage>–<lpage>1240</lpage>. doi:<pub-id pub-id-type="doi">10.1042/BST20150164</pub-id>.<pub-id pub-id-type="pmid">26614666</pub-id></mixed-citation>
</ref>
<ref id="B288">
<label>288.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yuan</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Frodin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Grummt</surname><given-names>I</given-names></name></person-group>
<year>2003</year>
<article-title>ERK-dependent phosphorylation of the transcription initiation factor TIF-IA is required for RNA polymerase I transcription and cell growth</article-title>. <source/>Mol Cell
<volume>11</volume>:<fpage>405</fpage>–<lpage>413</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1097-2765(03)00036-4</pub-id>.<pub-id pub-id-type="pmid">12620228</pub-id></mixed-citation>
</ref>
<ref id="B289">
<label>289.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jousse</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Oyadomari</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Novoa</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Harding</surname><given-names>HP</given-names></name>, <name name-style="western"><surname>Ron</surname><given-names>D</given-names></name></person-group>
<year>2003</year>
<article-title>Inhibition of a constitutive translation initiation factor 2alpha phosphatase, CReP, promotes survival of stressed cells</article-title>. <source/>J Cell Biol
<volume>163</volume>:<fpage>767</fpage>–<lpage>775</lpage>. doi:<pub-id pub-id-type="doi">10.1083/jcb.200308075</pub-id>.<pub-id pub-id-type="pmid">14638860</pub-id></mixed-citation>
</ref>
<ref id="B290">
<label>290.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Novoa</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Zeng</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Harding</surname><given-names>HP</given-names></name>, <name name-style="western"><surname>Ron</surname><given-names>D</given-names></name></person-group>
<year>2001</year>
<article-title>Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha</article-title>. <source/>J Cell Biol
<volume>153</volume>:<fpage>1011</fpage>–<lpage>1022</lpage>. doi:<pub-id pub-id-type="doi">10.1083/jcb.153.5.1011</pub-id>.<pub-id pub-id-type="pmid">11381086</pub-id></mixed-citation>
</ref>
<ref id="B291">
<label>291.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garcia-Barrio</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Dong</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cherkasova</surname><given-names>VA</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ufano</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lai</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Qin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hinnebusch</surname><given-names>AG</given-names></name></person-group>
<year>2002</year>
<article-title>Serine 577 is phosphorylated and negatively affects the tRNA binding and eIF2alpha kinase activities of GCN2</article-title>. <source/>J Biol Chem
<volume>277</volume>:<fpage>30675</fpage>–<lpage>30683</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M203187200</pub-id>.<pub-id pub-id-type="pmid">12070158</pub-id></mixed-citation>
</ref>
<ref id="B292">
<label>292.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wengrod</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Weiss</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zhong</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Osman</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Gardner</surname><given-names>LB</given-names></name></person-group>
<year>2015</year>
<article-title>Phosphorylation of eIF2alpha triggered by mTORC1 inhibition and PP6C activation is required for autophagy and is aberrant in PP6C-mutated melanoma</article-title>. <source/>Sci Signal
<volume>8</volume>:<fpage>ra27</fpage>. doi:<pub-id pub-id-type="doi">10.1126/scisignal.aaa0899</pub-id>.<pub-id pub-id-type="pmid">25759478</pub-id></mixed-citation>
</ref>
<ref id="B293">
<label>293.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andjelkovic</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Jakubowicz</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Cron</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ming</surname><given-names>XF</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Hemmings</surname><given-names>BA</given-names></name></person-group>
<year>1996</year>
<article-title>Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>93</volume>:<fpage>5699</fpage>–<lpage>5704</lpage>.<pub-id pub-id-type="pmid">8650155</pub-id></mixed-citation>
</ref>
<ref id="B294">
<label>294.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Furnari</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Newton</surname><given-names>AC</given-names></name></person-group>
<year>2005</year>
<article-title>PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth</article-title>. <source/>Mol Cell
<volume>18</volume>:<fpage>13</fpage>–<lpage>24</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molcel.2005.03.008</pub-id>.<pub-id pub-id-type="pmid">15808505</pub-id></mixed-citation>
</ref>
<ref id="B295">
<label>295.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pratt</surname><given-names>CP</given-names></name>, <name name-style="western"><surname>Zeeman</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Schultz</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>O'Neill</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Castillo-Martin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nowak</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Naguib</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Grace</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Murn</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Navin</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Atwal</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Sander</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Gerald</surname><given-names>WL</given-names></name>, <name name-style="western"><surname>Cordon-Cardo</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Newton</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Carver</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Trotman</surname><given-names>LC</given-names></name></person-group>
<year>2011</year>
<article-title>Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression</article-title>. <source/>Cancer Cell
<volume>20</volume>:<fpage>173</fpage>–<lpage>186</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ccr.2011.07.013</pub-id>.<pub-id pub-id-type="pmid">21840483</pub-id></mixed-citation>
</ref>
<ref id="B296">
<label>296.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peterson</surname><given-names>RT</given-names></name>, <name name-style="western"><surname>Desai</surname><given-names>BN</given-names></name>, <name name-style="western"><surname>Hardwick</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Schreiber</surname><given-names>SL</given-names></name></person-group>
<year>1999</year>
<article-title>Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycinassociated protein</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>96</volume>:<fpage>4438</fpage>–<lpage>4442</lpage>.<pub-id pub-id-type="pmid">10200280</pub-id></mixed-citation>
</ref>
<ref id="B297">
<label>297.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Stevens</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Eshleman</surname><given-names>NE</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>T</given-names></name></person-group>
<year>2013</year>
<article-title>Protein phosphatase PPM1G regulates protein translation and cell growth by dephosphorylating 4E binding protein 1 (4E-BP1)</article-title>. <source/>J Biol Chem
<volume>288</volume>:<fpage>23225</fpage>–<lpage>23233</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M113.492371</pub-id>.<pub-id pub-id-type="pmid">23814053</pub-id></mixed-citation>
</ref>
<ref id="B298">
<label>298.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Shu</surname><given-names>HK</given-names></name></person-group>
<year>2016</year>
<article-title>Phosphatidylinositol-3 kinase-dependent translational regulation of Id1 involves the PPM1G phosphatase</article-title>. <source/>Oncogene
<volume>35</volume>:<fpage>5807</fpage>–<lpage>5816</lpage>. doi:<pub-id pub-id-type="doi">10.1038/onc.2016.115</pub-id>.<pub-id pub-id-type="pmid">27065332</pub-id></mixed-citation>
</ref>
<ref id="B299">
<label>299.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nho</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Peterson</surname><given-names>M</given-names></name></person-group>
<year>2011</year>
<article-title>Eukaryotic translation initiation factor 4E binding protein 1 (4EBP-1) function is suppressed by Src and protein phosphatase 2A (PP2A) on extracellular matrix</article-title>. <source/>J Biol Chem
<volume>286</volume>:<fpage>31953</fpage>–<lpage>31965</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M111.222299</pub-id>.<pub-id pub-id-type="pmid">21784851</pub-id></mixed-citation>
</ref>
<ref id="B300">
<label>300.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guan</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Pysz</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Curry</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Hizli</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Danielpour</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Black</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Black</surname><given-names>JD</given-names></name></person-group>
<year>2007</year>
<article-title>Protein kinase C-mediated down-regulation of cyclin D1 involves activation of the translational repressor 4E-BP1 via a phosphoinositide 3-kinase/Akt-independent, protein phosphatase 2A-dependent mechanism in intestinal epithelial cells</article-title>. <source/>J Biol Chem
<volume>282</volume>:<fpage>14213</fpage>–<lpage>14225</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M610513200</pub-id>.<pub-id pub-id-type="pmid">17360714</pub-id></mixed-citation>
</ref>
<ref id="B301">
<label>301.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gardner</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Abcouwer</surname><given-names>SF</given-names></name>, <name name-style="western"><surname>Losiewicz</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Fort</surname><given-names>PE</given-names></name></person-group>
<year>2015</year>
<article-title>Phosphatase control of 4E-BP1 phosphorylation state is central for glycolytic regulation of retinal protein synthesis</article-title>. <source/>Am J Physiol Endocrinol Metab
<volume>309</volume>:<fpage>E546</fpage>–<lpage>E556</lpage>. doi:<pub-id pub-id-type="doi">10.1152/ajpendo.00180.2015</pub-id>.<pub-id pub-id-type="pmid">26199279</pub-id></mixed-citation>
</ref>
<ref id="B302">
<label>302.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Redpath</surname><given-names>NT</given-names></name>, <name name-style="western"><surname>Proud</surname><given-names>CG</given-names></name></person-group>
<year>1990</year>
<article-title>Activity of protein phosphatases against initiation factor-2 and elongation factor-2</article-title>. <source/>Biochem J
<volume>272</volume>:<fpage>175</fpage>–<lpage>180</lpage>. doi:<pub-id pub-id-type="doi">10.1042/bj2720175</pub-id>.<pub-id pub-id-type="pmid">2176079</pub-id></mixed-citation>
</ref>
<ref id="B303">
<label>303.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yue</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Ueda</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Fukunaga</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Khuri</surname><given-names>FR</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>SY</given-names></name></person-group>
<year>2010</year>
<article-title>Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E</article-title>. <source/>Neoplasia
<volume>12</volume>:<fpage>848</fpage>–<lpage>855</lpage>. doi:<pub-id pub-id-type="doi">10.1593/neo.10704</pub-id>.<pub-id pub-id-type="pmid">20927323</pub-id></mixed-citation>
</ref>
<ref id="B304">
<label>304.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grech</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Blazquez-Domingo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kolbus</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bakker</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Mullner</surname><given-names>EW</given-names></name>, <name name-style="western"><surname>Beug</surname><given-names>H</given-names></name>, <name name-style="western"><surname>von Lindern</surname><given-names>M</given-names></name></person-group>
<year>2008</year>
<article-title>Igbp1 is part of a positive feedback loop in stem cell factor-dependent, selective mRNA translation initiation inhibiting erythroid differentiation</article-title>. <source/>Blood
<volume>112</volume>:<fpage>2750</fpage>–<lpage>2760</lpage>. doi:<pub-id pub-id-type="doi">10.1182/blood-2008-01-133140</pub-id>.<pub-id pub-id-type="pmid">18625885</pub-id></mixed-citation>
</ref>
<ref id="B305">
<label>305.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Belandia</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Brautigan</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Martin-Perez</surname><given-names>J</given-names></name></person-group>
<year>1994</year>
<article-title>Attenuation of ribosomal protein S6 phosphatase activity in chicken embryo fibroblasts transformed by Rous sarcoma virus</article-title>. <source/>Mol Cell Biol
<volume>14</volume>:<fpage>200</fpage>–<lpage>206</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.14.1.200</pub-id>.<pub-id pub-id-type="pmid">8264587</pub-id></mixed-citation>
</ref>
<ref id="B306">
<label>306.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hirano</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ito</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hartshorne</surname><given-names>DJ</given-names></name></person-group>
<year>1995</year>
<article-title>Interaction of the ribosomal protein, L5, with protein phosphatase type 1</article-title>. <source/>J Biol Chem
<volume>270</volume>:<fpage>19786</fpage>–<lpage>19790</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.270.34.19786</pub-id>.<pub-id pub-id-type="pmid">7649987</pub-id></mixed-citation>
</ref>
<ref id="B307">
<label>307.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nandagopal</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Roux</surname><given-names>PP</given-names></name></person-group>
<year>2015</year>
<article-title>Regulation of global and specific mRNA translation by the mTOR signaling pathway</article-title>. <source/>Translation (Austin)
<volume>3</volume>:<fpage>e983402</fpage>.<pub-id pub-id-type="pmid">26779414</pub-id></mixed-citation>
</ref>
<ref id="B308">
<label>308.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jefferies</surname><given-names>HB</given-names></name>, <name name-style="western"><surname>Reinhard</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Kozma</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>G</given-names></name></person-group>
<year>1994</year>
<article-title>Rapamycin selectively represses translation of the “polypyrimidine tract” mRNA family</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>91</volume>:<fpage>4441</fpage>–<lpage>4445</lpage>.<pub-id pub-id-type="pmid">8183928</pub-id></mixed-citation>
</ref>
<ref id="B309">
<label>309.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grosso</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Volta</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Sala</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Vietri</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Marchisio</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Ron</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Biffo</surname><given-names>S</given-names></name></person-group>
<year>2008</year>
<article-title>PKCbetaII modulates translation independently from mTOR and through RACK1</article-title>. <source/>Biochem J
<volume>415</volume>:<fpage>77</fpage>–<lpage>85</lpage>. doi:<pub-id pub-id-type="doi">10.1042/BJ20080463</pub-id>.<pub-id pub-id-type="pmid">18557705</pub-id></mixed-citation>
</ref>
<ref id="B310">
<label>310.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ling</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Morley</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Traugh</surname><given-names>JA</given-names></name></person-group>
<year>2005</year>
<article-title>Inhibition of cap-dependent translation via phosphorylation of eIF4G by protein kinase Pak2</article-title>. <source/>EMBO J
<volume>24</volume>:<fpage>4094</fpage>–<lpage>4105</lpage>. doi:<pub-id pub-id-type="doi">10.1038/sj.emboj.7600868</pub-id>.<pub-id pub-id-type="pmid">16281055</pub-id></mixed-citation>
</ref>
<ref id="B311">
<label>311.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hershey</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>MA</given-names></name></person-group>
<year>2009</year>
<article-title>Phosphorylation of the eukaryotic initiation factor 3f by cyclin-dependent kinase 11 during apoptosis</article-title>. <source/>FEBS Lett
<volume>583</volume>:<fpage>971</fpage>–<lpage>977</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.febslet.2009.02.028</pub-id>.<pub-id pub-id-type="pmid">19245811</pub-id></mixed-citation>
</ref>
<ref id="B312">
<label>312.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xue</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Barna</surname><given-names>M</given-names></name></person-group>
<year>2012</year>
<article-title>Specialized ribosomes: a new frontier in gene regulation and organismal biology</article-title>. <source/>Nat Rev Mol Cell Biol
<volume>13</volume>:<fpage>355</fpage>–<lpage>369</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrm3359</pub-id>.<pub-id pub-id-type="pmid">22617470</pub-id></mixed-citation>
</ref>
<ref id="B313">
<label>313.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richter</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Bassell</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Klann</surname><given-names>E</given-names></name></person-group>
<year>2015</year>
<article-title>Dysregulation and restoration of translational homeostasis in fragile X syndrome</article-title>. <source/>Nat Rev Neurosci
<volume>16</volume>:<fpage>595</fpage>–<lpage>605</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrn4001</pub-id>.<pub-id pub-id-type="pmid">26350240</pub-id></mixed-citation>
</ref>
<ref id="B314">
<label>314.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sahin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sur</surname><given-names>M</given-names></name></person-group>
<year>2015</year>
<article-title>Genes, circuits, and precision therapies for autism and related neurodevelopmental disorders</article-title>. <source/>Science
<volume>350</volume>:<fpage>aab3897</fpage>. doi:<pub-id pub-id-type="doi">10.1126/science.aab3897</pub-id>.<pub-id pub-id-type="pmid">26472761</pub-id></mixed-citation>
</ref>
<ref id="B315">
<label>315.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Demontis</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Perrimon</surname><given-names>N</given-names></name></person-group>
<year>2010</year>
<article-title>FOXO/4E-BP signaling in Drosophila muscles regulates organism-wide proteostasis during aging</article-title>. <source/>Cell
<volume>143</volume>:<fpage>813</fpage>–<lpage>825</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2010.10.007</pub-id>.<pub-id pub-id-type="pmid">21111239</pub-id></mixed-citation>
</ref>
<ref id="B316">
<label>316.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zid</surname><given-names>BM</given-names></name>, <name name-style="western"><surname>Rogers</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Katewa</surname><given-names>SD</given-names></name>, <name name-style="western"><surname>Vargas</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Kolipinski</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Benzer</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kapahi</surname><given-names>P</given-names></name></person-group>
<year>2009</year>
<article-title>4E-BP extends lifespan upon dietary restriction by enhancing mitochondrial activity in Drosophila</article-title>. <source/>Cell
<volume>139</volume>:<fpage>149</fpage>–<lpage>160</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2009.07.034</pub-id>.<pub-id pub-id-type="pmid">19804760</pub-id></mixed-citation>
</ref>
<ref id="B317">
<label>317.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fadden</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Haystead</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Lawrence</surname><given-names>JC</given-names><suffix>Jr</suffix></name></person-group>
<year>1997</year>
<article-title>Identification of phosphorylation sites in the translational regulator, PHAS-I, that are controlled by insulin and rapamycin in rat adipocytes</article-title>. <source/>J Biol Chem
<volume>272</volume>:<fpage>10240</fpage>–<lpage>10247</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.272.15.10240</pub-id>.<pub-id pub-id-type="pmid">9092573</pub-id></mixed-citation>
</ref>
<ref id="B318">
<label>318.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yoon</surname><given-names>SO</given-names></name>, <name name-style="western"><surname>Poulogiannis</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>XM</given-names></name>, <name name-style="western"><surname>Villen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kubica</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Hoffman</surname><given-names>GR</given-names></name>, <name name-style="western"><surname>Cantley</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Gygi</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name></person-group>
<year>2011</year>
<article-title>Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling</article-title>. <source/>Science
<volume>332</volume>:<fpage>1322</fpage>–<lpage>1326</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1199484</pub-id>.<pub-id pub-id-type="pmid">21659605</pub-id></mixed-citation>
</ref>
<ref id="B319">
<label>319.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Canman</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Kastan</surname><given-names>MB</given-names></name></person-group>
<year>1999</year>
<article-title>Substrate specificities and identification of putative substrates of ATM kinase family members</article-title>. <source/>J Biol Chem
<volume>274</volume>:<fpage>37538</fpage>–<lpage>37543</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.274.53.37538</pub-id>.<pub-id pub-id-type="pmid">10608806</pub-id></mixed-citation>
</ref>
<ref id="B320">
<label>320.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Parra</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Beugnet</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Proud</surname><given-names>CG</given-names></name></person-group>
<year>2003</year>
<article-title>The C terminus of initiation factor 4E-binding protein 1 contains multiple regulatory features that influence its function and phosphorylation</article-title>. <source/>Mol Cell Biol
<volume>23</volume>:<fpage>1546</fpage>–<lpage>1557</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.23.5.1546-1557.2003</pub-id>.<pub-id pub-id-type="pmid">12588975</pub-id></mixed-citation>
</ref>
<ref id="B321">
<label>321.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heesom</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Avison</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Diggle</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Denton</surname><given-names>RM</given-names></name></person-group>
<year>1998</year>
<article-title>Insulin-stimulated kinase from rat fat cells that phosphorylates initiation factor 4E-binding protein 1 on the rapamycin-insensitive site (serine-111)</article-title>. <source/>Biochem J
<volume>336</volume>:<fpage>39</fpage>–<lpage>48</lpage>. doi:<pub-id pub-id-type="doi">10.1042/bj3360039</pub-id>.<pub-id pub-id-type="pmid">9806882</pub-id></mixed-citation>
</ref>
<ref id="B322">
<label>322.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Beugnet</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Murakami</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yamanaka</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Proud</surname><given-names>CG</given-names></name></person-group>
<year>2005</year>
<article-title>Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins</article-title>. <source/>Mol Cell Biol
<volume>25</volume>:<fpage>2558</fpage>–<lpage>2572</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.25.7.2558-2572.2005</pub-id>.<pub-id pub-id-type="pmid">15767663</pub-id></mixed-citation>
</ref>
<ref id="B323">
<label>323.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dobrikov</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Dobrikova</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Shveygert</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gromeier</surname><given-names>M</given-names></name></person-group>
<year>2011</year>
<article-title>Phosphorylation of eukaryotic translation initiation factor 4G1 (eIF4G1) by protein kinase Cα regulates eIF4G1 binding to Mnk1</article-title>. <source/>Mol Cell Biol
<volume>31</volume>:<fpage>2947</fpage>–<lpage>2959</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.05589-11</pub-id>.<pub-id pub-id-type="pmid">21576361</pub-id></mixed-citation>
</ref>
<ref id="B324">
<label>324.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Welsh</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Oguz</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Fang</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Bai</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kinose</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Bronk</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Remsing Rix</surname><given-names>LL</given-names></name>, <name name-style="western"><surname>Beg</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Rix</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Eschrich</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Koomen</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Haura</surname><given-names>EB</given-names></name></person-group>
<year>2013</year>
<article-title>Dissection of TBK1 signaling via phosphoproteomics in lung cancer cells</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>110</volume>:<fpage>12414</fpage>–<lpage>12419</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1220674110</pub-id>.<pub-id pub-id-type="pmid">23836654</pub-id></mixed-citation>
</ref>
<ref id="B325">
<label>325.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dobrikov</surname><given-names>MI</given-names></name>, <name name-style="western"><surname>Shveygert</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Gromeier</surname><given-names>M</given-names></name></person-group>
<year>2014</year>
<article-title>Mitotic phosphorylation of eukaryotic initiation factor 4G1 (eIF4G1) at Ser1232 by Cdk1:cyclin B inhibits eIF4A helicase complex binding with RNA</article-title>. <source/>Mol Cell Biol
<volume>34</volume>:<fpage>439</fpage>–<lpage>451</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.01046-13</pub-id>.<pub-id pub-id-type="pmid">24248602</pub-id></mixed-citation>
</ref>
<ref id="B326">
<label>326.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kudlicki</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Wettenhall</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Kemp</surname><given-names>BE</given-names></name>, <name name-style="western"><surname>Szyszka</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Kramer</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Hardesty</surname><given-names>B</given-names></name></person-group>
<year>1987</year>
<article-title>Evidence for a second phosphorylation site on eIF-2 alpha from rabbit reticulocytes</article-title>. <source/>FEBS Lett
<volume>215</volume>:<fpage>16</fpage>–<lpage>20</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0014-5793(87)80105-9</pub-id>.<pub-id pub-id-type="pmid">3569538</pub-id></mixed-citation>
</ref>
<ref id="B327">
<label>327.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Llorens</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Duarri</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sarro</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Roher</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Plana</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Itarte</surname><given-names>E</given-names></name></person-group>
<year>2006</year>
<article-title>The N-terminal domain of the human eIF2beta subunit and the CK2 phosphorylation sites are required for its function</article-title>. <source/>Biochem J
<volume>394</volume>:<fpage>227</fpage>–<lpage>236</lpage>. doi:<pub-id pub-id-type="doi">10.1042/BJ20050605</pub-id>.<pub-id pub-id-type="pmid">16225457</pub-id></mixed-citation>
</ref>
<ref id="B328">
<label>328.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krieg</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hofsteenge</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>G</given-names></name></person-group>
<year>1988</year>
<article-title>Identification of the 40 S ribosomal protein S6 phosphorylation sites induced by cycloheximide</article-title>. <source/>J Biol Chem
<volume>263</volume>:<fpage>11473</fpage>–<lpage>11477</lpage>.<pub-id pub-id-type="pmid">3403539</pub-id></mixed-citation>
</ref>
<ref id="B329">
<label>329.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Banerjee</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ahmad</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Grove</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Kozlosky</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Price</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Avruch</surname><given-names>J</given-names></name></person-group>
<year>1990</year>
<article-title>Molecular structure of a major insulin/mitogen-activated 70-kDa S6 protein kinase</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>87</volume>:<fpage>8550</fpage>–<lpage>8554</lpage>.<pub-id pub-id-type="pmid">2236064</pub-id></mixed-citation>
</ref>
<ref id="B330">
<label>330.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kozma</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Ferrari</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bassand</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Siegmann</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Totty</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>G</given-names></name></person-group>
<year>1990</year>
<article-title>Cloning of the mitogen-activated S6 kinase from rat liver reveals an enzyme of the second messenger subfamily</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>87</volume>:<fpage>7365</fpage>–<lpage>7369</lpage>.<pub-id pub-id-type="pmid">1699226</pub-id></mixed-citation>
</ref>
<ref id="B331">
<label>331.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cuesta</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Holz</surname><given-names>MK</given-names></name></person-group>
<year>2016</year>
<article-title>RSK-mediated down-regulation of PDCD4 is required for proliferation, survival, and migration in a model of triple-negative breast cancer</article-title>. <source/>Oncotarget
<volume>7</volume>:<fpage>27567</fpage>–<lpage>27583</lpage>. doi:<pub-id pub-id-type="doi">10.18632/oncotarget.8375</pub-id>.<pub-id pub-id-type="pmid">27028868</pub-id></mixed-citation>
</ref>
<ref id="B332">
<label>332.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santamaria</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Elowe</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Malik</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Bauer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Schmidt</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sillje</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Korner</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Nigg</surname><given-names>EA</given-names></name></person-group>
<year>2011</year>
<article-title>The Plk1-dependent phosphoproteome of the early mitotic spindle</article-title>. <source/>Mol Cell Proteomics
<volume>10</volume>:<fpage>M110 004457</fpage>. doi:<pub-id pub-id-type="doi">10.1074/mcp.M110.004457</pub-id>.</mixed-citation>
</ref>
<ref id="B333">
<label>333.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Begley</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>HT</given-names></name>, <name name-style="western"><surname>Lako</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Eck</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Gray</surname><given-names>NS</given-names></name>, <name name-style="western"><surname>Mitchison</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Cantley</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>JJ</given-names></name></person-group>
<year>2016</year>
<article-title>Mitotic MELK-eIF4B signaling controls protein synthesis and tumor cell survival</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>113</volume>:<fpage>9810</fpage>–<lpage>9815</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1606862113</pub-id>.<pub-id pub-id-type="pmid">27528663</pub-id></mixed-citation>
</ref>
<ref id="B334">
<label>334.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rush</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Moritz</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Goss</surname><given-names>VL</given-names></name>, <name name-style="western"><surname>Spek</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zha</surname><given-names>XM</given-names></name>, <name name-style="western"><surname>Polakiewicz</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Comb</surname><given-names>MJ</given-names></name></person-group>
<year>2005</year>
<article-title>Immunoaffinity profiling of tyrosine phosphorylation in cancer cells</article-title>. <source/>Nat Biotechnol
<volume>23</volume>:<fpage>94</fpage>–<lpage>101</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nbt1046</pub-id>.<pub-id pub-id-type="pmid">15592455</pub-id></mixed-citation>
</ref>
<ref id="B335">
<label>335.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Welsh</surname><given-names>GI</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Loughlin</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Price</surname><given-names>NT</given-names></name>, <name name-style="western"><surname>Proud</surname><given-names>CG</given-names></name></person-group>
<year>1998</year>
<article-title>Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin</article-title>. <source/>FEBS Lett
<volume>421</volume>:<fpage>125</fpage>–<lpage>130</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0014-5793(97)01548-2</pub-id>.<pub-id pub-id-type="pmid">9468292</pub-id></mixed-citation>
</ref>
<ref id="B336">
<label>336.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Woods</surname><given-names>YL</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Becker</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Jakes</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Goedert</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Proud</surname><given-names>CG</given-names></name></person-group>
<year>2001</year>
<article-title>The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase</article-title>. <source/>Biochem J
<volume>355</volume>:<fpage>609</fpage>–<lpage>615</lpage>. doi:<pub-id pub-id-type="doi">10.1042/bj3550609</pub-id>.<pub-id pub-id-type="pmid">11311121</pub-id></mixed-citation>
</ref>
<ref id="B337">
<label>337.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Paulin</surname><given-names>FE</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Gomez</surname><given-names>E</given-names></name>, <name name-style="western"><surname>O'Brien</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Morrice</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Proud</surname><given-names>CG</given-names></name></person-group>
<year>2001</year>
<article-title>Eukaryotic initiation factor 2B: identification of multiple phosphorylation sites in the epsilon-subunit and their functions in vivo</article-title>. <source/>EMBO J
<volume>20</volume>:<fpage>4349</fpage>–<lpage>4359</lpage>. doi:<pub-id pub-id-type="doi">10.1093/emboj/20.16.4349</pub-id>.<pub-id pub-id-type="pmid">11500362</pub-id></mixed-citation>
</ref>
<ref id="B338">
<label>338.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beausoleil</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Jedrychowski</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Schwartz</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Elias</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Villen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cohn</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Cantley</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Gygi</surname><given-names>SP.</given-names></name></person-group>
<year>2004</year>
<article-title>Large-scale characterization of HeLa cell nuclear phosphoproteins</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>101</volume>:<fpage>12130</fpage>–<lpage>12135</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0404720101</pub-id>.<pub-id pub-id-type="pmid">15302935</pub-id></mixed-citation>
</ref>
<ref id="B339">
<label>339.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gevaert</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Staes</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Van Damme</surname><given-names>J</given-names></name>, <name name-style="western"><surname>De Groot</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hugelier</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Demol</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Martens</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Goethals</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Vandekerckhove</surname><given-names>J</given-names></name></person-group>
<year>2005</year>
<article-title>Global phosphoproteome analysis on human HepG2 hepatocytes using reversed-phase diagonal LC</article-title>. <source/>Proteomics
<volume>5</volume>:<fpage>3589</fpage>–<lpage>3599</lpage>. doi:<pub-id pub-id-type="doi">10.1002/pmic.200401217</pub-id>.<pub-id pub-id-type="pmid">16097034</pub-id></mixed-citation>
</ref>
<ref id="B340">
<label>340.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Tannenbaum</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>White</surname><given-names>FM</given-names></name></person-group>
<year>2005</year>
<article-title>Global phosphoproteome of HT-29 human colon adenocarcinoma cells</article-title>. <source/>J Proteome Res
<volume>4</volume>:<fpage>1339</fpage>–<lpage>1346</lpage>. doi:<pub-id pub-id-type="doi">10.1021/pr050048h</pub-id>.<pub-id pub-id-type="pmid">16083285</pub-id></mixed-citation>
</ref>
<ref id="B341">
<label>341.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Goulet</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Vaillancourt</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Sachs</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Hershey</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>MA</given-names></name></person-group>
<year>2003</year>
<article-title>The p34cdc2-related cyclin-dependent kinase 11 interacts with the p47 subunit of eukaryotic initiation factor 3 during apoptosis</article-title>. <source/>J Biol Chem
<volume>278</volume>:<fpage>5062</fpage>–<lpage>5071</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M206427200</pub-id>.<pub-id pub-id-type="pmid">12446680</pub-id></mixed-citation>
</ref>
<ref id="B342">
<label>342.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Smit-McBride</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Rheinhardt</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hershey</surname><given-names>JW</given-names></name></person-group>
<year>2008</year>
<article-title>An oncogenic role for the phosphorylated h-subunit of human translation initiation factor eIF3</article-title>. <source/>J Biol Chem
<volume>283</volume>:<fpage>24047</fpage>–<lpage>24060</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M800956200</pub-id>.<pub-id pub-id-type="pmid">18544531</pub-id></mixed-citation>
</ref>
<ref id="B343">
<label>343.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zach</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Braunstein</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Stanhill</surname><given-names>A</given-names></name></person-group>
<year>2014</year>
<article-title>Stress-induced start codon fidelity regulates arsenite-inducible regulatory particle-associated protein (AIRAP) translation</article-title>. <source/>J Biol Chem
<volume>289</volume>:<fpage>20706</fpage>–<lpage>20716</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M114.547828</pub-id>.<pub-id pub-id-type="pmid">24898249</pub-id></mixed-citation>
</ref>
<ref id="B344">
<label>344.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Homma</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Wada</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Yamaki</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Krebs</surname><given-names>EG</given-names></name>, <name name-style="western"><surname>Homma</surname><given-names>Y</given-names></name></person-group>
<year>2005</year>
<article-title>CK2 phosphorylation of eukaryotic translation initiation factor 5 potentiates cell cycle progression</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>102</volume>:<fpage>15688</fpage>–<lpage>15693</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0506791102</pub-id>.<pub-id pub-id-type="pmid">16227438</pub-id></mixed-citation>
</ref>
<ref id="B345">
<label>345.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ballif</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Villen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Beausoleil</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Schwartz</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Gygi</surname><given-names>SP.</given-names></name></person-group>
<year>2004</year>
<article-title>Phosphoproteomic analysis of the developing mouse brain</article-title>. <source/>Mol Cell Proteomics
<volume>3</volume>:<fpage>1093</fpage>–<lpage>1101</lpage>. doi:<pub-id pub-id-type="doi">10.1074/mcp.M400085-MCP200</pub-id>.<pub-id pub-id-type="pmid">15345747</pub-id></mixed-citation>
</ref>
<ref id="B346">
<label>346.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Biswas</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mukherjee</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Das</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Shields</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Chow</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Maitra</surname><given-names>U</given-names></name></person-group>
<year>2011</year>
<article-title>Opposing action of casein kinase 1 and calcineurin in nucleo-cytoplasmic shuttling of mammalian translation initiation factor eIF6</article-title>. <source/>J Biol Chem
<volume>286</volume>:<fpage>3129</fpage>–<lpage>3138</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M110.188565</pub-id>.<pub-id pub-id-type="pmid">21084295</pub-id></mixed-citation>
</ref>
<ref id="B347">
<label>347.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ceci</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gaviraghi</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Gorrini</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Sala</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Offenhauser</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Marchisio</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Biffo</surname><given-names>S</given-names></name></person-group>
<year>2003</year>
<article-title>Release of eIF6 (p27BBP) from the 60S subunit allows 80S ribosome assembly</article-title>. <source/>Nature
<volume>426</volume>:<fpage>579</fpage>–<lpage>584</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature02160</pub-id>.<pub-id pub-id-type="pmid">14654845</pub-id></mixed-citation>
</ref>
<ref id="B348">
<label>348.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kielbassa</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Muller</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Meyer</surname><given-names>HE</given-names></name>, <name name-style="western"><surname>Marks</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Gschwendt</surname><given-names>M</given-names></name></person-group>
<year>1995</year>
<article-title>Protein kinase C delta-specific phosphorylation of the elongation factor eEF-alpha and an eEF-1 alpha peptide at threonine 431</article-title>. <source/>J Biol Chem
<volume>270</volume>:<fpage>6156</fpage>–<lpage>6162</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.270.11.6156</pub-id>.<pub-id pub-id-type="pmid">7890750</pub-id></mixed-citation>
</ref>
<ref id="B349">
<label>349.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sanges</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Scheuermann</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Zahedi</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Sickmann</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lamberti</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Migliaccio</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Baljuls</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Marra</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zappavigna</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Reinders</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Rapp</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Abbruzzese</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Caraglia</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Arcari</surname><given-names>P</given-names></name></person-group>
<year>2012</year>
<article-title>Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells</article-title>. <source/>Cell Death Dis
<volume>3</volume>:<fpage>e276</fpage>. doi:<pub-id pub-id-type="doi">10.1038/cddis.2012.16</pub-id>.<pub-id pub-id-type="pmid">22378069</pub-id></mixed-citation>
</ref>
<ref id="B350">
<label>350.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>KW</given-names></name>, <name name-style="western"><surname>Yakymovych</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Jia</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yakymovych</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Souchelnytskyi</surname><given-names>S</given-names></name></person-group>
<year>2010</year>
<article-title>Phosphorylation of eEF1A1 at Ser300 by TbetaR-I results in inhibition of mRNA translation</article-title>. <source/>Curr Biol
<volume>20</volume>:<fpage>1615</fpage>–<lpage>1625</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cub.2010.08.017</pub-id>.<pub-id pub-id-type="pmid">20832312</pub-id></mixed-citation>
</ref>
<ref id="B351">
<label>351.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gandin</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Gutierrez</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Brill</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Varsano</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Aza-Blanc</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Au</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>McLaughlan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ferreira</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Alain</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sonenberg</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Topisirovic</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Ronai</surname><given-names>ZA</given-names></name></person-group>
<year>2013</year>
<article-title>Degradation of newly synthesized polypeptides by ribosome-associated RACK1/c-Jun N-terminal kinase/eukaryotic elongation factor 1A2 complex</article-title>. <source/>Mol Cell Biol
<volume>33</volume>:<fpage>2510</fpage>–<lpage>2526</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.01362-12</pub-id>.<pub-id pub-id-type="pmid">23608534</pub-id></mixed-citation>
</ref>
<ref id="B352">
<label>352.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nairn</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Palfrey</surname><given-names>HC</given-names></name></person-group>
<year>1987</year>
<article-title>Identification of the major Mr 100,000 substrate for calmodulin-dependent protein kinase III in mammalian cells as elongation factor-2</article-title>. <source/>J Biol Chem
<volume>262</volume>:<fpage>17299</fpage>–<lpage>17303</lpage>.<pub-id pub-id-type="pmid">3693353</pub-id></mixed-citation>
</ref>
<ref id="B353">
<label>353.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Price</surname><given-names>NT</given-names></name>, <name name-style="western"><surname>Redpath</surname><given-names>NT</given-names></name>, <name name-style="western"><surname>Severinov</surname><given-names>KV</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Russell</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Proud</surname><given-names>CG</given-names></name></person-group>
<year>1991</year>
<article-title>Identification of the phosphorylation sites in elongation factor-2 from rabbit reticulocytes</article-title>. <source/>FEBS Lett
<volume>282</volume>:<fpage>253</fpage>–<lpage>258</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0014-5793(91)80489-P</pub-id>.<pub-id pub-id-type="pmid">2037042</pub-id></mixed-citation>
</ref>
<ref id="B354">
<label>354.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Horman</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Browne</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Krause</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Vertommen</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Bertrand</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Lavoinne</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hue</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Proud</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Rider</surname><given-names>M</given-names></name></person-group>
<year>2002</year>
<article-title>Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis</article-title>. <source/>Curr Biol
<volume>12</volume>:<fpage>1419</fpage>–<lpage>1423</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0960-9822(02)01077-1</pub-id>.<pub-id pub-id-type="pmid">12194824</pub-id></mixed-citation>
</ref>
<ref id="B355">
<label>355.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Diggle</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Redpath</surname><given-names>NT</given-names></name>, <name name-style="western"><surname>Heesom</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Denton</surname><given-names>RM</given-names></name></person-group>
<year>1998</year>
<article-title>Regulation of protein-synthesis elongation-factor-2 kinase by cAMP in adipocytes</article-title>. <source/>Biochem J
<volume>336</volume>:<fpage>525</fpage>–<lpage>529</lpage>. doi:<pub-id pub-id-type="doi">10.1042/bj3360525</pub-id>.<pub-id pub-id-type="pmid">9841860</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>